BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A, Fuks Z, Kolesnick R. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science. 2003;300:1155-1159. [PMID: 12750523 DOI: 10.1126/science.1082504] [Cited by in Crossref: 1090] [Cited by in F6Publishing: 928] [Article Influence: 57.4] [Reference Citation Analysis]
Number Citing Articles
1 Moeller BJ, Batinic-Haberle I, Spasojevic I, Rabbani ZN, Anscher MS, Vujaskovic Z, Dewhirst MW. A manganese porphyrin superoxide dismutase mimetic enhances tumor radioresponsiveness. Int J Radiat Oncol Biol Phys 2005;63:545-52. [PMID: 16168847 DOI: 10.1016/j.ijrobp.2005.05.026] [Cited by in Crossref: 62] [Cited by in F6Publishing: 61] [Article Influence: 3.6] [Reference Citation Analysis]
2 Desai NB, Laine AM, Timmerman RD. Stereotactic ablative body radiotherapy (SAbR) for oligometastatic cancer.Br J Radiol. 2017;90:20160500. [PMID: 28008774 DOI: 10.1259/bjr.20160500] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
3 Bergom C, Gao C, Newman PJ. Mechanisms of PECAM-1-mediated cytoprotection and implications for cancer cell survival. Leukemia & Lymphoma 2009;46:1409-21. [DOI: 10.1080/10428190500126091] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
4 Wang L, Huo M, Chen Y, Shi J. Tumor Microenvironment‐Enabled Nanotherapy. Adv Healthcare Mater 2018;7:1701156. [DOI: 10.1002/adhm.201701156] [Cited by in Crossref: 76] [Cited by in F6Publishing: 64] [Article Influence: 15.2] [Reference Citation Analysis]
5 Moeller BJ, Richardson RA, Dewhirst MW. Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment. Cancer Metastasis Rev 2007;26:241-8. [PMID: 17440683 DOI: 10.1007/s10555-007-9056-0] [Cited by in Crossref: 266] [Cited by in F6Publishing: 240] [Article Influence: 17.7] [Reference Citation Analysis]
6 Rak JW, Coomber B, Yu JL. Oncogenes and Tumor Suppressor Genes in Therapeutic Resistance. In: Teicher BA, editor. Cancer Drug Resistance. Totowa: Humana Press; 2006. pp. 67-103. [DOI: 10.1007/978-1-59745-035-5_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Chao L, Gast AP, Hatton TA, Jensen KF. Sphingomyelinase-induced phase transformations: causing morphology switches and multiple-time-domain ceramide generation in model raft membranes. Langmuir 2010;26:344-56. [PMID: 19863058 DOI: 10.1021/la902084u] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
8 Dalrymple SL, Becker RE, Zhou H, DeWeese TL, Isaacs JT. Tasquinimod prevents the angiogenic rebound induced by fractionated radiation resulting in an enhanced therapeutic response of prostate cancer xenografts. Prostate 2012;72:638-48. [PMID: 21837778 DOI: 10.1002/pros.21467] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
9 Feng X, Tian L, Zhang Z, Yu Y, Cheng J, Gong Y, Li CY, Huang Q. Caspase 3 in dying tumor cells mediates post-irradiation angiogenesis. Oncotarget 2015;6:32353-67. [PMID: 26431328 DOI: 10.18632/oncotarget.5898] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
10 Wickersheim A, Kerber M, de Miguel LS, Plate KH, Machein MR. Endothelial progenitor cells do not contribute to tumor endothelium in primary and metastatic tumors. Int J Cancer. 2009;125:1771-1777. [PMID: 19582874 DOI: 10.1002/ijc.24605] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
11 Kim ES, Choi YE, Hwang SJ, Han YH, Park MJ, Bae IH. IL-4, a direct target of miR-340/429, is involved in radiation-induced aggressive tumor behavior in human carcinoma cells. Oncotarget 2016;7:86836-56. [PMID: 27895317 DOI: 10.18632/oncotarget.13561] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
12 Lan J, Li R, Yin LM, Deng L, Gui J, Chen BQ, Zhou L, Meng MB, Huang QR, Mo XM, Wei YQ, Lu B, Dicker A, Xue JX, Lu Y. Targeting Myeloid-derived Suppressor Cells and Programmed Death Ligand 1 Confers Therapeutic Advantage of Ablative Hypofractionated Radiation Therapy Compared With Conventional Fractionated Radiation Therapy. Int J Radiat Oncol Biol Phys 2018;101:74-87. [PMID: 29619980 DOI: 10.1016/j.ijrobp.2018.01.071] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 9.8] [Reference Citation Analysis]
13 Nambiar DK, Rajamani P, Singh RP. Silibinin attenuates ionizing radiation-induced pro-angiogenic response and EMT in prostate cancer cells. Biochem Biophys Res Commun 2015;456:262-8. [PMID: 25446081 DOI: 10.1016/j.bbrc.2014.11.069] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
14 Gao D, Mittal V. The role of bone-marrow-derived cells in tumor growth, metastasis initiation and progression. Trends Mol Med. 2009;15:333-343. [PMID: 19665928 DOI: 10.1016/j.molmed.2009.06.006] [Cited by in Crossref: 70] [Cited by in F6Publishing: 62] [Article Influence: 5.4] [Reference Citation Analysis]
15 Cohen-jonathan Moyal E. Thérapies antiangiogéniques et radiothérapie : du concept à l’essai clinique. Cancer/Radiothérapie 2009;13:562-7. [DOI: 10.1016/j.canrad.2009.07.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
16 Dumitru CA, Weller M, Gulbins E. Ceramide metabolism determines glioma cell resistance to chemotherapy. J Cell Physiol 2009;221:688-95. [DOI: 10.1002/jcp.21907] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
17 Isenberg JS, Martin-Manso G, Maxhimer JB, Roberts DD. Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies. Nat Rev Cancer 2009;9:182-94. [PMID: 19194382 DOI: 10.1038/nrc2561] [Cited by in Crossref: 194] [Cited by in F6Publishing: 181] [Article Influence: 14.9] [Reference Citation Analysis]
18 Ren X, Xu J, Cooper JP, Kang MH, Erdreich-Epstein A. c-Abl is an upstream regulator of acid sphingomyelinase in apoptosis induced by inhibition of integrins αvβ3 and αvβ5. PLoS One 2012;7:e42291. [PMID: 22879933 DOI: 10.1371/journal.pone.0042291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
19 Salaun PY, Bodet-Milin C, Frampas E, Oudoux A, Saï-Maurel C, Faivre-Chauvet A, Barbet J, Paris F, Kraeber-Bodéré F. Toxicity and efficacy of combined radioimmunotherapy and bevacizumab in a mouse model of medullary thyroid carcinoma. Cancer. 2010;116:1053-1058. [PMID: 20127950 DOI: 10.1002/cncr.24792] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
20 Folkert MR, Tong WY, Laquaglia MP, Wexler LH, Chou AJ, Magnan H, Zelefsky MJ, Wolden SL. 20-Year Experience With Intraoperative High-Dose-Rate Brachytherapy for Pediatric Sarcoma: Outcomes, Toxicity, and Practice Recommendations. International Journal of Radiation Oncology*Biology*Physics 2014;90:362-8. [DOI: 10.1016/j.ijrobp.2014.06.016] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
21 Doki Y, Takachi K, Ishikawa O, Sasaki Y, Miyashiro I, Ohigashi H, Yano M, Ishihara R, Tsukamoto Y, Nishiyama K, Ishiguro S, Imaoka S. Reduced tumor vessel density and high expression of glucose transporter 1 suggest tumor hypoxia of squamous cell carcinoma of the esophagus surviving after radiotherapy. Surgery 2005;137:536-44. [DOI: 10.1016/j.surg.2005.01.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
22 Augustin HG. Translating angiogenesis research into the clinic: the challenges ahead. Br J Radiol 2003;76 Spec No 1:S3-10. [PMID: 15456709 DOI: 10.1259/bjr/68078705] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.5] [Reference Citation Analysis]
23 Moding EJ, Kastan MB, Kirsch DG. Strategies for optimizing the response of cancer and normal tissues to radiation. Nat Rev Drug Discov 2013;12:526-42. [PMID: 23812271 DOI: 10.1038/nrd4003] [Cited by in Crossref: 214] [Cited by in F6Publishing: 192] [Article Influence: 23.8] [Reference Citation Analysis]
24 Desai P, Jiménez JA, Kao C, Gardner TA. Future innovations in treating advanced prostate cancer. Urol Clin North Am 2006;33:247-72, viii. [PMID: 16631463 DOI: 10.1016/j.ucl.2005.12.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
25 Niaudet C, Bonnaud S, Guillonneau M, Gouard S, Gaugler MH, Dutoit S, Ripoche N, Dubois N, Trichet V, Corre I, Paris F. Plasma membrane reorganization links acid sphingomyelinase/ceramide to p38 MAPK pathways in endothelial cells apoptosis. Cell Signal 2017;33:10-21. [PMID: 28179144 DOI: 10.1016/j.cellsig.2017.02.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
26 Truman JP, García-Barros M, Kaag M, Hambardzumyan D, Stancevic B, Chan M, Fuks Z, Kolesnick R, Haimovitz-Friedman A. Endothelial membrane remodeling is obligate for anti-angiogenic radiosensitization during tumor radiosurgery. PLoS One 2010;5:e12310. [PMID: 20808818 DOI: 10.1371/journal.pone.0012310] [Cited by in Crossref: 64] [Cited by in F6Publishing: 67] [Article Influence: 5.3] [Reference Citation Analysis]
27 Riquier H, Abel D, Wera AC, Heuskin AC, Genard G, Lucas S, Michiels C. Effects of Alpha Particle and Proton Beam Irradiation as Putative Cross-Talk between A549 Cancer Cells and the Endothelial Cells in a Co-Culture System. Cancers (Basel) 2015;7:481-502. [PMID: 25794049 DOI: 10.3390/cancers7010481] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
28 Lee J, Karshafian R, Papanicolau N, Giles A, Kolios MC, Czarnota GJ. Quantitative ultrasound for the monitoring of novel microbubble and ultrasound radiosensitization. Ultrasound Med Biol 2012;38:1212-21. [PMID: 22579547 DOI: 10.1016/j.ultrasmedbio.2012.01.028] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
29 Castle KD, Kirsch DG. Establishing the Impact of Vascular Damage on Tumor Response to High-Dose Radiation Therapy. Cancer Res 2019;79:5685-92. [PMID: 31427377 DOI: 10.1158/0008-5472.CAN-19-1323] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 4.7] [Reference Citation Analysis]
30 Burnette B, Weichselbaum RR. The immunology of ablative radiation. Semin Radiat Oncol 2015;25:40-5. [PMID: 25481265 DOI: 10.1016/j.semradonc.2014.07.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
31 Montermini L, Meehan B, Garnier D, Lee WJ, Lee TH, Guha A, Al-Nedawi K, Rak J. Inhibition of oncogenic epidermal growth factor receptor kinase triggers release of exosome-like extracellular vesicles and impacts their phosphoprotein and DNA content. J Biol Chem 2015;290:24534-46. [PMID: 26272609 DOI: 10.1074/jbc.M115.679217] [Cited by in Crossref: 69] [Cited by in F6Publishing: 45] [Article Influence: 9.9] [Reference Citation Analysis]
32 Lehmann HI, Graeff C, Simoniello P, Constantinescu A, Takami M, Lugenbiel P, Richter D, Eichhorn A, Prall M, Kaderka R, Fiedler F, Helmbrecht S, Fournier C, Erbeldinger N, Rahm AK, Rivinius R, Thomas D, Katus HA, Johnson SB, Parker KD, Debus J, Asirvatham SJ, Bert C, Durante M, Packer DL. Feasibility Study on Cardiac Arrhythmia Ablation Using High-Energy Heavy Ion Beams. Sci Rep 2016;6:38895. [PMID: 27996023 DOI: 10.1038/srep38895] [Cited by in Crossref: 59] [Cited by in F6Publishing: 47] [Article Influence: 9.8] [Reference Citation Analysis]
33 Kaliberov SA, Kaliberova LN, Stockard CR, Grizzle WE, Buchsbaum DJ. Adenovirus-mediated FLT1-targeted proapoptotic gene therapy of human prostate cancer. Molecular Therapy 2004;10:1059-70. [DOI: 10.1016/j.ymthe.2004.08.024] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
34 Tozer GM, Bicknell R. Therapeutic targeting of the tumor vasculature. Seminars in Radiation Oncology 2004;14:222-32. [DOI: 10.1016/j.semradonc.2004.04.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
35 Kerbel RS, Kamen BA. The anti-angiogenic basis of metronomic chemotherapy. Nat Rev Cancer. 2004;4:423-436. [PMID: 15170445 DOI: 10.1038/nrc1369] [Cited by in Crossref: 979] [Cited by in F6Publishing: 856] [Article Influence: 54.4] [Reference Citation Analysis]
36 Bernier J, Bentzen SM, Vermorken JB. Molecular therapy in head and neck oncology. Nat Rev Clin Oncol 2009;6:266-77. [DOI: 10.1038/nrclinonc.2009.40] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 5.0] [Reference Citation Analysis]
37 Fokas E, Hänze J, Kamlah F, Eul BG, Lang N, Keil B, Heverhagen JT, Engenhart-Cabillic R, An H, Rose F. Irradiation-dependent effects on tumor perfusion and endogenous and exogenous hypoxia markers in an A549 xenograft model. Int J Radiat Oncol Biol Phys 2010;77:1500-8. [PMID: 20637978 DOI: 10.1016/j.ijrobp.2010.01.060] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
38 Avouac J, Uzan G, Kahan A, Boileau C, Allanore Y. Endothelial progenitor cells and rheumatic disorders. Joint Bone Spine 2008;75:131-7. [DOI: 10.1016/j.jbspin.2007.09.006] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
39 Vilalta M, Rafat M, Graves EE. Effects of radiation on metastasis and tumor cell migration. Cell Mol Life Sci 2016;73:2999-3007. [PMID: 27022944 DOI: 10.1007/s00018-016-2210-5] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 8.7] [Reference Citation Analysis]
40 Li W, Huang P, Chen DJ, Gerweck LE. Determinates of tumor response to radiation: tumor cells, tumor stroma and permanent local control. Radiother Oncol 2014;113:146-9. [PMID: 25284063 DOI: 10.1016/j.radonc.2014.09.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
41 Heo JI, Kim W, Choi KJ, Bae S, Jeong JH, Kim KS. XIAP-associating factor 1, a transcriptional target of BRD7, contributes to endothelial cell senescence. Oncotarget 2016;7:5118-30. [PMID: 26802028 DOI: 10.18632/oncotarget.6962] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
42 Grunewald M, Avraham I, Dor Y, Bachar-Lustig E, Itin A, Jung S, Chimenti S, Landsman L, Abramovitch R, Keshet E. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell. 2006;124:175-189. [PMID: 16413490 DOI: 10.1016/j.cell.2005.10.036] [Cited by in Crossref: 868] [Cited by in F6Publishing: 800] [Article Influence: 54.3] [Reference Citation Analysis]
43 Lockney DT, Shub T, Hopkins B, Lockney NA, Moussazadeh N, Lis E, Yamada Y, Schmitt AM, Higginson DS, Laufer I, Bilsky M. Spinal stereotactic body radiotherapy following intralesional curettage with separation surgery for initial or salvage chordoma treatment. Neurosurg Focus 2017;42:E4. [PMID: 28041314 DOI: 10.3171/2016.9.FOCUS16373] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
44 Wen N, Li H, Song K, Chin-Snyder K, Qin Y, Kim J, Bellon M, Gulam M, Gardner S, Doemer A, Devpura S, Gordon J, Chetty I, Siddiqui F, Ajlouni M, Pompa R, Hammoud Z, Simoff M, Kalkanis S, Movsas B, Siddiqui MS. Characteristics of a novel treatment system for linear accelerator-based stereotactic radiosurgery. J Appl Clin Med Phys 2015;16:125–148. [PMID: 26218998 DOI: 10.1120/jacmp.v16i4.5313] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
45 Dings RP, Williams BW, Song CW, Griffioen AW, Mayo KH, Griffin RJ. Anginex synergizes with radiation therapy to inhibit tumor growth by radiosensitizing endothelial cells. Int J Cancer 2005;115:312-9. [PMID: 15688384 DOI: 10.1002/ijc.20850] [Cited by in Crossref: 64] [Cited by in F6Publishing: 55] [Article Influence: 3.8] [Reference Citation Analysis]
46 El Kaffas A, Sadeghi-Naini A, Falou O, Tran WT, Zhou S, Hashim A, Fernandes J, Giles A, Czarnota GJ. Assessment of tumor response to radiation and vascular targeting therapy in mice using quantitative ultrasound spectroscopy. Med Phys 2015;42:4965-73. [PMID: 26233222 DOI: 10.1118/1.4926554] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
47 Cosset JM. [Hypofractionated irradiation of prostate cancer: What is the radiobiological understanding in 2017?]. Cancer Radiother 2017;21:447-53. [PMID: 28847464 DOI: 10.1016/j.canrad.2017.06.006] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
48 Maman S, Witz IP. A history of exploring cancer in context. Nat Rev Cancer 2018;18:359-76. [DOI: 10.1038/s41568-018-0006-7] [Cited by in Crossref: 153] [Cited by in F6Publishing: 143] [Article Influence: 38.3] [Reference Citation Analysis]
49 Hellevik T, Pettersen I, Berg V, Bruun J, Bartnes K, Busund LT, Chalmers A, Bremnes R, Martinez-Zubiaurre I. Changes in the Secretory Profile of NSCLC-Associated Fibroblasts after Ablative Radiotherapy: Potential Impact on Angiogenesis and Tumor Growth. Transl Oncol 2013;6:66-74. [PMID: 23418618 DOI: 10.1593/tlo.12349] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
50 Lin Y, Paganetti H, McMahon SJ, Schuemann J. Gold nanoparticle induced vasculature damage in radiotherapy: Comparing protons, megavoltage photons, and kilovoltage photons. Med Phys 2015;42:5890-902. [PMID: 26429263 DOI: 10.1118/1.4929975] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
51 Urbich C, Chavakis E, Dimmeler S. Homing and Differentiation of Endothelial Progenitor Cells. In: Marmé D, Fusenig N, editors. Tumor Angiogenesis. Berlin: Springer Berlin Heidelberg; 2008. pp. 309-24. [DOI: 10.1007/978-3-540-33177-3_17] [Cited by in Crossref: 1] [Reference Citation Analysis]
52 Covarrubias DJ, Rosen BR, Lev MH. Dynamic Magnetic Resonance Perfusion Imaging of Brain Tumors. The Oncologist 2004;9:528-37. [DOI: 10.1634/theoncologist.9-5-528] [Cited by in Crossref: 169] [Cited by in F6Publishing: 139] [Article Influence: 9.4] [Reference Citation Analysis]
53 Lee Y, Auh SL, Wang Y, Burnette B, Meng Y, Beckett M, Sharma R, Chin R, Tu T, Weichselbaum RR, Fu YX. Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. Blood. 2009;114:589-595. [PMID: 19349616 DOI: 10.1182/blood-2009-02-206870] [Cited by in Crossref: 805] [Cited by in F6Publishing: 732] [Article Influence: 61.9] [Reference Citation Analysis]
54 Palma CD, Perrotta C. Ceramide as a target of chemotherapy: its role in apoptosis and autophagy. Clinical Lipidology 2012;7:111-9. [DOI: 10.2217/clp.11.71] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
55 El Kaffas A, Al-Mahrouki A, Tran WT, Giles A, Czarnota GJ. Sunitinib effects on the radiation response of endothelial and breast tumor cells. Microvasc Res 2014;92:1-9. [PMID: 24215790 DOI: 10.1016/j.mvr.2013.10.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
56 Distler JH, Beyer C, Schett G, Lüscher TF, Gay S, Distler O. Endothelial progenitor cells: novel players in the pathogenesis of rheumatic diseases. Arthritis Rheum 2009;60:3168-79. [PMID: 19877034 DOI: 10.1002/art.24921] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
57 Kothari G, Loblaw A, Tree AC, van As NJ, Moghanaki D, Lo SS, Ost P, Siva S. Stereotactic Body Radiotherapy for Primary Prostate Cancer. Technol Cancer Res Treat 2018;17:1533033818789633. [PMID: 30064301 DOI: 10.1177/1533033818789633] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
58 Sapisochin G, Barry A, Doherty M, Fischer S, Goldaracena N, Rosales R, Russo M, Beecroft R, Ghanekar A, Bhat M, Brierley J, Greig PD, Knox JJ, Dawson LA, Grant DR. Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis. J Hepatol. 2017;67:92-99. [PMID: 28257902 DOI: 10.1016/j.jhep.2017.02.022] [Cited by in Crossref: 113] [Cited by in F6Publishing: 99] [Article Influence: 22.6] [Reference Citation Analysis]
59 van Weel V, Seghers L, de Vries MR, Kuiper EJ, Schlingemann RO, Bajema IM, Lindeman JH, Delis-van Diemen PM, van Hinsbergh VW, van Bockel JH, Quax PH. Expression of Vascular Endothelial Growth Factor, Stromal Cell-Derived Factor-1, and CXCR4 in Human Limb Muscle With Acute and Chronic Ischemia. ATVB 2007;27:1426-32. [DOI: 10.1161/atvbaha.107.139642] [Cited by in Crossref: 70] [Cited by in F6Publishing: 35] [Article Influence: 4.7] [Reference Citation Analysis]
60 Mohamed TM, Ji-bin LM, John REP. Recent Advances in Microbubble-Augmented Cancer Therapy. Advanced Ultrasound in Diagnosis and Therapy 2020;4:155. [DOI: 10.37015/audt.2020.200055] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Abdollahi A, Folkman J. Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy. Drug Resist Updat. 2010;13:16-28. [PMID: 20061178 DOI: 10.1016/j.drup.2009.12.001] [Cited by in Crossref: 167] [Cited by in F6Publishing: 156] [Article Influence: 13.9] [Reference Citation Analysis]
62 Peñate Medina T, Gerle M, Humbert J, Chu H, Köpnick AL, Barkmann R, M Garamus V, Sanz B, Purcz N, Will O, Appold L, Damm T, Suojanen J, Arnold P, Lucius R, Willumeit-Römer R, Açil Y, Wiltfang J, Goya GF, Glüer CC, Peñate Medina O. Lipid-Iron Nanoparticle with a Cell Stress Release Mechanism Combined with a Local Alternating Magnetic Field Enables Site-Activated Drug Release. Cancers (Basel) 2020;12:E3767. [PMID: 33327621 DOI: 10.3390/cancers12123767] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Tea MN, Poonnoose SI, Pitson SM. Targeting the Sphingolipid System as a Therapeutic Direction for Glioblastoma. Cancers (Basel) 2020;12:E111. [PMID: 31906280 DOI: 10.3390/cancers12010111] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
64 Kolesnick R, Fuks Z. Response to Comments on "Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis". Science 2003;302:1894-1894. [DOI: 10.1126/science.1091166] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
65 Li JJ, Tsang JY, Tse GM. Tumor Microenvironment in Breast Cancer-Updates on Therapeutic Implications and Pathologic Assessment. Cancers (Basel) 2021;13:4233. [PMID: 34439387 DOI: 10.3390/cancers13164233] [Reference Citation Analysis]
66 Her EJ, Haworth A, Rowshanfarzad P, Ebert MA. Progress towards Patient-Specific, Spatially-Continuous Radiobiological Dose Prescription and Planning in Prostate Cancer IMRT: An Overview. Cancers (Basel) 2020;12:E854. [PMID: 32244821 DOI: 10.3390/cancers12040854] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
67 Maurmann L, Belkacemi L, Adams NR, Majmudar PM, Moghaddas S, Bose RN. A novel cisplatin mediated apoptosis pathway is associated with acid sphingomyelinase and FAS proapoptotic protein activation in ovarian cancer. Apoptosis 2015;20:960-74. [DOI: 10.1007/s10495-015-1124-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
68 Aicher A, Rentsch M, Sasaki K, Ellwart JW, Fändrich F, Siebert R, Cooke JP, Dimmeler S, Heeschen C. Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ Res 2007;100:581-9. [PMID: 17272807 DOI: 10.1161/01.RES.0000259562.63718.35] [Cited by in Crossref: 180] [Cited by in F6Publishing: 74] [Article Influence: 12.0] [Reference Citation Analysis]
69 Li XM, Hu Z, Jorgenson ML, Wingard JR, Slayton WB. Bone marrow sinusoidal endothelial cells undergo nonapoptotic cell death and are replaced by proliferating sinusoidal cells in situ to maintain the vascular niche following lethal irradiation. Exp Hematol 2008;36:1143-56. [PMID: 18718416 DOI: 10.1016/j.exphem.2008.06.009] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 3.5] [Reference Citation Analysis]
70 Ziegler DS, Keating J, Kesari S, Fast EM, Zawel L, Ramakrishna N, Barnes J, Kieran MW, Veldhuijzen van Zanten SE, Kung AL. A small-molecule IAP inhibitor overcomes resistance to cytotoxic therapies in malignant gliomas in vitro and in vivo. Neuro Oncol 2011;13:820-9. [PMID: 21724651 DOI: 10.1093/neuonc/nor066] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
71 Buckel L, Advani SJ, Frentzen A, Zhang Q, Yu YA, Chen NG, Ehrig K, Stritzker J, Mundt AJ, Szalay AA. Combination of fractionated irradiation with anti-VEGF expressing vaccinia virus therapy enhances tumor control by simultaneous radiosensitization of tumor associated endothelium.Int J Cancer. 2013;133:2989-2999. [PMID: 23729266 DOI: 10.1002/ijc.28296] [Cited by in Crossref: 5] [Cited by in F6Publishing: 17] [Article Influence: 0.6] [Reference Citation Analysis]
72 Schatteman GC, Dunnwald M, Jiao C. Biology of bone marrow-derived endothelial cell precursors. Am J Physiol Heart Circ Physiol. 2007;292:H1-18. [PMID: 16980351 DOI: 10.1152/ajpheart.00662.2006] [Cited by in Crossref: 112] [Cited by in F6Publishing: 106] [Article Influence: 7.0] [Reference Citation Analysis]
73 Kawahara D, Nagata Y, Watanabe Y. Improved cellular automata model shows that indirect apoptotic cell death due to vascular damage enhances the local control of tumors by single fraction high-dose irradiation. Biomed Phys Eng Express 2021;8. [PMID: 34920444 DOI: 10.1088/2057-1976/ac4466] [Reference Citation Analysis]
74 Shaked Y. The pro-tumorigenic host response to cancer therapies. Nat Rev Cancer 2019;19:667-85. [PMID: 31645711 DOI: 10.1038/s41568-019-0209-6] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 16.0] [Reference Citation Analysis]
75 Winkler F, Kozin SV, Tong RT, Chae SS, Booth MF, Garkavtsev I, Xu L, Hicklin DJ, Fukumura D, di Tomaso E. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell. 2004;6:553-563. [PMID: 15607960 DOI: 10.1016/j.ccr.2004.10.011] [Cited by in Crossref: 220] [Cited by in F6Publishing: 512] [Article Influence: 12.9] [Reference Citation Analysis]
76 Hennequin C, Guillerm S, Quero L. Rationale for hypofractionation. Cancer Radiother 2019;23:500-2. [PMID: 31444076 DOI: 10.1016/j.canrad.2019.07.156] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
77 Henzler T, Goldstraw P, Wenz F, Pirker R, Weder W, Apfaltrer P, Meyer M, Buesing K, Crino L, Fennell D, Fink C, Grunenwald D, Manegold C, Pilz L, Schoenberg SO, Suresh S, Vansteenkiste J, Voigt W, Wängler B, Schmid-bindert G. Perspectives of Novel Imaging Techniques for Staging, Therapy Response Assessment, and Monitoring of Surveillance in Lung Cancer: Summary of the Dresden 2013 Post WCLC-IASLC State-of-the-Art Imaging Workshop. Journal of Thoracic Oncology 2015;10:237-49. [DOI: 10.1097/jto.0000000000000412] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
78 Feng X, He P, Zeng C, Li YH, Das SK, Li B, Yang HF, Du Y. Novel insights into the role of Clostridium novyi-NT related combination bacteriolytic therapy in solid tumors. Oncol Lett 2021;21:110. [PMID: 33376543 DOI: 10.3892/ol.2020.12371] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
79 Jenkins SV, Nedosekin DA, Miller EK, Zharov VP, Dings RPM, Chen J, Griffin RJ. Galectin-1-based tumour-targeting for gold nanostructure-mediated photothermal therapy. Int J Hyperthermia 2018;34:19-29. [PMID: 28540812 DOI: 10.1080/02656736.2017.1317845] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
80 Glaser UG, Fandrey J. Sphingolipids in inflammatory hypoxia. Biol Chem 2018;399:1169-74. [PMID: 29908122 DOI: 10.1515/hsz-2018-0173] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
81 Gabryś D, Greco O, Patel G, Prise KM, Tozer GM, Kanthou C. Radiation Effects on the Cytoskeleton of Endothelial Cells and Endothelial Monolayer Permeability. International Journal of Radiation Oncology*Biology*Physics 2007;69:1553-62. [DOI: 10.1016/j.ijrobp.2007.08.039] [Cited by in Crossref: 58] [Cited by in F6Publishing: 44] [Article Influence: 3.9] [Reference Citation Analysis]
82 Milano MT, Constine LS, Okunieff P. Normal tissue toxicity after small field hypofractionated stereotactic body radiation. Radiat Oncol 2008;3:36. [PMID: 18976463 DOI: 10.1186/1748-717X-3-36] [Cited by in Crossref: 95] [Cited by in F6Publishing: 32] [Article Influence: 6.8] [Reference Citation Analysis]
83 Schuemann J, Bagley AF, Berbeco R, Bromma K, Butterworth KT, Byrne HL, Chithrani BD, Cho SH, Cook JR, Favaudon V, Gholami YH, Gargioni E, Hainfeld JF, Hespeels F, Heuskin AC, Ibeh UM, Kuncic Z, Kunjachan S, Lacombe S, Lucas S, Lux F, McMahon S, Nevozhay D, Ngwa W, Payne JD, Penninckx S, Porcel E, Prise KM, Rabus H, Ridwan SM, Rudek B, Sanche L, Singh B, Smilowitz HM, Sokolov KV, Sridhar S, Stanishevskiy Y, Sung W, Tillement O, Virani N, Yantasee W, Krishnan S. Roadmap for metal nanoparticles in radiation therapy: current status, translational challenges, and future directions. Phys Med Biol 2020;65:21RM02. [PMID: 32380492 DOI: 10.1088/1361-6560/ab9159] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 12.0] [Reference Citation Analysis]
84 Hauck CR, Ye H, Chen PY, Gustafson GS, Limbacher A, Krauss DJ. Increasing Fractional Doses Increases the Probability of Benign PSA Bounce in Patients Undergoing Definitive HDR Brachytherapy for Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics 2017;98:108-14. [DOI: 10.1016/j.ijrobp.2017.01.025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
85 Göthert JR, Gustin SE, van Eekelen JA, Schmidt U, Hall MA, Jane SM, Green AR, Göttgens B, Izon DJ, Begley CG. Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium. Blood 2004;104:1769-77. [PMID: 15187022 DOI: 10.1182/blood-2003-11-3952] [Cited by in Crossref: 199] [Cited by in F6Publishing: 195] [Article Influence: 11.1] [Reference Citation Analysis]
86 Riquier H, Wera A, Heuskin A, Feron O, Lucas S, Michiels C. Comparison of X-ray and alpha particle effects on a human cancer and endothelial cells: Survival curves and gene expression profiles. Radiotherapy and Oncology 2013;106:397-403. [DOI: 10.1016/j.radonc.2013.02.017] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
87 Lin PC. Optical imaging and tumor angiogenesis. J Cell Biochem 2003;90:484-91. [PMID: 14523982 DOI: 10.1002/jcb.10630] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
88 Meyer J, Timmerman R. Stereotactic ablative radiotherapy in the framework of classical radiobiology: response to Drs. Brown, Diehn, and Loo. Int J Radiat Oncol Biol Phys 2011;79:1599-600; author reply 1600. [PMID: 21414517 DOI: 10.1016/j.ijrobp.2010.11.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
89 Denysenko T, Gennero L, Roos MA, Melcarne A, Juenemann C, Faccani G, Morra I, Cavallo G, Reguzzi S, Pescarmona G, Ponzetto A. Glioblastoma cancer stem cells: heterogeneity, microenvironment and related therapeutic strategies. Cell Biochem Funct 2010;28:343-51. [PMID: 20535838 DOI: 10.1002/cbf.1666] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 5.3] [Reference Citation Analysis]
90 Dong Y, Cheng Y, Hou Q, Wu J, Li D, Tian H. The Protective Effect of New Compound XH-103 on Radiation-Induced GI Syndrome. Oxid Med Cell Longev 2018;2018:3920147. [PMID: 30116481 DOI: 10.1155/2018/3920147] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
91 Ba S, Yu M. Ultrasound-stimulated microbubbles enhances radiosensitivity of ovarian cancer. Acta Radiol 2021;:2841851211038808. [PMID: 34463146 DOI: 10.1177/02841851211038808] [Reference Citation Analysis]
92 Nolan MW, Marolf AJ, Ehrhart EJ, Rao S, Kraft SL, Engel S, Yoshikawa H, Golden AE, Wasserman TH, LaRue SM. Pudendal nerve and internal pudendal artery damage may contribute to radiation-induced erectile dysfunction. Int J Radiat Oncol Biol Phys 2015;91:796-806. [PMID: 25752394 DOI: 10.1016/j.ijrobp.2014.12.025] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
93 Jiménez JA, Kao C, Raikwar S, Gardner TA. Current status of anti-angiogenesis therapy for prostate cancer. Urol Oncol 2006;24:260-8. [PMID: 16678061 DOI: 10.1016/j.urolonc.2005.11.022] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
94 Taniguchi M, Ogiso H, Takeuchi T, Kitatani K, Umehara H, Okazaki T. Lysosomal ceramide generated by acid sphingomyelinase triggers cytosolic cathepsin B-mediated degradation of X-linked inhibitor of apoptosis protein in natural killer/T lymphoma cell apoptosis. Cell Death Dis 2015;6:e1717. [PMID: 25855965 DOI: 10.1038/cddis.2015.82] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
95 De Palma M, Naldini L. Role of haematopoietic cells and endothelial progenitors in tumour angiogenesis. Biochim Biophys Acta 2006;1766:159-66. [PMID: 16857321 DOI: 10.1016/j.bbcan.2006.06.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 42] [Article Influence: 0.3] [Reference Citation Analysis]
96 Yao HH, Hong MKh, Corcoran NM, Siva S, Foroudi F. Advances in local and ablative treatment of oligometastasis in prostate cancer. Asia Pac J Clin Oncol 2014;10:308-21. [PMID: 25155557 DOI: 10.1111/ajco.12256] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
97 Luttun A, Carmeliet P. Angiogenesis and lymphangiogenesis: highlights of the past year: . Current Opinion in Hematology 2004;11:262-71. [DOI: 10.1097/01.moh.0000126936.58889.95] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
98 Smith EL, Schuchman EH. Acid Sphingomyelinase Overexpression Enhances the Antineoplastic Effects of Irradiation In Vitro and In Vivo. Molecular Therapy 2008;16:1565-71. [DOI: 10.1038/mt.2008.145] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
99 Dunphy MP, Entenberg D, Toledo-Crow R, Larson SM. In vivo microcartography and subcellular imaging of tumor angiogenesis: a novel platform for translational angiogenesis research. Microvasc Res 2009;78:51-6. [PMID: 19362098 DOI: 10.1016/j.mvr.2009.03.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
100 Robin AM, Yamada Y, McLaughlin LA, Schmitt A, Higginson D, Lis E, Bilsky MH. Stereotactic Radiosurgery: The Revolutionary Advance in the Treatment of Spine Metastases. Neurosurgery 2017;64:59-65. [PMID: 28899042 DOI: 10.1093/neuros/nyx222] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
101 Blakaj DM, Palmer JD, Dibs K, Olausson A, Bourekas EC, Boulter D, Ayan AS, Cochran E, Marras WS, Mageswaran P, Katzir M, Yildiz VO, Grecula J, Arnett A, Raval R, Scharschmidt T, Elder JB, Lonser R, Chakravarti A, Mendel E. Postoperative Stereotactic Body Radiotherapy for Spinal Metastasis and Predictors of Local Control. Neurosurgery 2021;88:1021-7. [PMID: 33575784 DOI: 10.1093/neuros/nyaa587] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
102 Wachsberger PR, Burd R, Cardi C, Thakur M, Daskalakis C, Holash J, Yancopoulos GD, Dicker AP. VEGF Trap in Combination With Radiotherapy Improves Tumor Control in U87 Glioblastoma. International Journal of Radiation Oncology*Biology*Physics 2007;67:1526-37. [DOI: 10.1016/j.ijrobp.2006.11.011] [Cited by in Crossref: 91] [Cited by in F6Publishing: 85] [Article Influence: 6.1] [Reference Citation Analysis]
103 Lee BS, Cho YW, Kim GC, Lee DH, Kim CJ, Kil HS, Chi DY, Byun Y, Yuk SH, Kim K, Kim I, Kwon IC, Kim SY. Induced Phenotype Targeted Therapy: Radiation-Induced Apoptosis-Targeted Chemotherapy. JNCI: Journal of the National Cancer Institute 2015;107. [DOI: 10.1093/jnci/dju403] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
104 Seo YS, Kim MS, Yoo HJ, Jang WI. Stereotactic body radiotherapy for oligo-recurrence within the nodal area from colorectal cancer. World J Gastroenterol 2014; 20(8): 2005-2013 [PMID: 24587675 DOI: 10.3748/wjg.v20.i8.2005] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
105 Lee JH, Jeong JU, Kim SH, Nam TK, Lee JH, Jeong S, Yu M, Jang HS. Nadir/pre-chemoradiotherapy ratio of white blood-cell count can predict tumor response and recurrence-free survival in locally advanced rectal cancer: a multi-institutional analysis. Int J Colorectal Dis 2019;34:105-12. [PMID: 30350135 DOI: 10.1007/s00384-018-3174-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
106 Chmura SJ, Salama JK. Stereotactic Treatment for Oligometastatic Breast Cancer. In: Arthur DW, Vicini FA, Wazer DE, Khan AJ, editors. Short Course Breast Radiotherapy. Cham: Springer International Publishing; 2016. pp. 467-81. [DOI: 10.1007/978-3-319-24388-7_29] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
107 Nasry WHS, Martin CK. Intersecting Mechanisms of Hypoxia and Prostaglandin E2-Mediated Inflammation in the Comparative Biology of Oral Squamous Cell Carcinoma. Front Oncol 2021;11:539361. [PMID: 34094895 DOI: 10.3389/fonc.2021.539361] [Reference Citation Analysis]
108 Karar J, Maity A. Modulating the tumor microenvironment to increase radiation responsiveness. Cancer Biol Ther. 2009;8:1994-2001. [PMID: 19823031 DOI: 10.4161/cbt.8.21.9988] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 5.1] [Reference Citation Analysis]
109 Mazeron R, Azria D, Deutsch E. Inhibiteurs de l’angiogenèse et radiothérapie : du concept à la clinique. Cancer/Radiothérapie 2009;13:568-73. [DOI: 10.1016/j.canrad.2009.06.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
110 Lima KM, Bedia C, Tauler R. A non-target chemometric strategy applied to UPLC-MS sphingolipid analysis of a cell line exposed to chlorpyrifos pesticide: A feasibility study. Microchemical Journal 2014;117:255-61. [DOI: 10.1016/j.microc.2014.07.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
111 Aktaş C, Kurtman C, Ozbilgin MK, Tek I, Toprak SK. An Experimental Study of Radiation Effect on Normal Tissue: Analysis of HIF-1α, VEGF, eIF2, TIA-1, and TSP-1 Expression. Turk J Haematol 2013;30:371-8. [PMID: 24385827 DOI: 10.4274/Tjh.2012.0142] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
112 Kunjachan S, Kotb S, Pola R, Pechar M, Kumar R, Singh B, Gremse F, Taleeli R, Trichard F, Motto-Ros V, Sancey L, Detappe A, Yasmin-Karim S, Protti A, Shanmugam I, Ireland T, Etrych T, Sridhar S, Tillement O, Makrigiorgos M, Berbeco RI. Selective Priming of Tumor Blood Vessels by Radiation Therapy Enhances Nanodrug Delivery. Sci Rep 2019;9:15844. [PMID: 31676822 DOI: 10.1038/s41598-019-50538-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
113 Denis F, Letellier C. Théorie du chaos en radiothérapie : la mésange et le papillon…. Cancer/Radiothérapie 2012;16:404-9. [DOI: 10.1016/j.canrad.2012.05.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
114 Korpela E, Yohan D, Chin LC, Kim A, Huang X, Sade S, Van Slyke P, Dumont DJ, Liu SK. Vasculotide, an Angiopoietin-1 mimetic, reduces acute skin ionizing radiation damage in a preclinical mouse model. BMC Cancer 2014;14:614. [PMID: 25159192 DOI: 10.1186/1471-2407-14-614] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
115 Savić R, Schuchman EH. Use of Acid Sphingomyelinase for Cancer Therapy. The Role of Sphingolipids in Cancer Development and Therapy. Elsevier; 2013. pp. 91-115. [DOI: 10.1016/b978-0-12-394274-6.00004-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
116 Chen H, Louie A, Higginson D, Palma D, Colaco R, Sahgal A. Stereotactic Radiosurgery and Stereotactic Body Radiotherapy in the Management of Oligometastatic Disease. Clinical Oncology 2020;32:713-27. [DOI: 10.1016/j.clon.2020.06.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
117 Folkins C, Shaked Y, Man S, Tang T, Lee CR, Zhu Z, Hoffman RM, Kerbel RS. Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1. Cancer Res. 2009;69:7243-7251. [PMID: 19738068 DOI: 10.1158/0008-5472.can-09-0167] [Cited by in Crossref: 233] [Cited by in F6Publishing: 143] [Article Influence: 17.9] [Reference Citation Analysis]
118 Harel R, Zach L. Spine radiosurgery for spinal metastases: indications, technique and outcome. Neurological Research 2014;36:550-6. [DOI: 10.1179/1743132814y.0000000364] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 1.6] [Reference Citation Analysis]
119 Spyropoulou D, Tsiganos P, Dimitrakopoulos FI, Tolia M, Koutras A, Velissaris D, Lagadinou M, Papathanasiou N, Gkantaifi A, Kalofonos H, Kardamakis D. Radiotherapy and Renal Cell Carcinoma: A Continuing Saga. In Vivo 2021;35:1365-77. [PMID: 33910814 DOI: 10.21873/invivo.12389] [Reference Citation Analysis]
120 Kabakov AE, Makarova YM, Malyutina YV. Radiosensitization of Human Vascular Endothelial Cells Through Hsp90 Inhibition With 17-N-Allilamino-17-Demethoxygeldanamycin. International Journal of Radiation Oncology*Biology*Physics 2008;71:858-65. [DOI: 10.1016/j.ijrobp.2008.02.034] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
121 Macdermed DM, Weichselbaum RR, Salama JK. A rationale for the targeted treatment of oligometastases with radiotherapy. J Surg Oncol. 2008;98:202-206. [PMID: 18618604 DOI: 10.1002/jso.21102] [Cited by in Crossref: 89] [Cited by in F6Publishing: 87] [Article Influence: 6.4] [Reference Citation Analysis]
122 Kerbel RS. Tumor angiogenesis. N Engl J Med. 2008;358:2039-2049. [PMID: 18463380 DOI: 10.1056/nejmra0706596] [Cited by in Crossref: 1525] [Cited by in F6Publishing: 799] [Article Influence: 108.9] [Reference Citation Analysis]
123 Riesterer O, Milas L, Ang KK. Combining molecular therapeutics with radiotherapy for head and neck cancer: Molecular Therapeutics and Radiotherapy. J Surg Oncol 2008;97:708-11. [DOI: 10.1002/jso.21011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
124 Ohnuma Y, Toda M, Fujita M, Hosono K, Suzuki T, Ogawa Y, Amano H, Kitasato H, Hayakawa K, Majima M. Blockade of an angiotensin type I receptor enhances effects of radiation on tumor growth and tumor-associated angiogenesis by reducing vascular endothelial growth factor expression. Biomed Pharmacother 2009;63:136-45. [PMID: 18691848 DOI: 10.1016/j.biopha.2007.11.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
125 Espenel S, Vallard A, Rancoule C, Garcia MA, Guy JB, Chargari C, Deutsch E, Magné N. Melanoma: Last call for radiotherapy. Crit Rev Oncol Hematol 2017;110:13-9. [PMID: 28109401 DOI: 10.1016/j.critrevonc.2016.12.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
126 Smith CA, Mont S, Traver G, Sekhar KR, Crooks PA, Freeman ML. Targeting Enox1 in tumor stroma increases the efficacy of fractionated radiotherapy. Oncotarget 2016;7:77926-36. [PMID: 27788492 DOI: 10.18632/oncotarget.12845] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
127 Yeung TP, Kurdi M, Wang Y, Al-Khazraji B, Morrison L, Hoffman L, Jackson D, Crukley C, Lee TY, Bauman G, Yartsev S. CT perfusion imaging as an early biomarker of differential response to stereotactic radiosurgery in C6 rat gliomas. PLoS One 2014;9:e109781. [PMID: 25329655 DOI: 10.1371/journal.pone.0109781] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
128 Tardy C, Codogno P, Autefage H, Levade T, Andrieu-Abadie N. Lysosomes and lysosomal proteins in cancer cell death (new players of an old struggle). Biochim Biophys Acta 2006;1765:101-25. [PMID: 16412578 DOI: 10.1016/j.bbcan.2005.11.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 34] [Article Influence: 0.6] [Reference Citation Analysis]
129 Mata J, Sheng K, Hagspiel K, Ruppert K, Sylvester P, Mugler J 3rd, Fernandes C, Guan S, Larner J, Read P. Pulmonary toxicity in a rabbit model of stereotactic lung radiation therapy: efficacy of a radioprotector. Exp Lung Res 2014;40:308-16. [PMID: 24926529 DOI: 10.3109/01902148.2014.918213] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
130 Anant S, Murmu N, Houchen CW, Mukhopadhyay D, Riehl TE, Young SG, Morrison AR, Stenson WF, Davidson NO. Apobec-1 protects intestine from radiation injury through posttranscriptional regulation of cyclooxygenase-2 expression. Gastroenterology 2004;127:1139-49. [PMID: 15480992 DOI: 10.1053/j.gastro.2004.06.022] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
131 Niu G, Chen X. Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy. Curr Drug Targets. 2010;11:1000-1017. [PMID: 20426765 DOI: 10.2174/138945010791591395] [Cited by in Crossref: 188] [Cited by in F6Publishing: 164] [Article Influence: 15.7] [Reference Citation Analysis]
132 Woywodt A. Circulating endothelial cells in vasculitis and transplantation. Pathophysiol Haemost Thromb 2003;33:500-2. [PMID: 15692267 DOI: 10.1159/000083852] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
133 Bibault JE. [Stereotactic body radiation therapy for oligometastatic prostate cancer]. Bull Cancer 2018;105:120-5. [PMID: 29191358 DOI: 10.1016/j.bulcan.2017.09.017] [Reference Citation Analysis]
134 Fokas E, Kamlah F, Hänze J, Engenhart-Cabillic R, Rose F, An HX. EphA2 blockade enhances the anti-endothelial effect of radiation and inhibits irradiated tumor cell-induced migration of endothelial cells. Thorac Cancer 2010;1:153-62. [PMID: 27755819 DOI: 10.1111/j.1759-7714.2010.00029.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
135 Rohrer Bley C, Furmanova P, Orlowski K, Grosse N, Broggini-Tenzer A, McSheehy PM, Pruschy M. Microtubule stabilising agents and ionising radiation: multiple exploitable mechanisms for combined treatment. Eur J Cancer 2013;49:245-53. [PMID: 22683167 DOI: 10.1016/j.ejca.2012.05.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
136 Kanda S, Miyata Y, Kanetake H. Current status and perspective of antiangiogenic therapy for cancer: urinary cancer. Int J Clin Oncol 2006;11:90-107. [DOI: 10.1007/s10147-006-0565-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
137 Erdreich-Epstein A, Tran LB, Cox OT, Huang EY, Laug WE, Shimada H, Millard M. Endothelial apoptosis induced by inhibition of integrins alphavbeta3 and alphavbeta5 involves ceramide metabolic pathways. Blood 2005;105:4353-61. [PMID: 15705795 DOI: 10.1182/blood-2004-08-3098] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 2.5] [Reference Citation Analysis]
138 Piatkowski A, Grieb G, Simons D, Bernhagen J, van der Hulst RR. Endothelial progenitor cells--potential new avenues to improve neoangiogenesis and reendothelialization. Int Rev Cell Mol Biol 2013;306:43-81. [PMID: 24016523 DOI: 10.1016/B978-0-12-407694-5.00002-X] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
139 Colleoni F, Torrente Y. The new challenge of stem cell: brain tumour therapy. Cancer Lett 2008;272:1-11. [PMID: 18621474 DOI: 10.1016/j.canlet.2008.05.046] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
140 Bernauer C, Man YKS, Chisholm JC, Lepicard EY, Robinson SP, Shipley JM. Hypoxia and its therapeutic possibilities in paediatric cancers. Br J Cancer 2021;124:539-51. [PMID: 33106581 DOI: 10.1038/s41416-020-01107-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
141 Shi M, Guo XT, Shu MG, Chen FL, Li LW. Cell-permeable hypoxia-inducible factor-1 (HIF-1) antagonists function as tumor radiosensitizers. Med Hypotheses 2007;69:33-5. [PMID: 17280792 DOI: 10.1016/j.mehy.2006.10.062] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
142 Kuwahara Y, Mori M, Kitahara S, Fukumoto M, Ezaki T, Mori S, Echigo S, Ohkubo Y, Fukumoto M. Targeting of tumor endothelial cells combining 2 Gy/day of X-ray with Everolimus is the effective modality for overcoming clinically relevant radioresistant tumors. Cancer Med 2014;3:310-21. [PMID: 24464839 DOI: 10.1002/cam4.185] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
143 Singleton DC, Macann A, Wilson WR. Therapeutic targeting of the hypoxic tumour microenvironment. Nat Rev Clin Oncol 2021. [PMID: 34326502 DOI: 10.1038/s41571-021-00539-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
144 Makari Y, Yasuda T, Doki Y, Miyata H, Fujiwara Y, Takiguchi S, Matsuyama J, Yamasaki M, Hirao T, Koyama MK, Nakamuara H, Monden M. Correlation between tumor blood flow assessed by perfusion CT and effect of neoadjuvant therapy in advanced esophageal cancers. J Surg Oncol. 2007;96:220-229. [PMID: 17450532 DOI: 10.1002/jso.20820] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
145 Shin D, Lee G, Lee S, Park S, Jung KH, Lee JH, Lee JM, Kim JY, Cho J, Bae H. Adenovirus-mediated Foxp3 expression in lung epithelial cells ameliorates acute radiation-induced pneumonitis in mice. Gene Ther 2017;24:104-12. [PMID: 27996966 DOI: 10.1038/gt.2016.86] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
146 Nakawatari M, Iwakawa M, Ohno T, Kato S, Nakamura E, Ohkubo Y, Tamaki T, Imai T. Change in fibroblast growth factor 2 expression as an early phase radiotherapy-responsive marker in sequential biopsy samples from patients with cervical cancer during fractionated radiotherapy. Cancer 2010;116:5082-92. [DOI: 10.1002/cncr.25433] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
147 Gutin PH, Iwamoto FM, Beal K, Mohile NA, Karimi S, Hou BL, Lymberis S, Yamada Y, Chang J, Abrey LE. Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 2009;75:156-63. [PMID: 19167838 DOI: 10.1016/j.ijrobp.2008.10.043] [Cited by in Crossref: 261] [Cited by in F6Publishing: 236] [Article Influence: 20.1] [Reference Citation Analysis]
148 Kwok SJ, El Kaffas A, Lai P, Al Mahrouki A, Lee J, Iradji S, Tran WT, Giles A, Czarnota GJ. Ultrasound-mediated microbubble enhancement of radiation therapy studied using three-dimensional high-frequency power Doppler ultrasound. Ultrasound Med Biol 2013;39:1983-90. [PMID: 23993051 DOI: 10.1016/j.ultrasmedbio.2013.03.025] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
149 Kasoji SK, Rivera JN, Gessner RC, Chang SX, Dayton PA. Early Assessment of Tumor Response to Radiation Therapy using High-Resolution Quantitative Microvascular Ultrasound Imaging. Theranostics 2018;8:156-68. [PMID: 29290799 DOI: 10.7150/thno.19703] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
150 Low JSH, Chua E, Gao F, Wee JTS. Stereotactic radiosurgery plus intracavitary irradiation in the salvage of nasopharyngeal carcinoma. Head Neck 2006;28:321-9. [DOI: 10.1002/hed.20338] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 2.9] [Reference Citation Analysis]
151 Koutsimpelas D, Brieger J, Kim DW, Stenzel M, Hast J, Mann WJ. Proangiogenic effects of ionizing irradiation on squamous cell carcinoma of the hypopharynx. Auris Nasus Larynx 2008;35:369-75. [PMID: 17980533 DOI: 10.1016/j.anl.2007.09.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
152 Katsoulakis E, Laufer I, Bilsky M, Agaram NP, Lovelock M, Yamada Y. Pathological characteristics of spine metastases treated with high-dose single-fraction stereotactic radiosurgery. Neurosurg Focus 2017;42:E7. [PMID: 28041326 DOI: 10.3171/2016.10.FOCUS16368] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 2.4] [Reference Citation Analysis]
153 Nesseler J, Peiffert D, Vogin G, Nickers P. Cancer, radiothérapie et système immunitaire. Cancer/Radiothérapie 2017;21:307-15. [DOI: 10.1016/j.canrad.2017.02.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
154 Lammers T, Subr V, Ulbrich K, Peschke P, Huber PE, Hennink WE, Storm G, Kiessling F. Long-Circulating and Passively Tumor-Targeted Polymer-Drug Conjugates Improve the Efficacy and Reduce the Toxicity of Radiochemotherapy. Adv Eng Mater 2010;12:B413-21. [DOI: 10.1002/adem.200980046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
155 Mauceri HJ, Beckett MA, Liang H, Sutton HG, Pitroda S, Galka E, Efimova E, Darga T, Khodarev NN, King CR, Posner MC, Hellman S, Kufe DW, Weichselbaum RR. Translational strategies exploiting TNF-alpha that sensitize tumors to radiation therapy. Cancer Gene Ther 2009;16:373-81. [PMID: 18974777 DOI: 10.1038/cgt.2008.86] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
156 Leung E, Cairns RA, Chaudary N, Vellanki RN, Kalliomaki T, Moriyama EH, Mujcic H, Wilson BC, Wouters BG, Hill R, Milosevic M. Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors. BMC Cancer 2017;17:418. [PMID: 28619042 DOI: 10.1186/s12885-017-3402-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
157 El Kaffas A, Giles A, Czarnota GJ. Dose-dependent response of tumor vasculature to radiation therapy in combination with Sunitinib depicted by three-dimensional high-frequency power Doppler ultrasound. Angiogenesis 2013;16:443-54. [PMID: 23314761 DOI: 10.1007/s10456-012-9329-2] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 4.3] [Reference Citation Analysis]
158 Spałek MJ, Kozak K, Czarnecka AM, Bartnik E, Borkowska A, Rutkowski P. Neoadjuvant Treatment Options in Soft Tissue Sarcomas. Cancers (Basel) 2020;12:E2061. [PMID: 32722580 DOI: 10.3390/cancers12082061] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
159 Wiesemann A, Ketteler J, Slama A, Wirsdörfer F, Hager T, Röck K, Engel DR, Fischer JW, Aigner C, Jendrossek V, Klein D. Inhibition of Radiation-Induced Ccl2 Signaling Protects Lungs from Vascular Dysfunction and Endothelial Cell Loss. Antioxidants & Redox Signaling 2019;30:213-31. [DOI: 10.1089/ars.2017.7458] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
160 Gao D, Nolan D, McDonnell K, Vahdat L, Benezra R, Altorki N, Mittal V. Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression. Biochim Biophys Acta 2009;1796:33-40. [PMID: 19460418 DOI: 10.1016/j.bbcan.2009.05.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 58] [Article Influence: 1.4] [Reference Citation Analysis]
161 Portulano C, Paroder-Belenitsky M, Carrasco N. The Na+/I- symporter (NIS): mechanism and medical impact. Endocr Rev 2014;35:106-49. [PMID: 24311738 DOI: 10.1210/er.2012-1036] [Cited by in Crossref: 139] [Cited by in F6Publishing: 120] [Article Influence: 15.4] [Reference Citation Analysis]
162 Yang G, Quan Y, Wang W, Fu Q, Wu J, Mei T, Li J, Tang Y, Luo C, Ouyang Q, Chen S, Wu L, Hei TK, Wang Y. Dynamic equilibrium between cancer stem cells and non-stem cancer cells in human SW620 and MCF-7 cancer cell populations. Br J Cancer. 2012;106:1512-1519. [PMID: 22472879 DOI: 10.1038/bjc.2012.126] [Cited by in Crossref: 68] [Cited by in F6Publishing: 58] [Article Influence: 6.8] [Reference Citation Analysis]
163 Cho J, Kodym R, Seliounine S, Richardson JA, Solberg TD, Story MD. High dose-per-fraction irradiation of limited lung volumes using an image-guided, highly focused irradiator: simulating stereotactic body radiotherapy regimens in a small-animal model. Int J Radiat Oncol Biol Phys 2010;77:895-902. [PMID: 20510200 DOI: 10.1016/j.ijrobp.2009.12.074] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
164 Kang KB, Wang TT, Woon CT, Cheah ES, Moore XL, Zhu C, Wong MC. Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib: inhibition of tumor angiogenesis with extensive tumor necrosis. Int J Radiat Oncol Biol Phys 2007;67:888-96. [PMID: 17293239 DOI: 10.1016/j.ijrobp.2006.09.055] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 3.8] [Reference Citation Analysis]
165 Greenfield JP, Cobb WS, Lyden D. Resisting arrest: a switch from angiogenesis to vasculogenesis in recurrent malignant gliomas. J Clin Invest 2010;120:663-7. [PMID: 20179347 DOI: 10.1172/JCI42345] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
166 Zhang B, Hu Y, Pang Z. Modulating the Tumor Microenvironment to Enhance Tumor Nanomedicine Delivery. Front Pharmacol 2017;8:952. [PMID: 29311946 DOI: 10.3389/fphar.2017.00952] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 11.4] [Reference Citation Analysis]
167 DeVita VT Jr, Eggermont AM, Hellman S, Kerr DJ. Clinical cancer research: the past, present and the future. Nat Rev Clin Oncol 2014;11:663-9. [PMID: 25245981 DOI: 10.1038/nrclinonc.2014.153] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
168 Nivet A, Schlienger M, Clavère P, Huguet F. Effets de l’irradiation à haute dose sur la vascularisation : physiopathologie et conséquences cliniques. Cancer/Radiothérapie 2019;23:161-7. [DOI: 10.1016/j.canrad.2018.05.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
169 Yazici G, Cengiz M, Akyol F. Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer: in regard to Roh et Al (Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1348-55. Int J Radiat Oncol Biol Phys 2010;76:1278; author reply 1278. [PMID: 20206031 DOI: 10.1016/j.ijrobp.2009.10.053] [Reference Citation Analysis]
170 Hellevik T, Pettersen I, Berg V, Winberg JO, Moe BT, Bartnes K, Paulssen RH, Busund LT, Bremnes R, Chalmers A, Martinez-Zubiaurre I. Cancer-associated fibroblasts from human NSCLC survive ablative doses of radiation but their invasive capacity is reduced. Radiat Oncol 2012;7:59. [PMID: 22500976 DOI: 10.1186/1748-717X-7-59] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 4.4] [Reference Citation Analysis]
171 Khalifa J, Fléchon A, Chevreau C. Brain metastases from germ cell tumor: time to reconsider radiotherapy? Crit Rev Oncol Hematol 2020;150:102946. [PMID: 32353705 DOI: 10.1016/j.critrevonc.2020.102946] [Reference Citation Analysis]
172 Corre I, Guillonneau M, Paris F. Membrane signaling induced by high doses of ionizing radiation in the endothelial compartment. Relevance in radiation toxicity. Int J Mol Sci 2013;14:22678-96. [PMID: 24252908 DOI: 10.3390/ijms141122678] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]
173 Siemann DW, Horsman MR. Small-Molecule Vascular Disrupting Agents in Cancer Therapy. In: Teicher BA, Ellis LM, editors. Antiangiogenic Agents in Cancer Therapy. Totowa: Humana Press; 2008. pp. 297-310. [DOI: 10.1007/978-1-59745-184-0_17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
174 Watanabe Y, Dahlman EL, Leder KZ, Hui SK. A mathematical model of tumor growth and its response to single irradiation. Theor Biol Med Model 2016;13:6. [PMID: 26921069 DOI: 10.1186/s12976-016-0032-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
175 Alongi F, Arcangeli S, Triggiani L, Mazzola R, Buglione di Monale E Bastia M, Fersino S, Baiguini A, Jereczek-Fossa BA, Magrini SM; on the behalf of Italian Association of Radiation Oncology [AIRO]. Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease. Crit Rev Oncol Hematol 2017;117:48-56. [PMID: 28807235 DOI: 10.1016/j.critrevonc.2017.07.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
176 Al-mahrouki AA, Karshafian R, Giles A, Czarnota GJ. Bioeffects of Ultrasound-Stimulated Microbubbles on Endothelial Cells: Gene Expression Changes Associated with Radiation Enhancement In Vitro. Ultrasound in Medicine & Biology 2012;38:1958-69. [DOI: 10.1016/j.ultrasmedbio.2012.07.009] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
177 van Weel V, van Tongeren RB, van Hinsbergh VW, van Bockel JH, Quax PH. Vascular growth in ischemic limbs: a review of mechanisms and possible therapeutic stimulation. Ann Vasc Surg 2008;22:582-97. [PMID: 18504100 DOI: 10.1016/j.avsg.2008.02.017] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 4.1] [Reference Citation Analysis]
178 Potiron V, Clément-Colmou K, Jouglar E, Pietri M, Chiavassa S, Delpon G, Paris F, Supiot S. Tumor vasculature remodeling by radiation therapy increases doxorubicin distribution and efficacy. Cancer Lett 2019;457:1-9. [PMID: 31078733 DOI: 10.1016/j.canlet.2019.05.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
179 Meyer J, Singal AG. Stereotactic ablative radiotherapy for hepatocellular carcinoma: History, current status, and opportunities. Liver Transpl 2018;24:420-7. [DOI: 10.1002/lt.24991] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
180 Hass P, Mohnike K. Extending the Frontiers Beyond Thermal Ablation by Radiofrequency Ablation: SBRT, Brachytherapy, SIRT (Radioembolization). Viszeralmedizin 2014;30:245-52. [PMID: 26288597 DOI: 10.1159/000366088] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
181 Leroi N, Lallemand F, Coucke P, Noel A, Martinive P. Impacts of Ionizing Radiation on the Different Compartments of the Tumor Microenvironment. Front Pharmacol 2016;7:78. [PMID: 27064581 DOI: 10.3389/fphar.2016.00078] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
182 Larson SM, Mariani G, Strauss HW. Tumor biology as a basis for molecular targeting in cancer. Clin Transl Imaging 2013;1:397-406. [DOI: 10.1007/s40336-013-0044-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
183 Sharan AD, Szulc A, Krystal J, Yassari R, Laufer I, Bilsky MH. The Integration of Radiosurgery for the Treatment of Patients With Metastatic Spine Diseases: . Journal of the American Academy of Orthopaedic Surgeons 2014;22:447-54. [DOI: 10.5435/jaaos-22-07-447] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
184 Goh V, Glynne-Jones R. Perfusion CT imaging of colorectal cancer. Br J Radiol. 2014;87:20130811. [PMID: 24434157 DOI: 10.1259/bjr.20130811] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
185 Duda DG, Jain RK. Pleiotropy of tissue-specific growth factors: from neurons to vessels via the bone marrow. J Clin Invest 2005;115:596-8. [DOI: 10.1172/jci24511] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
186 Limesand KH, Said S, Anderson SM. Suppression of radiation-induced salivary gland dysfunction by IGF-1. PLoS One 2009;4:e4663. [PMID: 19252741 DOI: 10.1371/journal.pone.0004663] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 4.2] [Reference Citation Analysis]
187 Futerman AH, van Meer G. The cell biology of lysosomal storage disorders. Nat Rev Mol Cell Biol 2004;5:554-65. [DOI: 10.1038/nrm1423] [Cited by in Crossref: 535] [Cited by in F6Publishing: 495] [Article Influence: 29.7] [Reference Citation Analysis]
188 Kumar SS, Higgins KA, McGarry RC. Emerging Therapies for Stage III Non-Small Cell Lung Cancer: Stereotactic Body Radiation Therapy and Immunotherapy. Front Oncol 2017;7:197. [PMID: 28929083 DOI: 10.3389/fonc.2017.00197] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
189 Al-Omair A, Masucci L, Masson-Cote L, Campbell M, Atenafu EG, Parent A, Letourneau D, Yu E, Rampersaud R, Massicotte E, Lewis S, Yee A, Thibault I, Fehlings MG, Sahgal A. Surgical resection of epidural disease improves local control following postoperative spine stereotactic body radiotherapy. Neuro Oncol 2013;15:1413-9. [PMID: 24057886 DOI: 10.1093/neuonc/not101] [Cited by in Crossref: 97] [Cited by in F6Publishing: 82] [Article Influence: 12.1] [Reference Citation Analysis]
190 Simonis A, Schubert-Unkmeir A. The role of acid sphingomyelinase and modulation of sphingolipid metabolism in bacterial infection. Biol Chem 2018;399:1135-46. [PMID: 29924727 DOI: 10.1515/hsz-2018-0200] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
191 Williamson SC, Hartley AE, Heer R. A review of tasquinimod in the treatment of advanced prostate cancer. Drug Des Devel Ther 2013;7:167-74. [PMID: 23662046 DOI: 10.2147/DDDT.S31500] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
192 Yomo S, Hayashi M. Is upfront stereotactic radiosurgery a rational treatment option for very elderly patients with brain metastases? A retrospective analysis of 106 consecutive patients age 80 years and older. BMC Cancer 2016;16:948. [PMID: 27978813 DOI: 10.1186/s12885-016-2983-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
193 Kaliberov SA, Kaliberova LN, Buchsbaum DJ. Combined ionizing radiation and sKDR gene delivery for treatment of prostate carcinomas. Gene Ther 2005;12:407-17. [DOI: 10.1038/sj.gt.3302432] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
194 Liang P, Ballou B, Lv X, Si W, Bruchez MP, Huang W, Dong X. Monotherapy and Combination Therapy Using Anti-Angiogenic Nanoagents to Fight Cancer. Adv Mater 2021;33:e2005155. [PMID: 33684242 DOI: 10.1002/adma.202005155] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
195 Calvin DP, Hammond ME, Pajak TF, Trotti AM, Meredith RF, Rotman M, Jones CU, Byhardt RW, Demas WF, Ang KK, Fu KK; Radiation Therapy Oncology Group 90-03 Trial. Microvessel density >or=60 does not predict for outcome after radiation treatment for locally advanced head and neck squamous cell carcinoma: results of a correlative study from the Radiation Therapy Oncology Group (RTOG) 90-03 Trial. Am J Clin Oncol 2007;30:406-19. [PMID: 17762442 DOI: 10.1097/COC.0b013e3180342fd4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
196 Yau T, Epstein RJ. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ. Lancet 2003;362:1154-5; author reply 1155-6. [PMID: 14550706 DOI: 10.1016/s0140-6736(03)14476-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
197 Li J, Huang S, Armstrong EA, Fowler JF, Harari PM. Angiogenesis and radiation response modulation after vascular endothelial growth factor receptor-2 (VEGFR2) blockade. International Journal of Radiation Oncology*Biology*Physics 2005;62:1477-85. [DOI: 10.1016/j.ijrobp.2005.04.028] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
198 Roy HK, Lynch HT. Diagnosing Lynch syndrome: is the answer in the mouth. Gut. 2003;52:1665-1667. [PMID: 14633939 DOI: 10.1136/gut.52.12.1665] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
199 Grassmé H, Riethmüller J, Gulbins E. Biological aspects of ceramide-enriched membrane domains. Progress in Lipid Research 2007;46:161-70. [DOI: 10.1016/j.plipres.2007.03.002] [Cited by in Crossref: 131] [Cited by in F6Publishing: 120] [Article Influence: 8.7] [Reference Citation Analysis]
200 Meyer JJ, Foster RD, Lev-Cohain N, Yokoo T, Dong Y, Schwarz RE, Rule W, Tian J, Xie Y, Hannan R, Nedzi L, Solberg T, Timmerman R. A Phase I Dose-Escalation Trial of Single-Fraction Stereotactic Radiation Therapy for Liver Metastases. Ann Surg Oncol 2016;23:218-24. [PMID: 25963478 DOI: 10.1245/s10434-015-4579-z] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 5.4] [Reference Citation Analysis]
201 Kim DN, Medin PM, Timmerman RD. Emphasis on Repair, Not Just Avoidance of Injury, Facilitates Prudent Stereotactic Ablative Radiotherapy. Seminars in Radiation Oncology 2017;27:378-92. [DOI: 10.1016/j.semradonc.2017.04.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
202 Eisele G, Weller M. Targeting apoptosis pathways in glioblastoma. Cancer Lett 2013;332:335-45. [PMID: 21269762 DOI: 10.1016/j.canlet.2010.12.012] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 4.4] [Reference Citation Analysis]
203 Letellier C, Denis F, Aguirre L. What can be learned from a chaotic cancer model? Journal of Theoretical Biology 2013;322:7-16. [DOI: 10.1016/j.jtbi.2013.01.003] [Cited by in Crossref: 64] [Cited by in F6Publishing: 35] [Article Influence: 7.1] [Reference Citation Analysis]
204 Tozer GM, Kanthou C, Baguley BC. Disrupting tumour blood vessels. Nat Rev Cancer 2005;5:423-35. [PMID: 15928673 DOI: 10.1038/nrc1628] [Cited by in Crossref: 687] [Cited by in F6Publishing: 626] [Article Influence: 40.4] [Reference Citation Analysis]
205 Wang SW, Hojabrpour P, Zhang P, Kolesnick RN, Steinbrecher UP, Gómez-Muñoz A, Duronio V. Regulation of ceramide generation during macrophage apoptosis by ASMase and de novo synthesis. Biochim Biophys Acta 2015;1851:1482-9. [PMID: 26253821 DOI: 10.1016/j.bbalip.2015.08.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
206 Rotolo JA, Maj JG, Feldman R, Ren D, Haimovitz-Friedman A, Cordon-Cardo C, Cheng EH, Kolesnick R, Fuks Z. Bax and Bak do not exhibit functional redundancy in mediating radiation-induced endothelial apoptosis in the intestinal mucosa. Int J Radiat Oncol Biol Phys 2008;70:804-15. [PMID: 18191336 DOI: 10.1016/j.ijrobp.2007.11.043] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 3.6] [Reference Citation Analysis]
207 Markovsky E, Budhu S, Samstein RM, Li H, Russell J, Zhang Z, Drill E, Bodden C, Chen Q, Powell SN, Merghoub T, Wolchok JD, Humm J, Deasy JO, Haimovitz-Friedman A. An Antitumor Immune Response Is Evoked by Partial-Volume Single-Dose Radiation in 2 Murine Models. Int J Radiat Oncol Biol Phys 2019;103:697-708. [PMID: 30342090 DOI: 10.1016/j.ijrobp.2018.10.009] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
208 Baliga S, Kabarriti R, Ohri N, Haynes-Lewis H, Yaparpalvi R, Kalnicki S, Garg MK. Stereotactic body radiotherapy for recurrent head and neck cancer: A critical review. Head Neck 2017;39:595-601. [PMID: 27997054 DOI: 10.1002/hed.24633] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
209 Czabanka M, Petrilli LL, Elvers-Hornung S, Bieback K, Albert Imhof B, Vajkoczy P, Vinci M. Junctional Adhesion Molecule-C Mediates the Recruitment of Embryonic-Endothelial Progenitor Cells to the Perivascular Niche during Tumor Angiogenesis. Int J Mol Sci 2020;21:E1209. [PMID: 32054130 DOI: 10.3390/ijms21041209] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
210 Kavanagh BD. Stereotactic body radiation therapy as a derivative of stereotactic radiosurgery: clinically independent but with enduring common themes. J Clin Oncol 2014;32:2827-31. [PMID: 25113758 DOI: 10.1200/JCO.2014.56.7362] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
211 Maeda A, Leung MK, Conroy L, Chen Y, Bu J, Lindsay PE, Mintzberg S, Virtanen C, Tsao J, Winegarden NA, Wang Y, Morikawa L, Vitkin IA, Jaffray DA, Hill RP, DaCosta RS. In vivo optical imaging of tumor and microvascular response to ionizing radiation. PLoS One 2012;7:e42133. [PMID: 22927920 DOI: 10.1371/journal.pone.0042133] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
212 Pajonk F, Vlashi E, McBride WH. Radiation resistance of cancer stem cells: the 4 R's of radiobiology revisited. Stem Cells 2010;28:639-48. [PMID: 20135685 DOI: 10.1002/stem.318] [Cited by in Crossref: 225] [Cited by in F6Publishing: 210] [Article Influence: 18.8] [Reference Citation Analysis]
213 Hoffe S, Rao N, Shridhar R. Neoadjuvant vs adjuvant therapy for resectable pancreatic cancer: the evolving role of radiation. Semin Radiat Oncol 2014;24:113-25. [PMID: 24635868 DOI: 10.1016/j.semradonc.2013.11.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
214 Moding EJ, Mowery YM, Kirsch DG. Opportunities for Radiosensitization in the Stereotactic Body Radiation Therapy (SBRT) Era. Cancer J 2016;22:267-73. [PMID: 27441746 DOI: 10.1097/PPO.0000000000000203] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
215 Ng SSW, Zhang H, Wang L, Citrin D, Dawson LA. Association of pro-inflammatory soluble cytokine receptors early during hepatocellular carcinoma stereotactic radiotherapy with liver toxicity. NPJ Precis Oncol 2020;4:17. [PMID: 32695883 DOI: 10.1038/s41698-020-0124-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
216 Wilson R, Espinosa-Diez C, Kanner N, Chatterjee N, Ruhl R, Hipfinger C, Advani SJ, Li J, Khan OF, Franovic A, Weis SM, Kumar S, Coussens LM, Anderson DG, Chen CC, Cheresh DA, Anand S. MicroRNA regulation of endothelial TREX1 reprograms the tumour microenvironment. Nat Commun 2016;7:13597. [PMID: 27886180 DOI: 10.1038/ncomms13597] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 5.5] [Reference Citation Analysis]
217 Siddiqui F, Raben D, Lu JJ, Grecula JC, Lo SS, Huang Z, Mayr NA, Teh BS, Yao M. Emerging applications of stereotactic body radiation therapy for head and neck cancer. Expert Review of Anticancer Therapy 2014;11:1429-36. [DOI: 10.1586/era.11.110] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
218 Ji X, Chen S, Guo Y, Li W, Qi X, Yang H, Xiao S, Fang G, Hu J, Wen C, Liu H, Han Z, Deng G, Yang Q, Yang X, Xu Y, Peng Z, Li F, Cai N, Li G, Huang R. Establishment and evaluation of four different types of patient-derived xenograft models. Cancer Cell Int 2017;17:122. [PMID: 29296105 DOI: 10.1186/s12935-017-0497-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
219 Maddalena ME, Fox J, Chen J, Feng W, Cagnolini A, Linder KE, Tweedle MF, Nunn AD, Lantry LE. 177 Lu-AMBA Biodistribution, Radiotherapeutic Efficacy, Imaging, and Autoradiography in Prostate Cancer Models with Low GRP-R Expression. J Nucl Med 2009;50:2017-24. [DOI: 10.2967/jnumed.109.064444] [Cited by in Crossref: 65] [Cited by in F6Publishing: 56] [Article Influence: 5.0] [Reference Citation Analysis]
220 Fersino S, Arcangeli S, Jereczek-fossa BA, D’angelillo R, Bertoni F, D’agostino GR, Triggiani L, Corvò R, Magrini SM, Alongi F; on the behalf of AIRO. GUROPA survey: genito-urinary radiation oncology prescription attitudes. Radiol med 2018;123:879-84. [DOI: 10.1007/s11547-018-0918-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
221 Moro K, Nagahashi M, Gabriel E, Takabe K, Wakai T. Clinical application of ceramide in cancer treatment. Breast Cancer 2019;26:407-15. [PMID: 30963461 DOI: 10.1007/s12282-019-00953-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
222 Kim DW, Huamani J, Fu A, Hallahan DE. Molecular strategies targeting the host component of cancer to enhance tumor response to radiation therapy. Int J Radiat Oncol Biol Phys 2006;64:38-46. [PMID: 16377414 DOI: 10.1016/j.ijrobp.2005.02.008] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
223 Donlon NE, Power R, Hayes C, Reynolds JV, Lysaght J. Radiotherapy, immunotherapy, and the tumour microenvironment: Turning an immunosuppressive milieu into a therapeutic opportunity. Cancer Lett 2021;502:84-96. [PMID: 33450360 DOI: 10.1016/j.canlet.2020.12.045] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
224 Ahn GO, Brown JM. Influence of bone marrow-derived hematopoietic cells on the tumor response to radiotherapy: experimental models and clinical perspectives. Cell Cycle 2009;8:970-6. [PMID: 19270527 DOI: 10.4161/cc.8.7.8075] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
225 D'Asti E, Chennakrishnaiah S, Lee TH, Rak J. Extracellular Vesicles in Brain Tumor Progression. Cell Mol Neurobiol 2016;36:383-407. [PMID: 26993504 DOI: 10.1007/s10571-015-0296-1] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 7.3] [Reference Citation Analysis]
226 Huang Q, Xie F, Ouyang X. Predictive SNPs for radiation-induced damage in lung cancer patients with radiotherapy: a potential strategy to individualize treatment. Int J Biol Markers 2015;30:e1-11. [PMID: 25262703 DOI: 10.5301/jbm.5000108] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
227 Milano MT, Katz AW, Zhang H, Okunieff P. Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study. Int J Radiat Oncol Biol Phys. 2012;83:878-886. [PMID: 22172903 DOI: 10.1016/j.ijrobp.2011.08.036] [Cited by in Crossref: 277] [Cited by in F6Publishing: 265] [Article Influence: 25.2] [Reference Citation Analysis]
228 Bionda C, Hadchity E, Alphonse G, Chapet O, Rousson R, Rodriguez-Lafrasse C, Ardail D. Radioresistance of human carcinoma cells is correlated to a defect in raft membrane clustering. Free Radic Biol Med 2007;43:681-94. [PMID: 17664132 DOI: 10.1016/j.freeradbiomed.2007.04.031] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.2] [Reference Citation Analysis]
229 Le QT, Shirato H, Giaccia AJ, Koong AC. Emerging Treatment Paradigms in Radiation Oncology. Clin Cancer Res 2015;21:3393-401. [PMID: 25991820 DOI: 10.1158/1078-0432.CCR-14-1191] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
230 Moschetta M, Mishima Y, Sahin I, Manier S, Glavey S, Vacca A, Roccaro AM, Ghobrial IM. Role of endothelial progenitor cells in cancer progression. Biochim Biophys Acta. 2014;1846:26-39. [PMID: 24709008 DOI: 10.1016/j.bbcan.2014.03.005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 48] [Article Influence: 3.0] [Reference Citation Analysis]
231 Qiu B, Aili A, Xue L, Jiang P, Wang J. Advances in Radiobiology of Stereotactic Ablative Radiotherapy. Front Oncol 2020;10:1165. [PMID: 32850333 DOI: 10.3389/fonc.2020.01165] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
232 Borovski T, Beke P, van Tellingen O, Rodermond HM, Verhoeff JJ, Lascano V, Daalhuisen JB, Medema JP, Sprick MR. Therapy-resistant tumor microvascular endothelial cells contribute to treatment failure in glioblastoma multiforme. Oncogene 2013;32:1539-48. [DOI: 10.1038/onc.2012.172] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
233 Hennequin C, Quero L, Favaudon V. Déterminants et facteurs prédictifs pour la radiosensibilité tumorale. Cancer/Radiothérapie 2008;12:3-13. [DOI: 10.1016/j.canrad.2007.11.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
234 Hanzly M, Creighton T, Mix M, Zeeck K, Fung-Kee-Fung S, Singh AK, Schwaab T. Stereotactic Body Radiotherapy for the Treatment of Renal Tumors. Urol Case Rep 2014;2:147-9. [PMID: 26958469 DOI: 10.1016/j.eucr.2014.05.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
235 Muraki C, Ohga N, Hida Y, Nishihara H, Kato Y, Tsuchiya K, Matsuda K, Totsuka Y, Shindoh M, Hida K. Cyclooxygenase-2 inhibition causes antiangiogenic effects on tumor endothelial and vascular progenitor cells. Int J Cancer 2012;130:59-70. [DOI: 10.1002/ijc.25976] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
236 Lammers T, Peschke P, Kühnlein R, Subr V, Ulbrich K, Debus J, Huber P, Hennink W, Storm G. Effect of radiotherapy and hyperthermia on the tumor accumulation of HPMA copolymer-based drug delivery systems. Journal of Controlled Release 2007;117:333-41. [DOI: 10.1016/j.jconrel.2006.10.032] [Cited by in Crossref: 84] [Cited by in F6Publishing: 84] [Article Influence: 5.6] [Reference Citation Analysis]
237 Klein J, Tran W, Lai P, Al‐mahrouki A, Giles A, Czarnota GJ. Effect of Treatment Sequencing on the Tumor Response to Combined Treatment With Ultrasound‐Stimulated Microbubbles and Radiotherapy. J Ultrasound Med 2020;39:2415-25. [DOI: 10.1002/jum.15363] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
238 Hu X, He Y, Chen X, Xia T, Cao T, Jia H, Zhang L. Impact of intraoperative radiotherapy on the perioperative period of patients after breast-conserving surgery. Gland Surg 2020;9:1535-42. [PMID: 33224829 DOI: 10.21037/gs-20-727] [Reference Citation Analysis]
239 Chan C, Cai Z, Su R, Reilly RM. 111In- or 99mTc-labeled recombinant VEGF bioconjugates: in vitro evaluation of their cytotoxicity on porcine aortic endothelial cells overexpressing Flt-1 receptors. Nucl Med Biol 2010;37:105-15. [PMID: 20152709 DOI: 10.1016/j.nucmedbio.2009.10.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
240 Mao XW. A quantitative study of the effects of ionizing radiation on endothelial cells and capillary-like network formation. Technol Cancer Res Treat 2006;5:127-34. [PMID: 16551132 DOI: 10.1177/153303460600500206] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
241 Thibault I, Chang EL, Sheehan J, Ahluwalia MS, Guckenberger M, Sohn MJ, Ryu S, Foote M, Lo SS, Muacevic A, Soltys SG, Chao S, Gerszten P, Lis E, Yu E, Bilsky M, Fisher C, Schiff D, Fehlings MG, Ma L, Chang S, Chow E, Parelukar WR, Vogelbaum MA, Sahgal A. Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in Neuro-Oncology (SPINO) group. Lancet Oncol. 2015;16:e595-e603. [PMID: 26678212 DOI: 10.1016/s1470-2045(15)00166-7] [Cited by in Crossref: 98] [Cited by in F6Publishing: 30] [Article Influence: 16.3] [Reference Citation Analysis]
242 Aghi M, Chiocca EA. Contribution of bone marrow-derived cells to blood vessels in ischemic tissues and tumors. Mol Ther 2005;12:994-1005. [PMID: 16137927 DOI: 10.1016/j.ymthe.2005.07.693] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 2.9] [Reference Citation Analysis]
243 Duval H, Johnson N, Li J, Evans A, Chen S, Licence D, Skepper J, Charnock-Jones DS, Smith S, Print C. Vascular development is disrupted by endothelial cell-specific expression of the anti-apoptotic protein Bcl-2. Angiogenesis 2007;10:55-68. [PMID: 17149535 DOI: 10.1007/s10456-006-9057-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
244 Joaquim AF, Powers A, Laufer I, Bilsky MH. An update in the management of spinal metastases. Arq Neuropsiquiatr 2015;73:795-802. [PMID: 26352500 DOI: 10.1590/0004-282X20150099] [Cited by in Crossref: 25] [Cited by in F6Publishing: 8] [Article Influence: 4.2] [Reference Citation Analysis]
245 Hoang T, Huang S, Armstrong E, Eickhoff JC, Harari PM. Augmentation of radiation response with the vascular targeting agent ZD6126. Int J Radiat Oncol Biol Phys 2006;64:1458-65. [PMID: 16488554 DOI: 10.1016/j.ijrobp.2005.11.017] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
246 Stancevic B, Varda-Bloom N, Cheng J, Fuller JD, Rotolo JA, García-Barros M, Feldman R, Rao S, Weichselbaum RR, Harats D, Haimovitz-Friedman A, Fuks Z, Sadelain M, Kolesnick R. Adenoviral transduction of human acid sphingomyelinase into neo-angiogenic endothelium radiosensitizes tumor cure. PLoS One 2013;8:e69025. [PMID: 23936314 DOI: 10.1371/journal.pone.0069025] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
247 Kim DW, Huamani J, Niermann KJ, Lee H, Geng L, Leavitt LL, Baheza RA, Jones CC, Tumkur S, Yankeelov TE, Fleischer AC, Hallahan DE. Noninvasive assessment of tumor vasculature response to radiation-mediated, vasculature-targeted therapy using quantified power Doppler sonography: implications for improvement of therapy schedules. J Ultrasound Med 2006;25:1507-17. [PMID: 17121945 DOI: 10.7863/jum.2006.25.12.1507] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
248 Allan DS, Morgan SC, Birch PE, Yang L, Halpenny MJ, Gunanayagam A, Li Y, Eapen L. Mobilization of circulating vascular progenitors in cancer patients receiving external beam radiation in response to tissue injury. Int J Radiat Oncol Biol Phys 2009;75:220-4. [PMID: 19695439 DOI: 10.1016/j.ijrobp.2009.04.033] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
249 Tan KV, Namdarian B, Costello AJ, Hovens CM. Potential use of circulating endothelial cells as a biomarker of renal cell carcinoma. Urol Oncol 2011;29:237-43. [PMID: 19914100 DOI: 10.1016/j.urolonc.2009.07.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
250 Ucker DS, Levine JS. Exploitation of Apoptotic Regulation in Cancer. Front Immunol 2018;9:241. [PMID: 29535707 DOI: 10.3389/fimmu.2018.00241] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
251 Joseph B, Supe SS, Ramachandra A. Cyberknife: A double edged sword? Rep Pract Oncol Radiother 2010;15:93-7. [PMID: 24376931 DOI: 10.1016/j.rpor.2010.05.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
252 Moeller BJ, Cao Y, Li CY, Dewhirst MW. Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors. Cancer Cell 2004;5:429-41. [DOI: 10.1016/s1535-6108(04)00115-1] [Cited by in Crossref: 689] [Cited by in F6Publishing: 369] [Article Influence: 38.3] [Reference Citation Analysis]
253 Gil Marques F, Poli E, Malaquias J, Carvalho T, Portêlo A, Ramires A, Aldeia F, Ribeiro RM, Vitorino E, Diegues I, Costa L, Coutinho J, Pina F, Mareel M, Constantino Rosa Santos S. Low doses of ionizing radiation activate endothelial cells and induce angiogenesis in peritumoral tissues. Radiotherapy and Oncology 2019;141:256-61. [DOI: 10.1016/j.radonc.2019.06.035] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
254 Park SW, Kim JS, Kim JY, Lee KH. Additional 4-week capecitabine during the resting periods after 6-week neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: long-term oncologic outcomes. Ann Surg Treat Res 2018;94:306-11. [PMID: 29854708 DOI: 10.4174/astr.2018.94.6.306] [Reference Citation Analysis]
255 Bader SB, Dewhirst MW, Hammond EM. Cyclic Hypoxia: An Update on Its Characteristics, Methods to Measure It and Biological Implications in Cancer. Cancers (Basel) 2020;13:E23. [PMID: 33374581 DOI: 10.3390/cancers13010023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
256 Patra SK, Szyf M. DNA methylation-mediated nucleosome dynamics and oncogenic Ras signaling: insights from FAS, FAS ligand and RASSF1A. FEBS J. 2008;275:5217-5235. [PMID: 18803665 DOI: 10.1111/j.1742-4658.2008.06658.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
257 Carvalho HA, Villar RC. Radiotherapy and immune response: the systemic effects of a local treatment. Clinics (Sao Paulo) 2018;73:e557s. [PMID: 30540123 DOI: 10.6061/clinics/2018/e557s] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 11.3] [Reference Citation Analysis]
258 McNabb E, Al-Mahrouki A, Law N, McKay S, Tarapacki C, Hussein F, Czarnota GJ. Ultrasound-stimulated microbubble radiation enhancement of tumors: Single-dose and fractionated treatment evaluation. PLoS One 2020;15:e0239456. [PMID: 32976517 DOI: 10.1371/journal.pone.0239456] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
259 Heeschen C, Chang E, Aicher A, Cooke JP. Endothelial progenitor cells participate in nicotine-mediated angiogenesis. J Am Coll Cardiol 2006;48:2553-60. [PMID: 17174197 DOI: 10.1016/j.jacc.2006.07.066] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 4.6] [Reference Citation Analysis]
260 Barzilai O, Laufer I, Yamada Y, Higginson DS, Schmitt AM, Lis E, Bilsky MH. Integrating Evidence-Based Medicine for Treatment of Spinal Metastases Into a Decision Framework: Neurologic, Oncologic, Mechanicals Stability, and Systemic Disease. J Clin Oncol 2017;35:2419-27. [PMID: 28640703 DOI: 10.1200/JCO.2017.72.7362] [Cited by in Crossref: 61] [Cited by in F6Publishing: 14] [Article Influence: 12.2] [Reference Citation Analysis]
261 Hacker BC, Rafat M. Organoids as Complex In Vitro Models for Studying Radiation-Induced Cell Recruitment. Cell Mol Bioeng 2020;13:341-57. [PMID: 32952734 DOI: 10.1007/s12195-020-00625-0] [Reference Citation Analysis]
262 Malik NH, Kim MS, Chen H, Poon I, Husain Z, Eskander A, Boldt G, Louie AV, Karam I. Stereotactic Radiation Therapy for De Novo Head and Neck Cancers: A Systematic Review and Meta-Analysis. Adv Radiat Oncol 2021;6:100628. [PMID: 33665492 DOI: 10.1016/j.adro.2020.11.013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
263 Nofiele JT, Karshafian R, Furukawa M, Al Mahrouki A, Giles A, Wong S, Czarnota GJ. Ultrasound-activated microbubble cancer therapy: ceramide production leading to enhanced radiation effect in vitro. Technol Cancer Res Treat 2013;12:53-60. [PMID: 22905807 DOI: 10.7785/tcrt.2012.500253] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
264 Luo M, Liu Z, Zhang X, Han C, Samandi LZ, Dong C, Sumer BD, Lea J, Fu Y, Gao J. Synergistic STING activation by PC7A nanovaccine and ionizing radiation improves cancer immunotherapy. Journal of Controlled Release 2019;300:154-60. [DOI: 10.1016/j.jconrel.2019.02.036] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 10.3] [Reference Citation Analysis]
265 Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res. 2004;95:343-353. [PMID: 15321944 DOI: 10.1161/01.res.0000137877.89448.78] [Cited by in Crossref: 1314] [Cited by in F6Publishing: 569] [Article Influence: 77.3] [Reference Citation Analysis]
266 Itasaka S, Komaki R, Herbst RS, Shibuya K, Shintani T, Hunter NR, Onn A, Bucana CD, Milas L, Ang KK, O'Reilly MS. Endostatin improves radioresponse and blocks tumor revascularization after radiation therapy for A431 xenografts in mice. Int J Radiat Oncol Biol Phys 2007;67:870-8. [PMID: 17293237 DOI: 10.1016/j.ijrobp.2006.10.030] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
267 Krause M, Zips D, Thames HD, Kummermehr J, Baumann M. Preclinical evaluation of molecular-targeted anticancer agents for radiotherapy. Radiotherapy and Oncology 2006;80:112-22. [DOI: 10.1016/j.radonc.2006.07.017] [Cited by in Crossref: 63] [Cited by in F6Publishing: 49] [Article Influence: 3.9] [Reference Citation Analysis]
268 Gosens MJ, Dresen RC, Rutten HJ, Nieuwenhuijzen GA, van der Laak JA, Martijn H, Tan-Go I, Nagtegaal ID, van den Brule AJ, van Krieken JH. Preoperative radiochemotherapy is successful also in patients with locally advanced rectal cancer who have intrinsically high apoptotic tumours. Ann Oncol. 2008;19:2026-2032. [PMID: 18664561 DOI: 10.1093/annonc/mdn428] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
269 Perrotta C, Cervia D, De Palma C, Assi E, Pellegrino P, Bassi MT, Clementi E. The emerging role of acid sphingomyelinase in autophagy. Apoptosis 2015;20:635-44. [PMID: 25666706 DOI: 10.1007/s10495-015-1101-9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
270 Liu T, Du X, Sheng X. Gene expression changes after ionizing radiation in endothelial cells derived from human endometrial cancer-preliminary outcomes. Arch Gynecol Obstet 2014;289:1315-23. [PMID: 24385285 DOI: 10.1007/s00404-013-3136-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
271 Loeffler JS, Durante M. Charged particle therapy--optimization, challenges and future directions. Nat Rev Clin Oncol 2013;10:411-24. [PMID: 23689752 DOI: 10.1038/nrclinonc.2013.79] [Cited by in Crossref: 259] [Cited by in F6Publishing: 203] [Article Influence: 28.8] [Reference Citation Analysis]
272 Laufer I, Bilsky MH. Advances in the treatment of metastatic spine tumors: the future is not what it used to be. J Neurosurg Spine 2019;30:299-307. [PMID: 30835704 DOI: 10.3171/2018.11.SPINE18709] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
273 Chevallier P, Eugene T, Robillard N, Isnard F, Nicolini F, Escoffre-barbe M, Huguet F, Hunault M, Marcais A, Gaschet J, Cherel M, Guillaume T, Delaunay J, Peterlin P, Eveillard M, Thomas X, Ifrah N, Lapusan S, Bodet-milin C, Barbet J, Faivre-chauvet A, Ferrer L, Bene MC, Le Houerou C, Goldenberg DM, Wegener WA, Kraeber-bodéré F. 90 Y-labelled anti-CD22 epratuzumab tetraxetan in adults with refractory or relapsed CD22-positive B-cell acute lymphoblastic leukaemia: a phase 1 dose-escalation study. The Lancet Haematology 2015;2:e108-17. [DOI: 10.1016/s2352-3026(15)00020-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 3.6] [Reference Citation Analysis]
274 Sabourdy F, Kedjouar B, Sorli SC, Colié S, Milhas D, Salma Y, Levade T. Functions of sphingolipid metabolism in mammals--lessons from genetic defects. Biochim Biophys Acta 2008;1781:145-83. [PMID: 18294974 DOI: 10.1016/j.bbalip.2008.01.004] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 3.6] [Reference Citation Analysis]
275 Gutiérrez E, Sánchez I, Díaz O, Valles A, Balderrama R, Fuentes J, Lara B, Olimón C, Ruiz V, Rodríguez J, Bayardo LH, Chan M, Villafuerte CJ, Padayachee J, Sun A. Current Evidence for Stereotactic Body Radiotherapy in Lung Metastases. Curr Oncol 2021;28:2560-78. [PMID: 34287274 DOI: 10.3390/curroncol28040233] [Reference Citation Analysis]
276 Loblaw A, Liu S, Cheung P. Stereotactic ablative body radiotherapy in patients with prostate cancer. Transl Androl Urol 2018;7:330-40. [PMID: 30050794 DOI: 10.21037/tau.2018.01.18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
277 Roses RE, Datta J, Czerniecki BJ. Radiation as immunomodulator: implications for dendritic cell-based immunotherapy. Radiat Res. 2014;182:211-218. [PMID: 24992163 DOI: 10.1667/rr13495.1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
278 Grellier N, Belkacemi Y. Effets biologiques des hautes doses par fraction. Cancer/Radiothérapie 2020;24:153-8. [DOI: 10.1016/j.canrad.2019.06.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
279 Maxhimer JB, Soto-Pantoja DR, Ridnour LA, Shih HB, Degraff WG, Tsokos M, Wink DA, Isenberg JS, Roberts DD. Radioprotection in normal tissue and delayed tumor growth by blockade of CD47 signaling. Sci Transl Med 2009;1:3ra7. [PMID: 20161613 DOI: 10.1126/scitranslmed.3000139] [Cited by in Crossref: 96] [Cited by in F6Publishing: 95] [Article Influence: 8.0] [Reference Citation Analysis]
280 Rüegg C, Monnier Y, Kuonen F, Imaizumi N. Radiation-induced modifications of the tumor microenvironment promote metastasis. Bulletin du Cancer 2011;98:E47-57. [DOI: 10.1684/bdc.2011.1372] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
281 Boscolo D, Kostyleva D, Safari MJ, Anagnostatou V, Äystö J, Bagchi S, Binder T, Dedes G, Dendooven P, Dickel T, Drozd V, Franczack B, Geissel H, Gianoli C, Graeff C, Grahn T, Greiner F, Haettner E, Haghani R, Harakeh MN, Horst F, Hornung C, Hucka JP, Kalantar-Nayestanaki N, Kazantseva E, Kindler B, Knöbel R, Kuzminchuk-Feuerstein N, Lommel B, Mukha I, Nociforo C, Ishikawa S, Lovatti G, Nitta M, Ozoemelam I, Pietri S, Plaß WR, Prochazka A, Purushothaman S, Reidel CA, Roesch H, Schirru F, Schuy C, Sokol O, Steinsberger T, Tanaka YK, Tanihata I, Thirolf P, Tinganelli W, Voss B, Weber U, Weick H, Winfield JS, Winkler M, Zhao J, Scheidenberger C, Parodi K, Durante M; Super-FRS Experiment Collaboration. Radioactive Beams for Image-Guided Particle Therapy: The BARB Experiment at GSI. Front Oncol 2021;11:737050. [PMID: 34504803 DOI: 10.3389/fonc.2021.737050] [Reference Citation Analysis]
282 Albert JM, Cao C, Geng L, Leavitt L, Hallahan DE, Lu B. Integrin alpha v beta 3 antagonist Cilengitide enhances efficacy of radiotherapy in endothelial cell and non-small-cell lung cancer models. Int J Radiat Oncol Biol Phys 2006;65:1536-43. [PMID: 16863930 DOI: 10.1016/j.ijrobp.2006.04.036] [Cited by in Crossref: 93] [Cited by in F6Publishing: 89] [Article Influence: 5.8] [Reference Citation Analysis]
283 Kim KW, Moretti L, Lu B. M867, a novel selective inhibitor of caspase-3 enhances cell death and extends tumor growth delay in irradiated lung cancer models. PLoS One 2008;3:e2275. [PMID: 18509530 DOI: 10.1371/journal.pone.0002275] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
284 Li J, Shan Z, Ou G, Liu X, Zhang C, Baum BJ, Wang S. Structural and functional characteristics of irradiation damage to parotid glands in the miniature pig. International Journal of Radiation Oncology*Biology*Physics 2005;62:1510-6. [DOI: 10.1016/j.ijrobp.2005.04.029] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 2.9] [Reference Citation Analysis]
285 Kim J, Jeon H, Kim H. The molecular mechanisms underlying the therapeutic resistance of cancer stem cells. Arch Pharm Res 2015;38:389-401. [DOI: 10.1007/s12272-014-0531-1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
286 Rapisarda A, Melillo G. Combination Strategies Targeting Hypoxia Inducible Factor 1 (HIF-1) for Cancer Therapy. In: Bagley RG, editor. The Tumor Microenvironment. New York: Springer; 2010. pp. 3-21. [DOI: 10.1007/978-1-4419-6615-5_1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
287 Silva RA, Moshfeghi AA, Kaiser PK, Singh RP, Moshfeghi DM. Radiation Treatment for Age-Related Macular Degeneration. Seminars in Ophthalmology 2011;26:121-30. [DOI: 10.3109/08820538.2011.554486] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
288 Klein D, Steens J, Wiesemann A, Schulz F, Kaschani F, Röck K, Yamaguchi M, Wirsdörfer F, Kaiser M, Fischer JW, Stuschke M, Jendrossek V. Mesenchymal Stem Cell Therapy Protects Lungs from Radiation-Induced Endothelial Cell Loss by Restoring Superoxide Dismutase 1 Expression. Antioxid Redox Signal 2017;26:563-82. [PMID: 27572073 DOI: 10.1089/ars.2016.6748] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 7.5] [Reference Citation Analysis]
289 Don AS, Lim XY, Couttas TA. Re-configuration of sphingolipid metabolism by oncogenic transformation. Biomolecules 2014;4:315-53. [PMID: 24970218 DOI: 10.3390/biom4010315] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
290 Lucchini G, Willasch AM, Daniel J, Soerensen J, Jarisch A, Bakhtiar S, Rettinger E, Brandt J, Klingebiel T, Bader P. Epidemiology, risk factors, and prognosis of capillary leak syndrome in pediatric recipients of stem cell transplants: a retrospective single-center cohort study. Pediatr Transplantation 2016;20:1132-6. [DOI: 10.1111/petr.12831] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
291 Ruan J, Hajjar K, Rafii S, Leonard JP. Angiogenesis and antiangiogenic therapy in non-Hodgkin's lymphoma. Ann Oncol 2009;20:413-24. [PMID: 19088170 DOI: 10.1093/annonc/mdn666] [Cited by in Crossref: 69] [Cited by in F6Publishing: 64] [Article Influence: 4.9] [Reference Citation Analysis]
292 Hirata E, Sahai E. Tumor Microenvironment and Differential Responses to Therapy. Cold Spring Harb Perspect Med 2017;7:a026781. [PMID: 28213438 DOI: 10.1101/cshperspect.a026781] [Cited by in Crossref: 130] [Cited by in F6Publishing: 120] [Article Influence: 26.0] [Reference Citation Analysis]
293 Vaugier L, Mirabel X, Martel-Lafay I, Racadot S, Carrie C, Vendrely V, Mahé MA, Senellart H, Raoul JL, Campion L, Rio E. Radiosensitizing Chemotherapy (Irinotecan) with Stereotactic Body Radiation Therapy for the Treatment of Inoperable Liver and/or Lung Metastases of Colorectal Cancer. Cancers (Basel) 2021;13:E248. [PMID: 33440832 DOI: 10.3390/cancers13020248] [Reference Citation Analysis]
294 Jalili-Firoozinezhad S, Prantil-Baun R, Jiang A, Potla R, Mammoto T, Weaver JC, Ferrante TC, Kim HJ, Cabral JMS, Levy O, Ingber DE. Modeling radiation injury-induced cell death and countermeasure drug responses in a human Gut-on-a-Chip. Cell Death Dis 2018;9:223. [PMID: 29445080 DOI: 10.1038/s41419-018-0304-8] [Cited by in Crossref: 82] [Cited by in F6Publishing: 71] [Article Influence: 20.5] [Reference Citation Analysis]
295 Kaur P, Asea A. Radiation-induced effects and the immune system in cancer. Front Oncol 2012;2:191. [PMID: 23251903 DOI: 10.3389/fonc.2012.00191] [Cited by in Crossref: 119] [Cited by in F6Publishing: 108] [Article Influence: 11.9] [Reference Citation Analysis]
296 Kabakov AE, Kudryavtsev VA, Gabai VL. Hsp90 inhibitors as promising agents for radiotherapy. J Mol Med (Berl) 2010;88:241-7. [PMID: 19946660 DOI: 10.1007/s00109-009-0562-0] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
297 Brown JM, Diehn M, Loo BW Jr. Stereotactic ablative radiotherapy should be combined with a hypoxic cell radiosensitizer. Int J Radiat Oncol Biol Phys 2010;78:323-7. [PMID: 20832663 DOI: 10.1016/j.ijrobp.2010.04.070] [Cited by in Crossref: 95] [Cited by in F6Publishing: 72] [Article Influence: 7.9] [Reference Citation Analysis]
298 Schwartz DL, Powis G, Thitai-Kumar A, He Y, Bankson J, Williams R, Lemos R, Oh J, Volgin A, Soghomonyan S, Nishii R, Alauddin M, Mukhopadhay U, Peng Z, Bornmann W, Gelovani J. The selective hypoxia inducible factor-1 inhibitor PX-478 provides in vivo radiosensitization through tumor stromal effects. Mol Cancer Ther 2009;8:947-58. [PMID: 19372568 DOI: 10.1158/1535-7163.MCT-08-0981] [Cited by in Crossref: 64] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
299 Moeller BJ, Dreher MR, Rabbani ZN, Schroeder T, Cao Y, Li CY, Dewhirst MW. Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity. Cancer Cell 2005;8:99-110. [PMID: 16098463 DOI: 10.1016/j.ccr.2005.06.016] [Cited by in Crossref: 261] [Cited by in F6Publishing: 228] [Article Influence: 15.4] [Reference Citation Analysis]
300 Feng L, Dong Z, Liang C, Chen M, Tao D, Cheng L, Yang K, Liu Z. Iridium nanocrystals encapsulated liposomes as near-infrared light controllable nanozymes for enhanced cancer radiotherapy. Biomaterials 2018;181:81-91. [DOI: 10.1016/j.biomaterials.2018.07.049] [Cited by in Crossref: 67] [Cited by in F6Publishing: 54] [Article Influence: 16.8] [Reference Citation Analysis]
301 Harting C, Peschke P, Borkenstein K, Karger CP. Single-cell-based computer simulation of the oxygen-dependent tumour response to irradiation. Phys Med Biol 2007;52:4775-89. [PMID: 17671335 DOI: 10.1088/0031-9155/52/16/005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
302 Krengli M, Apicella G, Deantonio L, Paolini M, Masini L. Stereotactic radiation therapy for skull base recurrences: Is a salvage approach still possible? Rep Pract Oncol Radiother 2015;20:430-9. [PMID: 26696783 DOI: 10.1016/j.rpor.2014.10.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
303 Barcellos-Hoff MH, Park C, Wright EG. Radiation and the microenvironment - tumorigenesis and therapy. Nat Rev Cancer 2005;5:867-75. [PMID: 16327765 DOI: 10.1038/nrc1735] [Cited by in Crossref: 344] [Cited by in F6Publishing: 340] [Article Influence: 21.5] [Reference Citation Analysis]
304 Gagne P, Akalu A, Brooks PC. Challenges facing antiangiogenic therapy for cancer: impact of the tumor extracellular environment. Expert Review of Anticancer Therapy 2014;4:129-40. [DOI: 10.1586/14737140.4.1.129] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
305 Finkelstein SE, Timmerman R, McBride WH, Schaue D, Hoffe SE, Mantz CA, Wilson GD. The confluence of stereotactic ablative radiotherapy and tumor immunology. Clin Dev Immunol 2011;2011:439752. [PMID: 22162711 DOI: 10.1155/2011/439752] [Cited by in Crossref: 96] [Cited by in F6Publishing: 87] [Article Influence: 8.7] [Reference Citation Analysis]
306 Loi M, Nuyttens JJ, Desideri I, Greto D, Livi L. Single-Fraction Radiotherapy (SFRT) For Bone Metastases: Patient Selection And Perspectives. Cancer Manag Res 2019;11:9397-408. [PMID: 31807069 DOI: 10.2147/CMAR.S186630] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
307 Damast S, Wright J, Bilsky M, Hsu M, Zhang Z, Lovelock M, Cox B, Zatcky J, Yamada Y. Impact of dose on local failure rates after image-guided reirradiation of recurrent paraspinal metastases. Int J Radiat Oncol Biol Phys 2011;81:819-26. [PMID: 20888133 DOI: 10.1016/j.ijrobp.2010.06.013] [Cited by in Crossref: 63] [Cited by in F6Publishing: 46] [Article Influence: 5.3] [Reference Citation Analysis]
308 Lara PC, López-Peñalver JJ, Farias Vde A, Ruiz-Ruiz MC, Oliver FJ, Ruiz de Almodóvar JM. Direct and bystander radiation effects: a biophysical model and clinical perspectives. Cancer Lett 2015;356:5-16. [PMID: 24045041 DOI: 10.1016/j.canlet.2013.09.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
309 Yu J, Zhang L. Apoptosis in human cancer cells. Curr Opin Oncol. 2004;16:19-24. [PMID: 14685088 DOI: 10.1097/00001622-200401000-00005] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 3.2] [Reference Citation Analysis]
310 Hua G, Kolesnick R. Using ASMase knockout mice to model human diseases. Handb Exp Pharmacol 2013;:29-54. [PMID: 23563650 DOI: 10.1007/978-3-7091-1511-4_2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
311 Dengina N, Mitin T, Gamayunov S, Safina S, Kreinina Y, Tsimafeyeu I. Stereotactic body radiation therapy in combination with systemic therapy for metastatic renal cell carcinoma: a prospective multicentre study. ESMO Open 2019;4:e000535. [PMID: 31673426 DOI: 10.1136/esmoopen-2019-000535] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
312 Cohen Jr. MM. Vascular update: Morphogenesis, tumors, malformations, and molecular dimensions. Am J Med Genet 2006;140A:2013-38. [DOI: 10.1002/ajmg.a.31333] [Cited by in Crossref: 73] [Cited by in F6Publishing: 48] [Article Influence: 4.6] [Reference Citation Analysis]
313 Jansen M, de Witt Hamer PC, Witmer AN, Troost D, van Noorden CJ. Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas. Brain Res Brain Res Rev. 2004;45:143-163. [PMID: 15210301 DOI: 10.1016/j.brainresrev.2004.03.001] [Cited by in Crossref: 77] [Cited by in F6Publishing: 67] [Article Influence: 4.3] [Reference Citation Analysis]
314 Briggs K, Al Mahrouki A, Nofiele J, El-Falou A, Stanisz M, Kim HC, Kolios MC, Czarnota GJ. Non-invasive monitoring of ultrasound-stimulated microbubble radiation enhancement using photoacoustic imaging. Technol Cancer Res Treat 2014;13:435-44. [PMID: 24000993 DOI: 10.7785/tcrtexpress.2013.600266] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 0.2] [Reference Citation Analysis]
315 Kumar P, Benedict R, Urzua F, Fischbach C, Mooney D, Polverini P. Combination treatment significantly enhances the efficacy of antitumor therapy by preferentially targeting angiogenesis. Lab Invest 2005;85:756-67. [DOI: 10.1038/labinvest.3700272] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
316 Yoder MC. Endothelial progenitor cell: a blood cell by many other names may serve similar functions. J Mol Med (Berl). 2013;91:285-295. [PMID: 23371317 DOI: 10.1007/s00109-013-1002-8] [Cited by in Crossref: 76] [Cited by in F6Publishing: 76] [Article Influence: 8.4] [Reference Citation Analysis]
317 Mayer A, Steimel M, Wree A, Kelleher D, Vaupel P. Solid tumours arising from differently pre-oxygenated cells: comparable growth rates despite dissimilar tissue oxygenation. Int J Radiat Biol 2009;85:981-8. [PMID: 19895275 DOI: 10.3109/09553000903232843] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
318 Kirsch DG, Santiago PM, di Tomaso E, Sullivan JM, Hou WS, Dayton T, Jeffords LB, Sodha P, Mercer KL, Cohen R, Takeuchi O, Korsmeyer SJ, Bronson RT, Kim CF, Haigis KM, Jain RK, Jacks T. p53 controls radiation-induced gastrointestinal syndrome in mice independent of apoptosis. Science 2010;327:593-6. [PMID: 20019247 DOI: 10.1126/science.1166202] [Cited by in Crossref: 166] [Cited by in F6Publishing: 152] [Article Influence: 12.8] [Reference Citation Analysis]
319 Guo C, Buranych A, Sarkar D, Fisher PB, Wang XY. The role of tumor-associated macrophages in tumor vascularization. Vasc Cell 2013;5:20. [PMID: 24314323 DOI: 10.1186/2045-824X-5-20] [Cited by in Crossref: 63] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
320 Shi J, Fu C, Su X, Feng S, Wang S. Ultrasound-Stimulated Microbubbles Inhibit Aggressive Phenotypes and Promotes Radiosensitivity of esophageal squamous cell carcinoma. Bioengineered 2021;12:3000-13. [PMID: 34180353 DOI: 10.1080/21655979.2021.1931641] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
321 Boss MK, Bristow R, Dewhirst MW. Linking the history of radiation biology to the hallmarks of cancer. Radiat Res 2014;181:561-77. [PMID: 24811865 DOI: 10.1667/RR13675.1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 9] [Article Influence: 3.6] [Reference Citation Analysis]
322 Willett CG, Kozin SV, Duda DG, di Tomaso E, Kozak KR, Boucher Y, Jain RK. Combined vascular endothelial growth factor-targeted therapy and radiotherapy for rectal cancer: theory and clinical practice. Semin Oncol 2006;33:S35-40. [PMID: 17145523 DOI: 10.1053/j.seminoncol.2006.08.007] [Cited by in Crossref: 66] [Cited by in F6Publishing: 53] [Article Influence: 4.4] [Reference Citation Analysis]
323 Bar J, Herbst RS, Onn A. Multitargeted inhibitors in lung cancer: new clinical data. Clin Lung Cancer 2008;9 Suppl 3:S92-9. [PMID: 19419930 DOI: 10.3816/CLC.2008.s.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
324 Smart D, Garcia-Glaessner A, Palmieri D, Wong-Goodrich SJ, Kramp T, Gril B, Shukla S, Lyle T, Hua E, Cameron HA, Camphausen K, Steeg PS. Analysis of radiation therapy in a model of triple-negative breast cancer brain metastasis. Clin Exp Metastasis 2015;32:717-27. [PMID: 26319493 DOI: 10.1007/s10585-015-9739-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
325 Khalifa J, Amini A, Popat S, Gaspar LE, Faivre-finn C. Brain Metastases from NSCLC: Radiation Therapy in the Era of Targeted Therapies. Journal of Thoracic Oncology 2016;11:1627-43. [DOI: 10.1016/j.jtho.2016.06.002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 5.5] [Reference Citation Analysis]
326 Shan S, Robson ND, Cao Y, Qiao T, Li CY, Kontos CD, Garcia‐blanco M, Dewhirst MW. Responses of vascular endothelial cells to angiogenic signaling are important for tumor cell survival. FASEB j 2003;18:326-8. [DOI: 10.1096/fj.03-0765fje] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
327 Senzer N, Mani S, Rosemurgy A, Nemunaitis J, Cunningham C, Guha C, Bayol N, Gillen M, Chu K, Rasmussen C. TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors. J Clin Oncol. 2004;22:592-601. [PMID: 14726502 DOI: 10.1200/jco.2004.01.227] [Cited by in Crossref: 142] [Cited by in F6Publishing: 50] [Article Influence: 7.9] [Reference Citation Analysis]
328 Weichselbaum R. Radiation's outer limits. Nat Med. 2005;11:477-478. [PMID: 15875051 DOI: 10.1038/nm0505-477] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
329 Prasanna A, Ahmed MM, Mohiuddin M, Coleman CN. Exploiting sensitization windows of opportunity in hyper and hypo-fractionated radiation therapy. J Thorac Dis 2014;6:287-302. [PMID: 24688774 DOI: 10.3978/j.issn.2072-1439.2014.01.14] [Cited by in F6Publishing: 28] [Reference Citation Analysis]
330 Golombek SK, May JN, Theek B, Appold L, Drude N, Kiessling F, Lammers T. Tumor targeting via EPR: Strategies to enhance patient responses. Adv Drug Deliv Rev 2018;130:17-38. [PMID: 30009886 DOI: 10.1016/j.addr.2018.07.007] [Cited by in Crossref: 437] [Cited by in F6Publishing: 405] [Article Influence: 109.3] [Reference Citation Analysis]
331 Short SC, Harney J. Radiobiology and vascular targeting in glioma: . Current Opinion in Neurology 2003;16:651-5. [DOI: 10.1097/00019052-200312000-00002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
332 Stapleton S, Jaffray D, Milosevic M. Radiation effects on the tumor microenvironment: Implications for nanomedicine delivery. Adv Drug Deliv Rev 2017;109:119-30. [PMID: 27262923 DOI: 10.1016/j.addr.2016.05.021] [Cited by in Crossref: 82] [Cited by in F6Publishing: 80] [Article Influence: 13.7] [Reference Citation Analysis]
333 Potiron VA, Abderrahmani R, Clément-Colmou K, Marionneau-Lambot S, Oullier T, Paris F, Supiot S. Improved functionality of the vasculature during conventionally fractionated radiation therapy of prostate cancer. PLoS One 2013;8:e84076. [PMID: 24391887 DOI: 10.1371/journal.pone.0084076] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
334 Purhonen S, Palm J, Rossi D, Kaskenpää N, Rajantie I, Ylä-Herttuala S, Alitalo K, Weissman IL, Salven P. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc Natl Acad Sci USA. 2008;105:6620-6625. [PMID: 18443294 DOI: 10.1073/pnas.0710516105] [Cited by in Crossref: 294] [Cited by in F6Publishing: 272] [Article Influence: 21.0] [Reference Citation Analysis]
335 Li G, Xie B, Li X, Chen Y, Wang Q, Xu Y, Xu-Welliver M, Zou L. Down-regulation of survivin and hypoxia-inducible factor-1 α by β-elemene enhances the radiosensitivity of lung adenocarcinoma xenograft. Cancer Biother Radiopharm 2012;27:56-64. [PMID: 22248028 DOI: 10.1089/cbr.2011.1003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
336 Ngwa W, Kumar R, Sridhar S, Korideck H, Zygmanski P, Cormack RA, Berbeco R, Makrigiorgos GM. Targeted radiotherapy with gold nanoparticles: current status and future perspectives. Nanomedicine (Lond) 2014;9:1063-82. [PMID: 24978464 DOI: 10.2217/nnm.14.55] [Cited by in Crossref: 111] [Cited by in F6Publishing: 94] [Article Influence: 15.9] [Reference Citation Analysis]
337 Jubb AM, Oates AJ, Holden S, Koeppen H. Predicting benefit from anti-angiogenic agents in malignancy. Nat Rev Cancer 2006;6:626-35. [DOI: 10.1038/nrc1946] [Cited by in Crossref: 170] [Cited by in F6Publishing: 156] [Article Influence: 10.6] [Reference Citation Analysis]
338 Skog J. Glioma-specific antigens for immune tumor therapy. Expert Review of Vaccines 2014;5:793-802. [DOI: 10.1586/14760584.5.6.793] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
339 Debatin K, Wei J, Beltinger C. Endothelial progenitor cells for cancer gene therapy. Gene Ther 2008;15:780-6. [DOI: 10.1038/gt.2008.36] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
340 Lis E, Saha A, Peck KK, Zatcky J, Zelefsky MJ, Yamada Y, Holodny AI, Bilsky MH, Karimi S. Dynamic contrast-enhanced magnetic resonance imaging of osseous spine metastasis before and 1 hour after high-dose image-guided radiation therapy. Neurosurg Focus 2017;42:E9. [PMID: 28041318 DOI: 10.3171/2016.9.FOCUS16378] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 2.4] [Reference Citation Analysis]
341 Bettegowda C, Dang LH, Abrams R, Huso DL, Dillehay L, Cheong I, Agrawal N, Borzillary S, McCaffery JM, Watson EL, Lin KS, Bunz F, Baidoo K, Pomper MG, Kinzler KW, Vogelstein B, Zhou S. Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria. Proc Natl Acad Sci U S A 2003;100:15083-8. [PMID: 14657371 DOI: 10.1073/pnas.2036598100] [Cited by in Crossref: 98] [Cited by in F6Publishing: 85] [Article Influence: 5.2] [Reference Citation Analysis]
342 Ohri N, Tomé WA, Méndez Romero A, Miften M, Ten Haken RK, Dawson LA, Grimm J, Yorke E, Jackson A. Local Control After Stereotactic Body Radiation Therapy for Liver Tumors. Int J Radiat Oncol Biol Phys 2021;110:188-95. [PMID: 29395629 DOI: 10.1016/j.ijrobp.2017.12.288] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 13.8] [Reference Citation Analysis]
343 Li F, Sonveaux P, Rabbani ZN, Liu S, Yan B, Huang Q, Vujaskovic Z, Dewhirst MW, Li CY. Regulation of HIF-1alpha stability through S-nitrosylation. Mol Cell. 2007;26:63-74. [PMID: 17434127 DOI: 10.1016/j.molcel.2007.02.024] [Cited by in Crossref: 315] [Cited by in F6Publishing: 308] [Article Influence: 21.0] [Reference Citation Analysis]
344 Ng Q, Goh V, Milner J, Padhani AR, Saunders MI, Hoskin PJ. Acute tumor vascular effects following fractionated radiotherapy in human lung cancer: In vivo whole tumor assessment using volumetric perfusion computed tomography. International Journal of Radiation Oncology*Biology*Physics 2007;67:417-24. [DOI: 10.1016/j.ijrobp.2006.10.005] [Cited by in Crossref: 65] [Cited by in F6Publishing: 54] [Article Influence: 4.3] [Reference Citation Analysis]
345 Lin B, Du H, Fan J, Huang D, Gao F, Li J, Zhang Y, Feng G, Dai T, Du X. Radioimmunotherapy Combined With Low-Intensity Ultrasound and Microbubbles: A Potential Novel Strategy for Treatment of Solid Tumors. Front Oncol 2021;11:750741. [PMID: 34745976 DOI: 10.3389/fonc.2021.750741] [Reference Citation Analysis]
346 Carpinteiro A, Dumitru C, Schenck M, Gulbins E. Ceramide-induced cell death in malignant cells. Cancer Letters 2008;264:1-10. [DOI: 10.1016/j.canlet.2008.02.020] [Cited by in Crossref: 87] [Cited by in F6Publishing: 82] [Article Influence: 6.2] [Reference Citation Analysis]
347 D'Ambrosio AL, DeYoung C, Isaacson SR. Radiosurgical management of brain metastases. Neurosurg Clin N Am 2011;22:45-51, vi. [PMID: 21109148 DOI: 10.1016/j.nec.2010.08.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
348 Gao H, Xue J, Zhou L, Lan J, He J, Na F, Yang L, Deng L, Lu Y. Bevacizumab radiosensitizes non-small cell lung cancer xenografts by inhibiting DNA double-strand break repair in endothelial cells. Cancer Lett 2015;365:79-88. [PMID: 25982206 DOI: 10.1016/j.canlet.2015.05.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
349 Yamada Y, Bilsky MH, Lovelock DM, Venkatraman ES, Toner S, Johnson J, Zatcky J, Zelefsky MJ, Fuks Z. High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. Int J Radiat Oncol Biol Phys 2008;71:484-90. [PMID: 18234445 DOI: 10.1016/j.ijrobp.2007.11.046] [Cited by in Crossref: 374] [Cited by in F6Publishing: 286] [Article Influence: 26.7] [Reference Citation Analysis]
350 Klein D, Schmetter A, Imsak R, Wirsdörfer F, Unger K, Jastrow H, Stuschke M, Jendrossek V. Therapy with Multipotent Mesenchymal Stromal Cells Protects Lungs from Radiation-Induced Injury and Reduces the Risk of Lung Metastasis. Antioxidants & Redox Signaling 2016;24:53-69. [DOI: 10.1089/ars.2014.6183] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 7.0] [Reference Citation Analysis]
351 Ventura AE, Mestre B, Silva LC. Ceramide Domains in Health and Disease: A Biophysical Perspective. In: Stiban J, editor. Bioactive Ceramides in Health and Disease. Cham: Springer International Publishing; 2019. pp. 79-108. [DOI: 10.1007/978-3-030-21162-2_6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
352 Seideman JH, Stancevic B, Rotolo JA, McDevitt MR, Howell RW, Kolesnick RN, Scheinberg DA. Alpha particles induce apoptosis through the sphingomyelin pathway. Radiat Res 2011;176:434-46. [PMID: 21631289 DOI: 10.1667/rr2472.1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
353 Cheng Y, Dong Y, Hou Q, Wu J, Zhang W, Tian H, Li D. The protective effects of XH-105 against radiation-induced intestinal injury. J Cell Mol Med 2019;23:2238-47. [PMID: 30663222 DOI: 10.1111/jcmm.14159] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
354 Moding EJ, Castle KD, Perez BA, Oh P, Min HD, Norris H, Ma Y, Cardona DM, Lee CL, Kirsch DG. Tumor cells, but not endothelial cells, mediate eradication of primary sarcomas by stereotactic body radiation therapy. Sci Transl Med 2015;7:278ra34. [PMID: 25761890 DOI: 10.1126/scitranslmed.aaa4214] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 7.0] [Reference Citation Analysis]
355 Kraeber-bodéré F, Bodet-milin C, Niaudet C, Saï-maurel C, Moreau A, Faivre-chauvet A, Thomare P, Deleris G, Estieu-gionnet K, Bikfalvi A, Barbet J, Paris F. Comparative Toxicity and Efficacy of Combined Radioimmunotherapy and Antiangiogenic Therapy in Carcinoembryonic Antigen–Expressing Medullary Thyroid Cancer Xenograft. J Nucl Med 2010;51:624-31. [DOI: 10.2967/jnumed.109.070714] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
356 Sia J, Szmyd R, Hau E, Gee HE. Molecular Mechanisms of Radiation-Induced Cancer Cell Death: A Primer. Front Cell Dev Biol 2020;8:41. [PMID: 32117972 DOI: 10.3389/fcell.2020.00041] [Cited by in Crossref: 45] [Cited by in F6Publishing: 51] [Article Influence: 22.5] [Reference Citation Analysis]
357 Ponnusamy S, Meyers-Needham M, Senkal CE, Saddoughi SA, Sentelle D, Selvam SP, Salas A, Ogretmen B. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance. Future Oncol 2010;6:1603-24. [PMID: 21062159 DOI: 10.2217/fon.10.116] [Cited by in Crossref: 203] [Cited by in F6Publishing: 191] [Article Influence: 18.5] [Reference Citation Analysis]
358 Shannon AM, Williams KJ. Antiangiogenics and radiotherapy. Journal of Pharmacy and Pharmacology 2008;60:1029-36. [DOI: 10.1211/jpp.60.8.0009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
359 Teckie S, Lok BH, Rao S, Gutiontov SI, Yamada Y, Berry SL, Zelefsky MJ, Lee NY. High-dose hypofractionated radiotherapy is effective and safe for tumors in the head-and-neck. Oral Oncol 2016;60:74-80. [PMID: 27531876 DOI: 10.1016/j.oraloncology.2016.06.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
360 Prezzi D, Khan A, Goh V. Perfusion CT imaging of treatment response in oncology. Eur J Radiol 2015;84:2380-5. [PMID: 25864440 DOI: 10.1016/j.ejrad.2015.03.022] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
361 Tabatabai G, Weller M, Nabors B, Picard M, Reardon D, Mikkelsen T, Ruegg C, Stupp R. Targeting integrins in malignant glioma. Target Oncol 2010;5:175-81. [PMID: 20820929 DOI: 10.1007/s11523-010-0156-3] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 5.5] [Reference Citation Analysis]
362 Tien CJ, Carlson DJ, Nath R, Chen ZJ. High-dose-rate brachytherapy as monotherapy for prostate cancer: The impact of cellular repair and source decay. Brachytherapy 2019;18:701-10. [PMID: 31109870 DOI: 10.1016/j.brachy.2019.04.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
363 Van Nest SJ, Nicholson LM, Pavey N, Hindi MN, Brolo AG, Jirasek A, Lum JJ. Raman spectroscopy detects metabolic signatures of radiation response and hypoxic fluctuations in non-small cell lung cancer. BMC Cancer 2019;19:474. [PMID: 31109312 DOI: 10.1186/s12885-019-5686-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
364 Kim JG, Park MT, Heo K, Yang KM, Yi JM. Epigenetics meets radiation biology as a new approach in cancer treatment. Int J Mol Sci. 2013;14:15059-15073. [PMID: 23873297 DOI: 10.3390/ijms140715059] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
365 Supiot S, Paris F. Radiobiologie appliquée à l’endothélium. Cancer/Radiothérapie 2012;16:11-5. [DOI: 10.1016/j.canrad.2011.10.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
366 Cabrera AR, Lee WR. Hypofractionation for Clinically Localized Prostate Cancer. Seminars in Radiation Oncology 2013;23:191-7. [DOI: 10.1016/j.semradonc.2013.01.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
367 Dünker N, Jendrossek V. Implementation of the Chick Chorioallantoic Membrane (CAM) Model in Radiation Biology and Experimental Radiation Oncology Research. Cancers (Basel) 2019;11:E1499. [PMID: 31591362 DOI: 10.3390/cancers11101499] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
368 Kulinich DP, Sheppard JP, Nguyen T, Kondajji AM, Unterberger A, Duong C, Enomoto A, Patel K, Yang I. Radiotherapy versus combination radiotherapy-bevacizumab for the treatment of recurrent high-grade glioma: a systematic review. Acta Neurochir (Wien) 2021;163:1921-34. [PMID: 33796887 DOI: 10.1007/s00701-021-04794-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
369 Jouanneau E. Angiogenesis and gliomas: current issues and development of surrogate markers. Neurosurgery 2008;62:31-50; discussion 50-2. [PMID: 18300890 DOI: 10.1227/01.NEU.0000311060.65002.4E] [Cited by in Crossref: 39] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
370 Moreira D, Sampath S, Won H, White SV, Su YL, Alcantara M, Wang C, Lee P, Maghami E, Massarelli E, Kortylewski M. Myeloid cell-targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell-mediated immunity. J Clin Invest 2021;131:137001. [PMID: 33232304 DOI: 10.1172/JCI137001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
371 Guedea F. Perspectives of brachytherapy: Patterns of care, new technologies, and “new biology”. Cancer/Radiothérapie 2014;18:434-6. [DOI: 10.1016/j.canrad.2014.07.143] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
372 Kioi M, Vogel H, Schultz G, Hoffman RM, Harsh GR, Brown JM. Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. J Clin Invest. 2010;120:694-705. [PMID: 20179352 DOI: 10.1172/jci40283] [Cited by in Crossref: 544] [Cited by in F6Publishing: 323] [Article Influence: 45.3] [Reference Citation Analysis]
373 Qin W, Huang G, Chen Z, Zhang Y. Nanomaterials in Targeting Cancer Stem Cells for Cancer Therapy. Front Pharmacol 2017;8:1. [PMID: 28149278 DOI: 10.3389/fphar.2017.00001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
374 Banerjee D, Barton SM, Grabham PW, Rumeld AL, Okochi S, Street C, Kadenhe-Chiweshe A, Boboila S, Yamashiro DJ, Connolly EP. High-Dose Radiation Increases Notch1 in Tumor Vasculature. Int J Radiat Oncol Biol Phys 2020;106:857-66. [PMID: 31759078 DOI: 10.1016/j.ijrobp.2019.11.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
375 Ahn GO, Brown JM. Role of endothelial progenitors and other bone marrow-derived cells in the development of the tumor vasculature. Angiogenesis. 2009;12:159-164. [PMID: 19221886 DOI: 10.1007/s10456-009-9135-7] [Cited by in Crossref: 73] [Cited by in F6Publishing: 77] [Article Influence: 5.6] [Reference Citation Analysis]
376 Urbich C, Dimmeler S. Endothelial progenitor cells functional characterization. Trends Cardiovasc Med 2004;14:318-22. [PMID: 15596109 DOI: 10.1016/j.tcm.2004.10.001] [Cited by in Crossref: 185] [Cited by in F6Publishing: 162] [Article Influence: 10.9] [Reference Citation Analysis]
377 Lee AS, Tang C, Hong WX, Park S, Bazalova-Carter M, Nelson G, Sanchez-Freire V, Bakerman I, Zhang W, Neofytou E, Connolly AJ, Chan CK, Graves EE, Weissman IL, Nguyen PK, Wu JC. Brief Report: External Beam Radiation Therapy for the Treatment of Human Pluripotent Stem Cell-Derived Teratomas. Stem Cells 2017;35:1994-2000. [PMID: 28600830 DOI: 10.1002/stem.2653] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
378 Song CW, Lee YJ, Griffin RJ, Park I, Koonce NA, Hui S, Kim MS, Dusenbery KE, Sperduto PW, Cho LC. Indirect Tumor Cell Death After High-Dose Hypofractionated Irradiation: Implications for Stereotactic Body Radiation Therapy and Stereotactic Radiation Surgery. Int J Radiat Oncol Biol Phys 2015;93:166-72. [PMID: 26279032 DOI: 10.1016/j.ijrobp.2015.05.016] [Cited by in Crossref: 77] [Cited by in F6Publishing: 70] [Article Influence: 11.0] [Reference Citation Analysis]
379 Magnon C, Opolon P, Connault E, Mir LM, Perricaudet M, Martel-renoir D. Canstatin gene electrotransfer combined with radiotherapy: preclinical trials for cancer treatment. Gene Ther 2008;15:1436-45. [DOI: 10.1038/gt.2008.100] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
380 Rak J. Extracellular vesicles - biomarkers and effectors of the cellular interactome in cancer. Front Pharmacol 2013;4:21. [PMID: 23508692 DOI: 10.3389/fphar.2013.00021] [Cited by in Crossref: 90] [Cited by in F6Publishing: 98] [Article Influence: 10.0] [Reference Citation Analysis]
381 Revannasiddaiah S, Susheela SP. Chemically enhanced radiotherapy: visions for the future. Ann Transl Med 2016;4:52. [PMID: 26904574 DOI: 10.3978/j.issn.2305-5839.2015.11.06] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
382 Kim JY, Shin D, Lee G, Kim JM, Kim D, An YM, Yoo BR, Chang H, Kim M, Cho J, Bae H. Standardized Herbal Formula PM014 Inhibits Radiation-Induced Pulmonary Inflammation in Mice. Sci Rep 2017;7:45001. [PMID: 28322297 DOI: 10.1038/srep45001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
383 Yazici G, Cengiz M, Ozyigit G, Eren G, Yildiz F, Akyol F, Gurkaynak M, Zorlu F. Hypofractionated stereotactic reirradiation for recurrent glioblastoma.J Neurooncol. 2014;120:117-123. [PMID: 25012955 DOI: 10.1007/s11060-014-1524-0] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
384 Majumder D, Mukherjee A. A passage through systems biology to systems medicine: adoption of middle-out rational approaches towards the understanding of therapeutic outcomes in cancer. Analyst 2011;136:663-78. [DOI: 10.1039/c0an00746c] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
385 Mollica V, Santoni M, Di Nunno V, Cimadamore A, Cheng L, Lopez-Beltran A, Battelli N, Montironi R, Massari F. Immunotherapy and Radiation Therapy in Renal Cell Carcinoma. Curr Drug Targets 2020;21:1463-75. [PMID: 32160846 DOI: 10.2174/1389450121666200311121540] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
386 Salama JK, Chmura SJ. The role of surgery and ablative radiotherapy in oligometastatic breast cancer. Semin Oncol 2014;41:790-7. [PMID: 25499637 DOI: 10.1053/j.seminoncol.2014.09.016] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
387 Jain S, Poon I, Soliman H, Keller B, Kim A, Lochray F, Yeung L, Cheung P. Lung stereotactic body radiation therapy (SBRT) delivered over 4 or 11days: A comparison of acute toxicity and quality of life. Radiotherapy and Oncology 2013;108:320-5. [DOI: 10.1016/j.radonc.2013.06.045] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
388 Meier V, Guscetti F, Roos M, Ohlerth S, Pruschy M, Rohrer Bley C. Hypoxia-Related Marker GLUT-1, CAIX, Proliferative Index and Microvessel Density in Canine Oral Malignant Neoplasia. PLoS One 2016;11:e0149993. [PMID: 26906567 DOI: 10.1371/journal.pone.0149993] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
389 Pisani C, Ramella M, Boldorini R, Loi G, Billia M, Boccafoschi F, Volpe A, Krengli M. Apoptotic and predictive factors by Bax, Caspases 3/9, Bcl-2, p53 and Ki-67 in prostate cancer after 12 Gy single-dose. Sci Rep 2020;10:7050. [PMID: 32341393 DOI: 10.1038/s41598-020-64062-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
390 Huang Q, Li F, Liu X, Li W, Shi W, Liu FF, O'Sullivan B, He Z, Peng Y, Tan AC, Zhou L, Shen J, Han G, Wang XJ, Thorburn J, Thorburn A, Jimeno A, Raben D, Bedford JS, Li CY. Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat Med 2011;17:860-6. [PMID: 21725296 DOI: 10.1038/nm.2385] [Cited by in Crossref: 478] [Cited by in F6Publishing: 475] [Article Influence: 43.5] [Reference Citation Analysis]
391 Barzilai O, Fisher CG, Bilsky MH. State of the Art Treatment of Spinal Metastatic Disease. Neurosurgery 2018;82:757-69. [DOI: 10.1093/neuros/nyx567] [Cited by in Crossref: 50] [Cited by in F6Publishing: 33] [Article Influence: 12.5] [Reference Citation Analysis]
392 Kruk-Bachonko J, Krupski W, Czechowski M, Kurys-Denis E, Mądro P, Sierocińska-Sawa J, Dąbrowski A, Wallner G, Skoczylas T. Perfusion CT - A novel quantitative and qualitative imaging biomarker in gastric cancer. Eur J Radiol 2017;95:399-408. [PMID: 28987697 DOI: 10.1016/j.ejrad.2017.08.033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
393 Wouters BG. Oncology scan--How radiation effects on cells in the stromal microenvironment influence tumor development, proliferation, and recovery. Int J Radiat Oncol Biol Phys 2013;86:593-5. [PMID: 23773382 DOI: 10.1016/j.ijrobp.2013.03.001] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
394 Bochet L, Meulle A, Imbert S, Salles B, Valet P, Muller C. Cancer-associated adipocytes promotes breast tumor radioresistance. Biochem Biophys Res Commun. 2011;411:102-106. [PMID: 21712027 DOI: 10.1016/j.bbrc.2011.06.101] [Cited by in Crossref: 81] [Cited by in F6Publishing: 81] [Article Influence: 7.4] [Reference Citation Analysis]
395 Zumsteg A, Baeriswyl V, Imaizumi N, Schwendener R, Rüegg C, Christofori G. Myeloid cells contribute to tumor lymphangiogenesis. PLoS One. 2009;4:e7067. [PMID: 19759906 DOI: 10.1371/journal.pone.0007067] [Cited by in Crossref: 84] [Cited by in F6Publishing: 80] [Article Influence: 6.5] [Reference Citation Analysis]
396 Suen CM, Mei SH, Kugathasan L, Stewart DJ. Targeted delivery of genes to endothelial cells and cell- and gene-based therapy in pulmonary vascular diseases. Compr Physiol 2013;3:1749-79. [PMID: 24265244 DOI: 10.1002/cphy.c120034] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
397 Chi A, Komaki R. Treatment of brain metastasis from lung cancer. Cancers (Basel) 2010;2:2100-37. [PMID: 24281220 DOI: 10.3390/cancers2042100] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
398 Virani NA, Kelada OJ, Kunjachan S, Detappe A, Kwon J, Hayashi J, Vazquez-Pagan A, Biancur DE, Ireland T, Kumar R, Sridhar S, Makrigiorgos GM, Berbeco RI. Noninvasive imaging of tumor hypoxia after nanoparticle-mediated tumor vascular disruption. PLoS One 2020;15:e0236245. [PMID: 32706818 DOI: 10.1371/journal.pone.0236245] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
399 Donini M, Buti S, Massari F, Mollica V, Rizzo A, Montironi R, Bersanelli M, Santoni M. Management of oligometastatic and oligoprogressive renal cell carcinoma: state of the art and future directions. Expert Rev Anticancer Ther 2020;20:491-501. [PMID: 32479120 DOI: 10.1080/14737140.2020.1770601] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
400 Gupta M. Circulating endothelial cells and circulating endothelial cell progenitors as surrogate markers for determining response to antiangiogenic agents. Clin Colorectal Cancer 2007;6:337-8. [PMID: 17311697 DOI: 10.1016/S1533-0028(11)70260-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
401 Lee AK, Pan D, Bao X, Hu M, Li F, Li CY. Endogenous Retrovirus Activation as a Key Mechanism of Anti-Tumor Immune Response in Radiotherapy. Radiat Res 2020;193:305-17. [PMID: 32074012 DOI: 10.1667/RADE-20-00013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
402 Sharma D, Giles A, Hashim A, Yip J, Ji Y, Do NNA, Sebastiani J, Tran WT, Farhat G, Oelze M, Czarnota GJ. Ultrasound microbubble potentiated enhancement of hyperthermia-effect in tumours. PLoS One 2019;14:e0226475. [PMID: 31851698 DOI: 10.1371/journal.pone.0226475] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
403 Kady N, Yan Y, Salazar T, Wang Q, Chakravarthy H, Huang C, Beli E, Navitskaya S, Grant M, Busik J. Increase in acid sphingomyelinase level in human retinal endothelial cells and CD34+ circulating angiogenic cells isolated from diabetic individuals is associated with dysfunctional retinal vasculature and vascular repair process in diabetes. J Clin Lipidol 2017;11:694-703. [PMID: 28457994 DOI: 10.1016/j.jacl.2017.03.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
404 Jain RK, Duda DG, Clark JW, Loeffler JS. Lessons from phase III clinical trials on anti-VEGF therapy for cancer. Nat Clin Pract Oncol. 2006;3:24-40. [PMID: 16407877 DOI: 10.1038/ncponc0403] [Cited by in Crossref: 771] [Cited by in F6Publishing: 668] [Article Influence: 48.2] [Reference Citation Analysis]
405 Pernin V, Beuzeboc P, Peurien D, Louvet C, Kirova Y. Réirradiation de métastases ganglionnaires d’un adénocarcinome œsogastrique par une technique de tomothérapie associée à de l’évérolimus. Cancer/Radiothérapie 2014;18:681-4. [DOI: 10.1016/j.canrad.2014.04.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
406 El Ouadih Y, Lemaire JJ, Vigier B, Gabrillargues J, Mulliez A, Dedieu V, Dupic G, Verrelle P, Biau J, Khalil T. Patterns of Failure After Linear Accelerator Radiosurgery for Cerebral Arteriovenous Malformations. World Neurosurg 2020;136:e141-8. [PMID: 31874295 DOI: 10.1016/j.wneu.2019.12.044] [Reference Citation Analysis]
407 Lammers T, Subr V, Peschke P, Kühnlein R, Hennink WE, Ulbrich K, Kiessling F, Heilmann M, Debus J, Huber PE, Storm G. Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy. Br J Cancer 2008;99:900-10. [PMID: 19238631 DOI: 10.1038/sj.bjc.6604561] [Cited by in Crossref: 83] [Cited by in F6Publishing: 84] [Article Influence: 6.4] [Reference Citation Analysis]
408 Shah AV, Bennett MR. DNA damage-dependent mechanisms of ageing and disease in the macro- and microvasculature. Eur J Pharmacol 2017;816:116-28. [PMID: 28347738 DOI: 10.1016/j.ejphar.2017.03.050] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
409 Bailo M, Gagliardi F, Boari N, Castellano A, Spina A, Mortini P. The Role of Surgery in Meningiomas. Curr Treat Options Neurol 2019;21:51. [PMID: 31560106 DOI: 10.1007/s11940-019-0587-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
410 Kim WY, Lee HY. Brain angiogenesis in developmental and pathological processes: mechanism and therapeutic intervention in brain tumors. FEBS J 2009;276:4653-64. [PMID: 19664069 DOI: 10.1111/j.1742-4658.2009.07177.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
411 Mitera G, Bjarnason GA, Pirouzmand F, Bilbao J, Danjoux C, Sahgal A. Preoperative stereotactic body radiotherapy to a skull renal cell metastasis: an alternative to preoperative embolization? J Palliat Med 2011;14:157-60. [PMID: 21226619 DOI: 10.1089/jpm.2010.0231] [Reference Citation Analysis]
412 Lu F, Li YQ, Aubert I, Wong CS. Endothelial cells regulate p53-dependent apoptosis of neural progenitors after irradiation. Cell Death Dis 2012;3:e324. [PMID: 22717579 DOI: 10.1038/cddis.2012.59] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
413 Yoon C, Lee HJ, Park DJ, Lee YJ, Tap WD, Eisinger-Mathason TS, Hart CP, Choy E, Simon MC, Yoon SS. Hypoxia-activated chemotherapeutic TH-302 enhances the effects of VEGF-A inhibition and radiation on sarcomas. Br J Cancer 2015;113:46-56. [PMID: 26010414 DOI: 10.1038/bjc.2015.186] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
414 Choi SH, Kim AR, Nam JK, Kim JM, Kim JY, Seo HR, Lee HJ, Cho J, Lee YJ. Tumour-vasculature development via endothelial-to-mesenchymal transition after radiotherapy controls CD44v6+ cancer cell and macrophage polarization. Nat Commun 2018;9:5108. [PMID: 30504836 DOI: 10.1038/s41467-018-07470-w] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 9.5] [Reference Citation Analysis]
415 Chen YL, Chang MC, Cheng WF. Metronomic chemotherapy and immunotherapy in cancer treatment. Cancer Lett 2017;400:282-92. [PMID: 28189534 DOI: 10.1016/j.canlet.2017.01.040] [Cited by in Crossref: 63] [Cited by in F6Publishing: 63] [Article Influence: 12.6] [Reference Citation Analysis]
416 Li Y, Cozzi PJ. Angiogenesis as a strategic target for prostate cancer therapy. Med Res Rev 2010;30:23-66. [PMID: 19536866 DOI: 10.1002/med.20161] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
417 Taha TA, Mullen TD, Obeid LM. A house divided: ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell death. Biochim Biophys Acta 2006;1758:2027-36. [PMID: 17161984 DOI: 10.1016/j.bbamem.2006.10.018] [Cited by in Crossref: 215] [Cited by in F6Publishing: 207] [Article Influence: 13.4] [Reference Citation Analysis]
418 Arnold KM, Flynn NJ, Raben A, Romak L, Yu Y, Dicker AP, Mourtada F, Sims-Mourtada J. The Impact of Radiation on the Tumor Microenvironment: Effect of Dose and Fractionation Schedules. Cancer Growth Metastasis. 2018;11:1179064418761639. [PMID: 29551910 DOI: 10.1177/1179064418761639] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 12.8] [Reference Citation Analysis]
419 Corre I, Paris F, Huot J. The p38 pathway, a major pleiotropic cascade that transduces stress and metastatic signals in endothelial cells. Oncotarget 2017;8:55684-714. [PMID: 28903453 DOI: 10.18632/oncotarget.18264] [Cited by in Crossref: 74] [Cited by in F6Publishing: 69] [Article Influence: 14.8] [Reference Citation Analysis]
420 Yang J, Wu Z, Chen Y, Hu C, Li D, Chen Y, Imani S, Wen Q, Fu S, Wu J. Pre-treatment with Bifidobacterium infantis and its specific antibodies enhance targeted radiosensitization in a murine model for lung cancer. J Cancer Res Clin Oncol 2021;147:411-22. [PMID: 33130941 DOI: 10.1007/s00432-020-03434-0] [Reference Citation Analysis]
421 Provencio M, Sánchez A. Therapeutic integration of new molecule-targeted therapies with radiotherapy in lung cancer. Transl Lung Cancer Res 2014;3:89-94. [PMID: 25806286 DOI: 10.3978/j.issn.2218-6751.2014.03.06] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
422 Gangeh MJ, Hashim A, Giles A, Sannachi L, Czarnota GJ. Computer aided prognosis for cell death categorization and prediction in vivo using quantitative ultrasound and machine learning techniques. Med Phys 2016;43:6439. [PMID: 27908167 DOI: 10.1118/1.4967265] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
423 Cesaretti JA, Pennathur A, Rosenstein BS, Swanson SJ, Fernando HC. Stereotactic Radiosurgery for Thoracic Malignancies. The Annals of Thoracic Surgery 2008;85:S785-91. [DOI: 10.1016/j.athoracsur.2007.10.101] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
424 Guo MF, Zhao Y, Tian R, Li L, Guo L, Xu F, Liu YM, He YB, Bai S, Wang J. In vivo99mTc-HYNIC-annexin V imaging of early tumor apoptosis in mice after single dose irradiation. J Exp Clin Cancer Res 2009;28:136. [PMID: 19814783 DOI: 10.1186/1756-9966-28-136] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
425 Cerciello F, Hofstetter B, Fatah SA, Zaghloul M, Odermatt B, Bodis S, Varga Z, Pruschy M, Ciernik IF. G2/M cell cycle checkpoint is functional in cervical cancer patients after initiation of external beam radiotherapy. Int J Radiat Oncol Biol Phys 2005;62:1390-8. [PMID: 16029798 DOI: 10.1016/j.ijrobp.2004.12.086] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
426 Henzler T, Shi J, Jafarov H, Schoenberg SO, Manegold C, Fink C, Schmid-Bindert G. Functional CT imaging techniques for the assessment of angiogenesis in lung cancer. Transl Lung Cancer Res 2012;1:78-83. [PMID: 25806158 DOI: 10.3978/j.issn.2218-6751.2012.01.02] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
427 Czarnota GJ, Karshafian R, Burns PN, Wong S, Al Mahrouki A, Lee JW, Caissie A, Tran W, Kim C, Furukawa M, Wong E, Giles A. Tumor radiation response enhancement by acoustical stimulation of the vasculature. Proc Natl Acad Sci U S A 2012;109:E2033-41. [PMID: 22778441 DOI: 10.1073/pnas.1200053109] [Cited by in Crossref: 104] [Cited by in F6Publishing: 94] [Article Influence: 10.4] [Reference Citation Analysis]
428 Meyer J, Toomay S. Update on treatment of liver metastases: focus on ablation therapies. Curr Oncol Rep. 2015;17:420. [PMID: 25416314 DOI: 10.1007/s11912-014-0420-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
429 Jenkins RW, Canals D, Hannun YA. Roles and regulation of secretory and lysosomal acid sphingomyelinase. Cell Signal. 2009;21:836-846. [PMID: 19385042 DOI: 10.1016/j.cellsig.2009.01.026] [Cited by in Crossref: 185] [Cited by in F6Publishing: 185] [Article Influence: 14.2] [Reference Citation Analysis]
430 Heneweer C, Peñate Medina T, Tower R, Kalthoff H, Kolesnick R, Larson S, Peñate Medina O. Acid-Sphingomyelinase Triggered Fluorescently Labeled Sphingomyelin Containing Liposomes in Tumor Diagnosis after Radiation-Induced Stress. Int J Mol Sci 2021;22:3864. [PMID: 33917976 DOI: 10.3390/ijms22083864] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
431 . Long-term effects of endovascular radiation after balloon angioplasty: assessment by OCT and histology. In: Regar E, van Leeuwen A, Serruys PW, editors. Optical Coherence Tomography in Cardiovascular Research. CRC Press; 2007. pp. 163-8. [DOI: 10.3109/9780203931561-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
432 Rousseau M, Gaugler M, Rodallec A, Bonnaud S, Paris F, Corre I. RhoA GTPase regulates radiation-induced alterations in endothelial cell adhesion and migration. Biochemical and Biophysical Research Communications 2011;414:750-5. [DOI: 10.1016/j.bbrc.2011.09.150] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
433 Song CW, Kim M, Cho LC, Dusenbery K, Sperduto PW. Radiobiological basis of SBRT and SRS. Int J Clin Oncol 2014;19:570-8. [DOI: 10.1007/s10147-014-0717-z] [Cited by in Crossref: 96] [Cited by in F6Publishing: 82] [Article Influence: 12.0] [Reference Citation Analysis]
434 Ngwa W, Makrigiorgos GM, Berbeco RI. Gold nanoparticle-aided brachytherapy with vascular dose painting: Estimation of dose enhancement to the tumor endothelial cell nucleus: Gold nanoparticle-aided brachytherapy with vascular dose painting. Med Phys 2012;39:392-8. [DOI: 10.1118/1.3671905] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
435 Greco C, Zelefsky MJ, Lovelock M, Fuks Z, Hunt M, Rosenzweig K, Zatcky J, Kim B, Yamada Y. Predictors of local control after single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases. Int J Radiat Oncol Biol Phys. 2011;79:1151-1157. [PMID: 20510537 DOI: 10.1016/j.ijrobp.2009.12.038] [Cited by in Crossref: 78] [Cited by in F6Publishing: 66] [Article Influence: 6.5] [Reference Citation Analysis]
436 Appelbe OK, Zhang Q, Pelizzari CA, Weichselbaum RR, Kron SJ. Image-Guided Radiotherapy Targets Macromolecules through Altering the Tumor Microenvironment. Mol Pharm 2016;13:3457-67. [PMID: 27560921 DOI: 10.1021/acs.molpharmaceut.6b00465] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
437 Hilleary LA, Wratten C, Siva S, Hilleary J, Martin JM. Intratumoural renal cell carcinoma haemorrhage following stereotactic radiotherapy: a case report. BMC Cancer 2019;19:671. [PMID: 31286870 DOI: 10.1186/s12885-019-5899-3] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
438 Huo D, Jiang X, Hu Y. Recent Advances in Nanostrategies Capable of Overcoming Biological Barriers for Tumor Management. Adv Mater 2020;32:e1904337. [PMID: 31663198 DOI: 10.1002/adma.201904337] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 13.0] [Reference Citation Analysis]
439 Sheehan J. SMART Syndrome: A Reversible Complication After Radiation Therapy and Surgery for Brain Tumors. World Neurosurgery 2014;82:e193-4. [DOI: 10.1016/j.wneu.2013.01.101] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
440 Lund EL, Høg A, Olsen MW, Hansen LT, Engelholm SA, Kristjansen PE. Differential regulation of VEGF, HIF1alpha and angiopoietin-1, -2 and -4 by hypoxia and ionizing radiation in human glioblastoma. Int J Cancer 2004;108:833-8. [PMID: 14712484 DOI: 10.1002/ijc.11662] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 2.4] [Reference Citation Analysis]
441 Semenza GL. Vasculogenesis, angiogenesis, and arteriogenesis: mechanisms of blood vessel formation and remodeling. J Cell Biochem. 2007;102:840-847. [PMID: 17891779 DOI: 10.1002/jcb.21523] [Cited by in Crossref: 192] [Cited by in F6Publishing: 175] [Article Influence: 13.7] [Reference Citation Analysis]
442 Laschke MW, Giebels C, Nickels RM, Scheuer C, Menger MD. Endothelial progenitor cells contribute to the vascularization of endometriotic lesions. Am J Pathol 2011;178:442-50. [PMID: 21224081 DOI: 10.1016/j.ajpath.2010.11.037] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 4.2] [Reference Citation Analysis]
443 Herter-Sprie GS, Korideck H, Christensen CL, Herter JM, Rhee K, Berbeco RI, Bennett DG, Akbay EA, Kozono D, Mak RH, Mike Makrigiorgos G, Kimmelman AC, Wong KK. Image-guided radiotherapy platform using single nodule conditional lung cancer mouse models. Nat Commun 2014;5:5870. [PMID: 25519892 DOI: 10.1038/ncomms6870] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
444 Ohri N, Dicker AP, Lawrence YR. Can drugs enhance hypofractionated radiotherapy? A novel method of modeling radiosensitization using in vitro data. Int J Radiat Oncol Biol Phys 2012;83:385-93. [PMID: 22265460 DOI: 10.1016/j.ijrobp.2011.06.1990] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
445 Yamada Y, Gounder M, Laufer I. Multidisciplinary Management of Recurrent Chordomas. Curr Treat Options in Oncol 2013;14:442-53. [DOI: 10.1007/s11864-013-0247-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
446 Liu Y, Nagata K, Masunaga S, Suzuki M, Kashino G, Kinashi Y, Tanaka H, Sakurai Y, Maruhashi A, Ono K. γ-ray Irradiation Enhanced Boron-10 Compound Accumulation in Murine Tumors. JRR 2009;50:553-7. [DOI: 10.1269/jrr.09071] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
447 Moretti L, Kim KW, Jung DK, Willey CD, Lu B. Radiosensitization of solid tumors by Z-VAD, a pan-caspase inhibitor. Mol Cancer Ther 2009;8:1270-9. [PMID: 19417149 DOI: 10.1158/1535-7163.MCT-08-0893] [Cited by in Crossref: 30] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
448 Foster WK, Ford NL. Investigating the effect of longitudinal micro-CT imaging on tumour growth in mice. Phys Med Biol 2011;56:315-26. [PMID: 21160110 DOI: 10.1088/0031-9155/56/2/002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
449 Dilmanian FA, Qu Y, Liu S, Cool CD, Gilbert J, Hainfeld JF, Kruse CA, Laterra J, Lenihan D, Nawrocky MM, Pappas G, Sze CI, Yuasa T, Zhong N, Zhong Z, McDonald JW. X-ray microbeams: Tumor therapy and central nervous system research. Nucl Instrum Methods Phys Res A 2005;548:30-7. [PMID: 17369874 DOI: 10.1016/j.nima.2005.03.062] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 2.8] [Reference Citation Analysis]
450 Magnon C, Opolon P, Ricard M, Connault E, Ardouin P, Galaup A, Métivier D, Bidart JM, Germain S, Perricaudet M, Schlumberger M. Radiation and inhibition of angiogenesis by canstatin synergize to induce HIF-1alpha-mediated tumor apoptotic switch. J Clin Invest 2007;117:1844-55. [PMID: 17557121 DOI: 10.1172/JCI30269] [Cited by in Crossref: 48] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
451 Lo SS, Teh BS, Wang JZ, Huang Z, Zook J, Price T, Mayr NA, Grecula JC, Timmerman RD, Cardenes HR. Imaging changes after stereotactic body radiation therapy for lung and liver tumors. Expert Review of Anticancer Therapy 2014;11:613-20. [DOI: 10.1586/era.10.164] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
452 Bernier J, Hall EJ, Giaccia A. Radiation oncology: a century of achievements. Nat Rev Cancer 2004;4:737-47. [PMID: 15343280 DOI: 10.1038/nrc1451] [Cited by in Crossref: 327] [Cited by in F6Publishing: 273] [Article Influence: 18.2] [Reference Citation Analysis]
453 Farinha P, Kyle AH, Minchinton AI, Connors JM, Karsan A, Gascoyne RD. Vascularization predicts overall survival and risk of transformation in follicular lymphoma. Haematologica 2010;95:2157-60. [PMID: 20713461 DOI: 10.3324/haematol.2009.021766] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
454 Schmid MC, Varner JA. Myeloid cells in the tumor microenvironment: modulation of tumor angiogenesis and tumor inflammation. J Oncol 2010;2010:201026. [PMID: 20490273 DOI: 10.1155/2010/201026] [Cited by in Crossref: 97] [Cited by in F6Publishing: 105] [Article Influence: 8.1] [Reference Citation Analysis]
455 Williams KJ, Telfer BA, Xenaki D, Sheridan MR, Desbaillets I, Peters HJ, Honess D, Harris AL, Dachs GU, van der Kogel A. Enhanced response to radiotherapy in tumours deficient in the function of hypoxia-inducible factor-1. Radiother Oncol. 2005;75:89-98. [PMID: 15878106 DOI: 10.1016/j.radonc.2005.01.009] [Cited by in Crossref: 100] [Cited by in F6Publishing: 90] [Article Influence: 5.9] [Reference Citation Analysis]
456 Chang DT, Schellenberg D, Shen J, Kim J, Goodman KA, Fisher GA, Ford JM, Desser T, Quon A, Koong AC. Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas. Cancer. 2009;115:665-672. [PMID: 19117351 DOI: 10.1002/cncr.24059] [Cited by in Crossref: 264] [Cited by in F6Publishing: 231] [Article Influence: 20.3] [Reference Citation Analysis]
457 Kotlinowski J, Jozkowicz A. PPAR Gamma and Angiogenesis: Endothelial Cells Perspective. J Diabetes Res 2016;2016:8492353. [PMID: 28053991 DOI: 10.1155/2016/8492353] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
458 Mohiuddin M, Lynch C, Gao M, Hartsell W. Early clinical results of proton spatially fractionated GRID radiation therapy (SFGRT). Br J Radiol 2020;93:20190572. [PMID: 31651185 DOI: 10.1259/bjr.20190572] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
459 Ko EC, Forsythe K, Buckstein M, Kao J, Rosenstein BS. Radiobiological rationale and clinical implications of hypofractionated radiation therapy. Cancer Radiother 2011;15:221-9. [PMID: 21514198 DOI: 10.1016/j.canrad.2010.12.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
460 Yamazaki T, Young KH. Effects of radiation on tumor vasculature. Mol Carcinog 2021. [PMID: 34644811 DOI: 10.1002/mc.23360] [Reference Citation Analysis]
461 Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol. 2005;23:1011-1027. [PMID: 15585754 DOI: 10.1200/jco.2005.06.081] [Cited by in Crossref: 1878] [Cited by in F6Publishing: 799] [Article Influence: 104.3] [Reference Citation Analysis]
462 Hlushchuk R, Riesterer O, Baum O, Wood J, Gruber G, Pruschy M, Djonov V. Tumor recovery by angiogenic switch from sprouting to intussusceptive angiogenesis after treatment with PTK787/ZK222584 or ionizing radiation. Am J Pathol 2008;173:1173-85. [PMID: 18787105 DOI: 10.2353/ajpath.2008.071131] [Cited by in Crossref: 84] [Cited by in F6Publishing: 73] [Article Influence: 6.0] [Reference Citation Analysis]
463 Smith EL, Schuchman EH. The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases. FASEB J 2008;22:3419-31. [PMID: 18567738 DOI: 10.1096/fj.08-108043] [Cited by in Crossref: 146] [Cited by in F6Publishing: 150] [Article Influence: 10.4] [Reference Citation Analysis]
464 Gustafson DL, Frederick B, Merz AL, Raben D. Dose scheduling of the dual VEGFR and EGFR tyrosine kinase inhibitor vandetanib (ZD6474, Zactima) in combination with radiotherapy in EGFR-positive and EGFR-null human head and neck tumor xenografts. Cancer Chemother Pharmacol 2008;61:179-88. [PMID: 17393165 DOI: 10.1007/s00280-007-0460-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
465 Giaj-Levra N, Borghetti P, Bruni A, Ciammella P, Cuccia F, Fozza A, Franceschini D, Scotti V, Vagge S, Alongi F. Current radiotherapy techniques in NSCLC: challenges and potential solutions. Expert Rev Anticancer Ther 2020;20:387-402. [PMID: 32321330 DOI: 10.1080/14737140.2020.1760094] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
466 Chakravarthy H, Navitskaya S, O'Reilly S, Gallimore J, Mize H, Beli E, Wang Q, Kady N, Huang C, Blanchard GJ, Grant MB, Busik JV. Role of Acid Sphingomyelinase in Shifting the Balance Between Proinflammatory and Reparative Bone Marrow Cells in Diabetic Retinopathy. Stem Cells 2016;34:972-83. [PMID: 26676316 DOI: 10.1002/stem.2259] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
467 Hoffer OA, Ben-David MA, Katz E, Zoltnik Kirshenabum D, Alezra D, Zimmer Y, Kelson I, Gannot I. Thermal imaging as a tool for evaluating tumor treatment efficacy. J Biomed Opt 2018;23:1-6. [PMID: 29726127 DOI: 10.1117/1.JBO.23.5.058001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
468 Kirkpatrick JP, Soltys SG, Lo SS, Beal K, Shrieve DC, Brown PD. The radiosurgery fractionation quandary: single fraction or hypofractionation? Neuro Oncol 2017;19:ii38-49. [PMID: 28380634 DOI: 10.1093/neuonc/now301] [Cited by in Crossref: 70] [Cited by in F6Publishing: 48] [Article Influence: 14.0] [Reference Citation Analysis]
469 Kubicek L, Vanderhart D, Wirth K, An Q, Chang M, Farese J, Bova F, Sudhyadhom A, Kow K, Bacon NJ, Milner R. ASSOCIATION BETWEEN COMPUTED TOMOGRAPHIC CHARACTERISTICS AND FRACTURES FOLLOWING STEREOTACTIC RADIOSURGERY IN DOGS WITH APPENDICULAR OSTEOSARCOMA. Vet Radiol Ultrasound 2016;57:321-30. [PMID: 26916056 DOI: 10.1111/vru.12351] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
470 Vlad RM, Kolios MC, Moseley JL, Czarnota GJ, Brock KK. Evaluating the extent of cell death in 3D high frequency ultrasound by registration with whole-mount tumor histopathology. Med Phys 2010;37:4288-97. [PMID: 20879589 DOI: 10.1118/1.3459020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
471 Fadhel MN, Hysi E, Strohm EM, Kolios MC. Optical and photoacoustic radiofrequency spectroscopic analysis for detecting red blood cell death. J Biophotonics 2019;12. [DOI: 10.1002/jbio.201800431] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
472 Senan S, Smit EF. Design of clinical trials of radiation combined with antiangiogenic therapy. Oncologist 2007;12:465-77. [PMID: 17470689 DOI: 10.1634/theoncologist.12-4-465] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 4.5] [Reference Citation Analysis]
473 Higa GM. Signaling multiplex of the epidermal growth factor receptor. Expert Rev Anticancer Ther 2004;4:1145-56. [PMID: 15606339 DOI: 10.1586/14737140.4.6.1145] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
474 Song CW, Park H, Griffin RJ, Levitt SH. Radiobiology of Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy. In: Levitt SH, Purdy JA, Perez CA, Poortmans P, editors. Technical Basis of Radiation Therapy. Berlin: Springer Berlin Heidelberg; 2012. pp. 51-61. [DOI: 10.1007/174_2011_264] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
475 Huang M, Zhang D, Wu JY, Xing K, Yeo E, Li C, Zhang L, Holland E, Yao L, Qin L, Binder ZA, O'Rourke DM, Brem S, Koumenis C, Gong Y, Fan Y. Wnt-mediated endothelial transformation into mesenchymal stem cell-like cells induces chemoresistance in glioblastoma. Sci Transl Med 2020;12:eaay7522. [PMID: 32102932 DOI: 10.1126/scitranslmed.aay7522] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 19.0] [Reference Citation Analysis]
476 Fang C, Dai CY, Mei Z, Jiang MJ, Gu DN, Huang Q, Tian L. microRNA-193a stimulates pancreatic cancer cell repopulation and metastasis through modulating TGF-β2/TGF-βRIII signalings. J Exp Clin Cancer Res 2018;37:25. [PMID: 29433538 DOI: 10.1186/s13046-018-0697-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
477 Henry B, Ziobro R, Becker KA, Kolesnick R, Gulbins E. Acid sphingomyelinase. Handb Exp Pharmacol 2013;:77-88. [PMID: 23579450 DOI: 10.1007/978-3-7091-1368-4_4] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 4.2] [Reference Citation Analysis]
478 Lin Y, Wang J, Hong J, Lin Y, Lee C, Wai Y, Ng S, Wu Y, Wang C. Noninvasive Monitoring of Microvascular Changes With Partial Irradiation Using Dynamic Contrast-Enhanced and Blood Oxygen Level-Dependent Magnetic Resonance Imaging. International Journal of Radiation Oncology*Biology*Physics 2013;85:1367-74. [DOI: 10.1016/j.ijrobp.2012.10.022] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
479 Du S, Barcellos-Hoff MH. Tumors as organs: biologically augmenting radiation therapy by inhibiting transforming growth factor β activity in carcinomas. Semin Radiat Oncol 2013;23:242-51. [PMID: 24012338 DOI: 10.1016/j.semradonc.2013.05.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
480 Jacobi J, García-Barros M, Rao S, Rotolo JA, Thompson C, Mizrachi A, Feldman R, Manova K, Bielawska A, Bielawska J, Fuks Z, Kolesnick R, Haimovitz-Friedman A. Targeting acid sphingomyelinase with anti-angiogenic chemotherapy. Cell Signal 2017;29:52-61. [PMID: 27702691 DOI: 10.1016/j.cellsig.2016.09.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
481 Ge YZ, Wu R, Lu TZ, Xin H, Yu P, Zhao Y, Liu H, Xu Z, Xu LW, Shen JW, Xu X, Zhou LH, Li WC, Zhu JG, Jia RP. Circulating endothelial progenitor cell: a promising biomarker in clinical oncology. Med Oncol 2015;32:332. [PMID: 25428376 DOI: 10.1007/s12032-014-0332-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
482 Weiss C, Schulze B, Ottinger A, Rödel C. To combine or not combine: the role of radiotherapy and targeted agents in the treatment for renal cell carcinoma. World J Urol 2014;32:59-67. [DOI: 10.1007/s00345-013-1068-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
483 Patterson DM, Rustin GJ. Vascular damaging agents. Clin Oncol (R Coll Radiol) 2007;19:443-56. [PMID: 17459681 DOI: 10.1016/j.clon.2007.03.014] [Cited by in Crossref: 107] [Cited by in F6Publishing: 95] [Article Influence: 7.1] [Reference Citation Analysis]
484 Paganetti H. Mechanisms and Review of Clinical Evidence of Variations in Relative Biological Effectiveness in Proton Therapy. Int J Radiat Oncol Biol Phys 2021:S0360-3016(21)02684-5. [PMID: 34407443 DOI: 10.1016/j.ijrobp.2021.08.015] [Reference Citation Analysis]
485 Patel PR, Yoo DS, Niibe Y, Urbanic JJ, Salama JK. A call for the aggressive treatment of oligometastatic and oligo-recurrent non-small cell lung cancer. Pulm Med 2012;2012:480961. [PMID: 23125927 DOI: 10.1155/2012/480961] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
486 Connell PP, Kron SJ, Weichselbaum RR. Relevance and irrelevance of DNA damage response to radiotherapy. DNA Repair (Amst) 2004;3:1245-51. [PMID: 15279813 DOI: 10.1016/j.dnarep.2004.04.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
487 Duda DG, Cohen KS, Kozin SV, Perentes JY, Fukumura D, Scadden DT, Jain RK. Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors. Blood 2006;107:2774-6. [PMID: 16339405 DOI: 10.1182/blood-2005-08-3210] [Cited by in Crossref: 114] [Cited by in F6Publishing: 100] [Article Influence: 6.7] [Reference Citation Analysis]
488 Jiang Y, DiVittore NA, Young MM, Jia Z, Xie K, Ritty TM, Kester M, Fox TE. Altered sphingolipid metabolism in patients with metastatic pancreatic cancer. Biomolecules 2013;3:435-48. [PMID: 24970174 DOI: 10.3390/biom3030435] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
489 Cheng J, Fuller J, Feldman R, Tap W, Owa T, Fuks Z, Kolesnick R. Enhancement of Soft Tissue Sarcoma Response to Gemcitabine through Timed Administration of a Short-Acting Anti-Angiogenic Agent. Cell Physiol Biochem 2020;54:707-18. [PMID: 32722909 DOI: 10.33594/000000250] [Reference Citation Analysis]
490 Zubatkina I, Ivanov P. Early imaging radioresponsiveness of melanoma brain metastases as a predictor of patient prognosis. J Neurosurg 2018;129:354-65. [PMID: 28841116 DOI: 10.3171/2017.1.JNS162075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
491 Kim WY, Oh SH, Woo JK, Hong WK, Lee HY. Targeting heat shock protein 90 overrides the resistance of lung cancer cells by blocking radiation-induced stabilization of hypoxia-inducible factor-1alpha. Cancer Res 2009;69:1624-32. [PMID: 19176399 DOI: 10.1158/0008-5472.CAN-08-0505] [Cited by in Crossref: 94] [Cited by in F6Publishing: 49] [Article Influence: 7.2] [Reference Citation Analysis]
492 Jia R, Wang T, Jiang Q, Wang Z, Song C, Ding B. Self-Assembled DNA Nanostructures for Drug Delivery. Chin J Chem 2016;34:265-72. [DOI: 10.1002/cjoc.201500838] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
493 Yamada Y, Bilsky MH. Technology impacting on biology: spine radiosurgery. Cancer 2011;117:3290-2. [PMID: 21319145 DOI: 10.1002/cncr.25921] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
494 Henare K, Wang L, Wang LC, Thomsen L, Tijono S, Chen CJ, Winkler S, Dunbar PR, Print C, Ching LM. Dissection of stromal and cancer cell-derived signals in melanoma xenografts before and after treatment with DMXAA. Br J Cancer 2012;106:1134-47. [PMID: 22415295 DOI: 10.1038/bjc.2012.63] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
495 Di Lascio S, Pagani O. Oligometastatic breast cancer: a shift from palliative to potentially curative treatment? Breast Care (Basel) 2014;9:7-14. [PMID: 24803881 DOI: 10.1159/000358750] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
496 Singh AK, Winslow TB, Kermany MH, Goritz V, Heit L, Miller A, Hoffend NC, Stein LC, Kumaraswamy LK, Warren GW, Bshara W, Odunsi K, Matsuzaki J, Abrams SI, Schwaab T, Muhitch JB. A Pilot Study of Stereotactic Body Radiation Therapy Combined with Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma. Clin Cancer Res 2017;23:5055-65. [PMID: 28630212 DOI: 10.1158/1078-0432.CCR-16-2946] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 5.4] [Reference Citation Analysis]
497 Nielsen T, Mouridsen K, Maxwell RJ, Stødkilde-Jørgensen H, Østergaard L, Horsman MR. Segmentation of dynamic contrast enhanced magnetic resonance imaging data. Acta Oncol 2008;47:1265-70. [PMID: 18661437 DOI: 10.1080/02841860802277489] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
498 Roncalli JG, Tongers J, Renault MA, Losordo DW. Endothelial progenitor cells in regenerative medicine and cancer: a decade of research. Trends Biotechnol. 2008;26:276-283. [PMID: 18359114 DOI: 10.1016/j.tibtech.2008.01.005] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 3.2] [Reference Citation Analysis]
499 Casamassima F, Masi L, Bonucci I, Polli C, Menichelli C, Gulisano M, Pacini S, Aterini S, Cavedon C. Relevance of Biologically Equivalent Dose Values in Outcome Evaluation of Stereotactic Radiotherapy for Lung Nodules. International Journal of Radiation Oncology*Biology*Physics 2008;71:145-51. [DOI: 10.1016/j.ijrobp.2007.09.036] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
500 Moccia F, Poletto V. May the remodeling of the Ca²⁺ toolkit in endothelial progenitor cells derived from cancer patients suggest alternative targets for anti-angiogenic treatment? Biochim Biophys Acta 2015;1853:1958-73. [PMID: 25447551 DOI: 10.1016/j.bbamcr.2014.10.024] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
501 Dougherty MC, Shibata SB, Hansen MR. The biological underpinnings of radiation therapy for vestibular schwannomas: Review of the literature. Laryngoscope Investig Otolaryngol 2021;6:458-68. [PMID: 34195368 DOI: 10.1002/lio2.553] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
502 Karam SD, Bhatia S. The radiobiological targets of SBRT: tumor cells or endothelial cells? Ann Transl Med 2015;3:290. [PMID: 26697450 DOI: 10.3978/j.issn.2305-5839.2015.09.17] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
503 Azimian H, Dayyani M, Toossi MTB, Mahmoudi M. Bax/Bcl-2 expression ratio in prediction of response to breast cancer radiotherapy. Iran J Basic Med Sci 2018;21:325-32. [PMID: 29511500 DOI: 10.22038/IJBMS.2018.26179.6429] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
504 Yamada Y, Katsoulakis E, Laufer I, Lovelock M, Barzilai O, McLaughlin LA, Zhang Z, Schmitt AM, Higginson DS, Lis E, Zelefsky MJ, Mechalakos J, Bilsky MH. The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery. Neurosurg Focus 2017;42:E6. [PMID: 28041329 DOI: 10.3171/2016.9.FOCUS16369] [Cited by in Crossref: 81] [Cited by in F6Publishing: 29] [Article Influence: 16.2] [Reference Citation Analysis]
505 Brown M. The remarkable yin and yang of tumour hypoxia. International Journal of Radiation Biology 2010;86:907-17. [DOI: 10.3109/09553002.2010.492492] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
506 Park MT, Oh ET, Song MJ, Lee H, Park HJ. Radio-sensitivities and angiogenic signaling pathways of irradiated normal endothelial cells derived from diverse human organs. J Radiat Res 2012;53:570-80. [PMID: 22843622 DOI: 10.1093/jrr/rrs011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
507 Medhora M, Haworth S, Liu Y, Narayanan J, Gao F, Zhao M, Audi S, Jacobs ER, Fish BL, Clough AV. Biomarkers for Radiation Pneumonitis Using Noninvasive Molecular Imaging. J Nucl Med 2016;57:1296-301. [PMID: 27033892 DOI: 10.2967/jnumed.115.160291] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
508 Schröder S, Broese S, Baake J, Juerß D, Kriesen S, Hildebrandt G, Manda K. Effect of Ionizing Radiation on Human EA.hy926 Endothelial Cells under Inflammatory Conditions and Their Interactions with A549 Tumour Cells. J Immunol Res 2019;2019:9645481. [PMID: 31565662 DOI: 10.1155/2019/9645481] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
509 Negri A, Naponelli V, Rizzi F, Bettuzzi S. Molecular Targets of Epigallocatechin-Gallate (EGCG): A Special Focus on Signal Transduction and Cancer. Nutrients. 2018;10. [PMID: 30563268 DOI: 10.3390/nu10121936] [Cited by in Crossref: 82] [Cited by in F6Publishing: 76] [Article Influence: 20.5] [Reference Citation Analysis]
510 Daly T. Evolution of definitive external beam radiation therapy in the treatment of prostate cancer. World J Urol 2020;38:565-91. [PMID: 30850855 DOI: 10.1007/s00345-019-02661-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
511 Fischer C, Schneider M, Carmeliet P. Principles and therapeutic implications of angiogenesis, vasculogenesis and arteriogenesis. Handb Exp Pharmacol 2006;:157-212. [PMID: 16999228 DOI: 10.1007/3-540-36028-x_6] [Cited by in Crossref: 57] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
512 Alghisi GC, Rüegg C. Vascular Integrins in Tumor Angiogenesis: Mediators and Therapeutic Targets. Endothelium 2009;13:113-35. [DOI: 10.1080/10623320600698037] [Cited by in Crossref: 130] [Cited by in F6Publishing: 116] [Article Influence: 10.0] [Reference Citation Analysis]
513 Lammertink BH, Bos C, van der Wurff-jacobs KM, Storm G, Moonen CT, Deckers R. Increase of intracellular cisplatin levels and radiosensitization by ultrasound in combination with microbubbles. Journal of Controlled Release 2016;238:157-65. [DOI: 10.1016/j.jconrel.2016.07.049] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
514 Ryu S, Yoon H, Stessin A, Gutman F, Rosiello A, Davis R. Contemporary treatment with radiosurgery for spine metastasis and spinal cord compression in 2015. Radiat Oncol J 2015;33:1-11. [PMID: 25874172 DOI: 10.3857/roj.2015.33.1.1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
515 Nabavizadeh N, Qi Y, Kaempf A, Chen Y, Tanyi JA, Lindner JR, Wu MD. Contrast-Enhanced Ultrasound to Detect Early Microvascular Changes in Skeletal Muscle after High-Dose Radiation Treatment. Radiat Res 2020;193:155-60. [PMID: 31841082 DOI: 10.1667/RR15471.1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
516 Baguley BC, Siemann DW. Temporal aspects of the action of ASA404 (vadimezan; DMXAA). Expert Opin Investig Drugs 2010;19:1413-25. [PMID: 20964495 DOI: 10.1517/13543784.2010.529128] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
517 Jia D, Koonce NA, Halakatti R, Li X, Yaccoby S, Swain FL, Suva LJ, Hennings L, Berridge MS, Apana SM, Mayo K, Corry PM, Griffin RJ. Repression of multiple myeloma growth and preservation of bone with combined radiotherapy and anti-angiogenic agent. Radiat Res 2010;173:809-17. [PMID: 20518660 DOI: 10.1667/RR1734.1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
518 Protopapa M, Kouloulias V, Kougioumtzopoulou A, Liakouli Z, Papadimitriou C, Zygogianni A. Novel treatment planning approaches to enhance the therapeutic ratio: targeting the molecular mechanisms of radiation therapy. Clin Transl Oncol 2020;22:447-56. [PMID: 31254253 DOI: 10.1007/s12094-019-02165-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
519 Mathew AS, Dawson LA. Current Understanding of Ablative Radiation Therapy in Hepatocellular Carcinoma. J Hepatocell Carcinoma 2021;8:575-86. [PMID: 34164350 DOI: 10.2147/JHC.S284403] [Reference Citation Analysis]
520 Salama JK, Chmura SJ. Surgery or Ablative Radiotherapy for Breast Cancer Oligometastases. American Society of Clinical Oncology Educational Book 2015. [DOI: 10.14694/edbook_am.2015.35.e8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 2.1] [Reference Citation Analysis]
521 Pennati M, Folini M, Zaffaroni N. Targeting survivin in cancer therapy. Expert Opinion on Therapeutic Targets 2008;12:463-76. [DOI: 10.1517/14728222.12.4.463] [Cited by in Crossref: 121] [Cited by in F6Publishing: 113] [Article Influence: 8.6] [Reference Citation Analysis]
522 Hannun YA, Obeid LM. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol. 2008;9:139-150. [PMID: 18216770 DOI: 10.1038/nrm2329] [Cited by in Crossref: 2097] [Cited by in F6Publishing: 2010] [Article Influence: 149.8] [Reference Citation Analysis]
523 Oldham M, Sakhalkar H, Oliver T, Allan Johnson G, Dewhirst M. Optical clearing of unsectioned specimens for three-dimensional imaging via optical transmission and emission tomography. J Biomed Opt 2008;13:021113. [PMID: 18465962 DOI: 10.1117/1.2907968] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
524 Bollinger CR, Teichgräber V, Gulbins E. Ceramide-enriched membrane domains. Biochim Biophys Acta. 2005;1746:284-294. [PMID: 16226325 DOI: 10.1016/j.bbamcr.2005.09.001] [Cited by in Crossref: 229] [Cited by in F6Publishing: 225] [Article Influence: 13.5] [Reference Citation Analysis]
525 Rao SS, Thompson C, Cheng J, Haimovitz-Friedman A, Powell SN, Fuks Z, Kolesnick RN. Axitinib sensitization of high Single Dose Radiotherapy. Radiother Oncol 2014;111:88-93. [PMID: 24794795 DOI: 10.1016/j.radonc.2014.02.010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
526 Khodarev NN, Labay E, Darga T, Yu J, Mauceri H, Gupta N, Kataoka Y, Weichselbaum RR. Endothelial cells co-cultured with wild-type and dominant/negative p53-transfected glioblastoma cells exhibit differential sensitivity to radiation-induced apoptosis. Int J Cancer 2004;109:214-9. [PMID: 14750172 DOI: 10.1002/ijc.11728] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
527 Salama JK, Kirkpatrick JP, Yin FF. Stereotactic body radiotherapy treatment of extracranial metastases. Nat Rev Clin Oncol 2012;9:654-65. [PMID: 23007273 DOI: 10.1038/nrclinonc.2012.166] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
528 Cacicedo J, Navarro A, Alongi F, Gómez de Iturriaga A, Del Hoyo O, Boveda E, Casquero F, Perez JF, Bilbao P. The role of re-irradiation of secondary and recurrent head and neck carcinomas. Is it a potentially curative treatment? A practical approach. Cancer Treat Rev 2014;40:178-89. [PMID: 23993769 DOI: 10.1016/j.ctrv.2013.08.002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
529 Pedrosa L, Esposito F, Thomson TM, Maurel J. The Tumor Microenvironment in Colorectal Cancer Therapy. Cancers (Basel) 2019;11:E1172. [PMID: 31416205 DOI: 10.3390/cancers11081172] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 8.7] [Reference Citation Analysis]
530 Tran WT, Suraweera H, Quaioit K, Cardenas D, Leong KX, Karam I, Poon I, Jang D, Sannachi L, Gangeh M, Tabbarah S, Lagree A, Sadeghi-Naini A, Czarnota GJ. Predictive quantitative ultrasound radiomic markers associated with treatment response in head and neck cancer. Future Sci OA 2019;6:FSO433. [PMID: 31915534 DOI: 10.2144/fsoa-2019-0048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
531 Burnette B, Weichselbaum RR. Radiation as an immune modulator. Semin Radiat Oncol 2013;23:273-80. [PMID: 24012341 DOI: 10.1016/j.semradonc.2013.05.009] [Cited by in Crossref: 92] [Cited by in F6Publishing: 92] [Article Influence: 11.5] [Reference Citation Analysis]
532 Billena C, Khan AJ. A Current Review of Spatial Fractionation: Back to the Future? Int J Radiat Oncol Biol Phys 2019;104:177-87. [PMID: 30684666 DOI: 10.1016/j.ijrobp.2019.01.073] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 11.7] [Reference Citation Analysis]
533 Giaccia AJ, Simon MC, Johnson R. The biology of hypoxia: the role of oxygen sensing in development, normal function, and disease. Genes Dev 2004;18:2183-94. [PMID: 15371333 DOI: 10.1101/gad.1243304] [Cited by in Crossref: 240] [Cited by in F6Publishing: 228] [Article Influence: 13.3] [Reference Citation Analysis]
534 Kumar KA, Peck KK, Karimi S, Lis E, Holodny AI, Bilsky MH, Yamada Y. A Pilot Study Evaluating the Use of Dynamic Contrast-Enhanced Perfusion MRI to Predict Local Recurrence After Radiosurgery on Spinal Metastases. Technol Cancer Res Treat 2017;16:857-65. [PMID: 28449626 DOI: 10.1177/1533034617705715] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
535 Fukumura D, Jain RK. Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. Microvasc Res. 2007;74:72-84. [PMID: 17560615 DOI: 10.1016/j.mvr.2007.05.003] [Cited by in Crossref: 446] [Cited by in F6Publishing: 433] [Article Influence: 29.7] [Reference Citation Analysis]
536 Loriot Y, Mordant P, Dorvault N, De la motte Rouge T, Bourhis J, Soria JC, Deutsch E. BMS-690514, a VEGFR and EGFR tyrosine kinase inhibitor, shows anti-tumoural activity on non-small-cell lung cancer xenografts and induces sequence-dependent synergistic effect with radiation. Br J Cancer 2010;103:347-53. [PMID: 20628392 DOI: 10.1038/sj.bjc.6605748] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
537 Feng X, Yu Y, He S, Cheng J, Gong Y, Zhang Z, Yang X, Xu B, Liu X, Li CY, Tian L, Huang Q. Dying glioma cells establish a proangiogenic microenvironment through a caspase 3 dependent mechanism. Cancer Lett 2017;385:12-20. [PMID: 27826040 DOI: 10.1016/j.canlet.2016.10.042] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 7.3] [Reference Citation Analysis]
538 Yamada Y, Laufer I, Cox BW, Lovelock DM, Maki RG, Zatcky JM, Boland PJ, Bilsky MH. Preliminary Results of High-Dose Single-Fraction Radiotherapy for the Management of Chordomas of the Spine and Sacrum. Neurosurgery 2013;73:673-80. [DOI: 10.1227/neu.0000000000000083] [Cited by in Crossref: 55] [Cited by in F6Publishing: 13] [Article Influence: 6.1] [Reference Citation Analysis]
539 Antoni D, Burckel H, Josset É, Noël G, Mornex F. Radiobiologie des doses ablatives en radiothérapie stéréotaxique : mise au point des données récentes. Cancer/Radiothérapie 2014;18:264-9. [DOI: 10.1016/j.canrad.2014.04.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
540 Knizetova P, Darling JL, Bartek J. Vascular endothelial growth factor in astroglioma stem cell biology and response to therapy. J Cell Mol Med 2008;12:111-25. [PMID: 18031298 DOI: 10.1111/j.1582-4934.2007.00153.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
541 Al-Mahrouki AA, Wong E, Czarnota GJ. Ultrasound-stimulated microbubble enhancement of radiation treatments: endothelial cell function and mechanism. Oncoscience 2015;2:944-57. [PMID: 26909363 DOI: 10.18632/oncoscience.277] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
542 Zhang L, Su H, Wang H, Li Q, Li X, Zhou C, Xu J, Chai Y, Liang X, Xiong L, Zhang C. Tumor Chemo-Radiotherapy with Rod-Shaped and Spherical Gold Nano Probes: Shape and Active Targeting Both Matter. Theranostics 2019;9:1893-908. [PMID: 31037146 DOI: 10.7150/thno.30523] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
543 Preusser M, Winkler F, Valiente M, Manegold C, Moyal E, Widhalm G, Tonn JC, Zielinski C. Recent advances in the biology and treatment of brain metastases of non-small cell lung cancer: summary of a multidisciplinary roundtable discussion. ESMO Open 2018;3:e000262. [PMID: 29387475 DOI: 10.1136/esmoopen-2017-000262] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 11.0] [Reference Citation Analysis]
544 Fix SM, Papadopoulou V, Velds H, Kasoji SK, Rivera JN, Borden MA, Chang S, Dayton PA. Oxygen microbubbles improve radiotherapy tumor control in a rat fibrosarcoma model - A preliminary study. PLoS One. 2018;13:e0195667. [PMID: 29630640 DOI: 10.1371/journal.pone.0195667] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
545 Gultekin M, Cengiz M, Sezen D, Zorlu F, Yildiz F, Yazici G, Hurmuz P, Ozyigit G, Akyol F, Gurkaynak M. Reirradiation of Pediatric Tumors Using Hypofractionated Stereotactic Radiotherapy. Technol Cancer Res Treat 2017;16:195-202. [PMID: 27352857 DOI: 10.1177/1533034616655952] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
546 Wang J, Wu N, Cham MD, Song Y. Tumor response in patients with advanced non-small cell lung cancer: perfusion CT evaluation of chemotherapy and radiation therapy. AJR Am J Roentgenol 2009;193:1090-6. [PMID: 19770333 DOI: 10.2214/AJR.08.1367] [Cited by in Crossref: 108] [Cited by in F6Publishing: 41] [Article Influence: 8.3] [Reference Citation Analysis]
547 Zhang J, Cui YX, Feng XN, Cheng M, Tang AN, Kong DM. pH-Controlled Intracellular in Situ Reversible Assembly of a Photothermal Agent for Smart Chemo-Photothermal Synergetic Therapy and ATP Imaging. ACS Appl Mater Interfaces 2019;11:39624-32. [PMID: 31573175 DOI: 10.1021/acsami.9b14186] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
548 Russell JA, Connor NP. Effects of age and radiation treatment on function of extrinsic tongue muscles. Radiat Oncol 2014;9:254. [PMID: 25472556 DOI: 10.1186/s13014-014-0254-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
549 Alongi F, Fiorentino A, De Bari B. SBRT and extreme hypofractionation: A new era in prostate cancer treatments? Rep Pract Oncol Radiother 2015;20:411-6. [PMID: 26696780 DOI: 10.1016/j.rpor.2014.09.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
550 Chen FH, Chiang CS, Wang CC, Tsai CS, Jung SM, Lee CC, McBride WH, Hong JH. Radiotherapy decreases vascular density and causes hypoxia with macrophage aggregation in TRAMP-C1 prostate tumors. Clin Cancer Res 2009;15:1721-9. [PMID: 19240176 DOI: 10.1158/1078-0432.CCR-08-1471] [Cited by in Crossref: 89] [Cited by in F6Publishing: 49] [Article Influence: 6.8] [Reference Citation Analysis]
551 Kleibeuker EA, Fokas E, Allen PD, Kersemans V, Griffioen AW, Beech J, Im JH, Smart SC, Castricum KC, van den Berg J, Schulkens IA, Hill SA, Harris AL, Slotman BJ, Verheul HM, Muschel RJ, Thijssen VL. Low dose angiostatic treatment counteracts radiotherapy-induced tumor perfusion and enhances the anti-tumor effect. Oncotarget 2016;7:76613-27. [PMID: 27780936 DOI: 10.18632/oncotarget.12814] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
552 Horsman MR, Nielsen T, Østergaard L, Overgaard J. Radiation administered as a large single dose or in a fractionated schedule: Role of the tumour vasculature as a target for influencing response. Acta Oncologica 2009;45:876-80. [DOI: 10.1080/02841860600900068] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
553 Zeng M, Han LF. Stereotactic radiosurgery: a "targeted" therapy for cancer. Chin J Cancer 2012;31:471-5. [PMID: 22835385 DOI: 10.5732/cjc.012.10011] [Reference Citation Analysis]
554 Good JS, Harrington KJ. The hallmarks of cancer and the radiation oncologist: updating the 5Rs of radiobiology. Clin Oncol (R Coll Radiol) 2013;25:569-77. [PMID: 23850153 DOI: 10.1016/j.clon.2013.06.009] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 4.4] [Reference Citation Analysis]
555 Kim SR, Kim EH. Effect of acidic environment on the response of endothelial cells to irradiation: implications for microbeam radiation therapy. Int J Radiat Biol 2014;90:325-33. [PMID: 24467329 DOI: 10.3109/09553002.2014.887867] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
556 Khodarev NN, Beckett M, Labay E, Darga T, Roizman B, Weichselbaum RR. STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells. Proc Natl Acad Sci U S A 2004;101:1714-9. [PMID: 14755057 DOI: 10.1073/pnas.0308102100] [Cited by in Crossref: 205] [Cited by in F6Publishing: 182] [Article Influence: 11.4] [Reference Citation Analysis]
557 Delaney LJ, Tantawi M, Wessner CE, Machado P, Forsberg F, Lyshchik A, O'Kane P, Liu JB, Civan J, Tan A, Anton K, Shaw CM, Eisenbrey JR. Predicting Long-Term Hepatocellular Carcinoma Response to Transarterial Radioembolization Using Contrast-Enhanced Ultrasound: Initial Experiences. Ultrasound Med Biol 2021;47:2523-31. [PMID: 34130880 DOI: 10.1016/j.ultrasmedbio.2021.05.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
558 Ito K, Yamaguchi T, Ogawa H, Nakajima Y, Karasawa K. Stereotactic body radiotherapy for bone metastases in patients with colorectal cancer. Jpn J Clin Oncol 2020;50:1442-6. [PMID: 32719860 DOI: 10.1093/jjco/hyaa128] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
559 Zhang H, Takayama K, Su B, Jiao X, Li R, Wang J. Effect of Sunitinib Combined with Ionizing Radiation on Endothelial Cells. JRR 2011;52:1-8. [DOI: 10.1269/jrr.10013] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
560 Goldberg JS, Hirschi KK. Diverse roles of the vasculature within the neural stem cell niche. Regen Med 2009;4:879-97. [PMID: 19903006 DOI: 10.2217/rme.09.61] [Cited by in Crossref: 84] [Cited by in F6Publishing: 79] [Article Influence: 7.0] [Reference Citation Analysis]
561 Tseng CL, Eppinga W, Charest-Morin R, Soliman H, Myrehaug S, Maralani PJ, Campbell M, Lee YK, Fisher C, Fehlings MG, Chang EL, Lo SS, Sahgal A. Spine Stereotactic Body Radiotherapy: Indications, Outcomes, and Points of Caution. Global Spine J 2017;7:179-97. [PMID: 28507888 DOI: 10.1177/2192568217694016] [Cited by in Crossref: 43] [Cited by in F6Publishing: 25] [Article Influence: 8.6] [Reference Citation Analysis]
562 Koukourakis MI, Giatromanolaki A, Sivridis E, Gatter KC, Harris AL. High DLL4 expression in tumour-associated vessels predicts for favorable radiotherapy outcome in locally advanced squamous cell head-neck cancer (HNSCC). Angiogenesis 2013;16:343-51. [PMID: 23108591 DOI: 10.1007/s10456-012-9318-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
563 Kerbel RS. Improving conventional or low dose metronomic chemotherapy with targeted antiangiogenic drugs. Cancer Res Treat 2007;39:150-9. [PMID: 19746237 DOI: 10.4143/crt.2007.39.4.150] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
564 Sharma D, Czarnota GJ. Role of acid sphingomyelinase-induced ceramide generation in response to radiation. Oncotarget 2019;10:6-7. [PMID: 30713596 DOI: 10.18632/oncotarget.26526] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
565 Denis F, Letellier C. Théorie du chaos : un concept fascinant pour l’oncologue. Cancer/Radiothérapie 2012;16:230-6. [DOI: 10.1016/j.canrad.2012.01.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
566 Bunevicius A, Laws ER, Vance ML, Iuliano S, Sheehan J. Surgical and radiosurgical treatment strategies for Cushing’s disease. J Neurooncol 2019;145:403-13. [DOI: 10.1007/s11060-019-03325-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
567 Garg AK, Shiu AS, Yang J, Wang XS, Allen P, Brown BW, Grossman P, Frija EK, McAleer MF, Azeem S, Brown PD, Rhines LD, Chang EL. Phase 1/2 trial of single-session stereotactic body radiotherapy for previously unirradiated spinal metastases. Cancer 2012;118:5069-77. [PMID: 22511344 DOI: 10.1002/cncr.27530] [Cited by in Crossref: 120] [Cited by in F6Publishing: 93] [Article Influence: 12.0] [Reference Citation Analysis]
568 Prechl J, Czirják L. The endothelial deprotection hypothesis for lupus pathogenesis: the dual role of C1q as a mediator of clearance and regulator of endothelial permeability. F1000Res 2015;4:24. [PMID: 25901277 DOI: 10.12688/f1000research.6075.2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
569 Paudyal R, LoCastro E, Reyngold M, Do RK, Konar AS, Oh JH, Dave A, Yu K, Goodman KA, Shukla-Dave A. Longitudinal Monitoring of Simulated Interstitial Fluid Pressure for Pancreatic Ductal Adenocarcinoma Patients Treated with Stereotactic Body Radiotherapy. Cancers (Basel) 2021;13:4319. [PMID: 34503129 DOI: 10.3390/cancers13174319] [Reference Citation Analysis]
570 Murakami M, Sakai H, Kodama A, Mori T, Maruo K, Yanai T, Masegi T. Expression of the Anti-apoptotic Factors Bcl-2 and Survivin in Canine Vascular Tumours. Journal of Comparative Pathology 2008;139:1-7. [DOI: 10.1016/j.jcpa.2008.02.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
571 Koning GA, Fretz MM, Woroniecka U, Storm G, Krijger GC. Targeting liposomes to tumor endothelial cells for neutron capture therapy. Applied Radiation and Isotopes 2004;61:963-7. [DOI: 10.1016/j.apradiso.2004.05.020] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
572 Pouget JP, Santoro L, Piron B, Paillas S, Ladjohounlou R, Pichard A, Poty S, Deshayes E, Constanzo J, Bardiès M. From the target cell theory to a more integrated view of radiobiology in Targeted radionuclide therapy: The Montpellier group's experience. Nucl Med Biol 2021;104-105:53-64. [PMID: 34922279 DOI: 10.1016/j.nucmedbio.2021.11.005] [Reference Citation Analysis]
573 Lai P, Tarapacki C, Tran WT, El Kaffas A, Lee J, Hupple C, Iradji S, Giles A, Al-Mahrouki A, Czarnota GJ. Breast tumor response to ultrasound mediated excitation of microbubbles and radiation therapy in vivo. Oncoscience 2016;3:98-108. [PMID: 27226983 DOI: 10.18632/oncoscience.299] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
574 Kavanagh BD, Miften M, Rabinovitch RA. Advances in Treatment Techniques: Stereotactic Body Radiation Therapy and the Spread of Hypofractionation. The Cancer Journal 2011;17:177-81. [DOI: 10.1097/ppo.0b013e31821f7dbd] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
575 Held KD, Kawamura H, Kaminuma T, Paz AE, Yoshida Y, Liu Q, Willers H, Takahashi A. Effects of Charged Particles on Human Tumor Cells. Front Oncol 2016;6:23. [PMID: 26904502 DOI: 10.3389/fonc.2016.00023] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 7.2] [Reference Citation Analysis]
576 Demidov V, Maeda A, Sugita M, Madge V, Sadanand S, Flueraru C, Vitkin IA. Preclinical longitudinal imaging of tumor microvascular radiobiological response with functional optical coherence tomography. Sci Rep 2018;8:38. [PMID: 29311686 DOI: 10.1038/s41598-017-18635-w] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
577 Selzer E, Kornek G. Targeted drugs in combination with radiotherapy for the treatment of solid tumors: current state and future developments. Expert Rev Clin Pharmacol 2013;6:663-76. [PMID: 24164614 DOI: 10.1586/17512433.2013.841540] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
578 Lammers T, Subr V, Ulbrich K, Peschke P, Huber PE, Hennink WE, Storm G, Kiessling F. HPMA-based polymer therapeutics improve the efficacy of surgery, of radiotherapy and of chemotherapy combinations. Nanomedicine (Lond) 2010;5:1501-23. [PMID: 21143030 DOI: 10.2217/nnm.10.130] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
579 Dirbas FM, Jeffrey SS, Goffinet DR. The evolution of accelerated, partial breast irradiation as a potential treatment option for women with newly diagnosed breast cancer considering breast conservation. Cancer Biother Radiopharm 2004;19:673-705. [PMID: 15665616 DOI: 10.1089/cbr.2004.19.673] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
580 Lo SS, Fakiris AJ, Chang EL, Mayr NA, Wang JZ, Papiez L, Teh BS, McGarry RC, Cardenes HR, Timmerman RD. Stereotactic body radiation therapy: a novel treatment modality. Nat Rev Clin Oncol. 2010;7:44-54. [PMID: 19997074 DOI: 10.1038/nrclinonc.2009.188] [Cited by in Crossref: 213] [Cited by in F6Publishing: 183] [Article Influence: 16.4] [Reference Citation Analysis]
581 Paul-Gilloteaux P, Potiron V, Delpon G, Supiot S, Chiavassa S, Paris F, Costes SV. Optimizing radiotherapy protocols using computer automata to model tumour cell death as a function of oxygen diffusion processes. Sci Rep 2017;7:2280. [PMID: 28536438 DOI: 10.1038/s41598-017-01757-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
582 Steinbach JP, Weller M. Apoptosis in gliomas: molecular mechanisms and therapeutic implications. J Neurooncol 2004;70:245-54. [PMID: 15674481 DOI: 10.1007/s11060-004-2753-4] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 3.9] [Reference Citation Analysis]
583 Gao M, Liu Y, Chen Y, Yin C, Chen JJ, Liu S. miR-214 protects erythroid cells against oxidative stress by targeting ATF4 and EZH2. Free Radic Biol Med 2016;92:39-49. [PMID: 26791102 DOI: 10.1016/j.freeradbiomed.2016.01.005] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 5.7] [Reference Citation Analysis]
584 Fernandes BF, Weisbrod D, Yücel YH, Follwell M, Krema H, Heydarian M, Xu W, Payne D, Mcgowan H, Simpson ER, Laperriere N, Sahgal A. Neovascular Glaucoma After Stereotactic Radiotherapy for Juxtapapillary Choroidal Melanoma: Histopathologic and Dosimetric Findings. International Journal of Radiation Oncology*Biology*Physics 2011;80:377-84. [DOI: 10.1016/j.ijrobp.2010.04.073] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
585 Verheij M, Vens C, van Triest B. Novel therapeutics in combination with radiotherapy to improve cancer treatment: Rationale, mechanisms of action and clinical perspective. Drug Resistance Updates 2010;13:29-43. [DOI: 10.1016/j.drup.2010.01.002] [Cited by in Crossref: 54] [Cited by in F6Publishing: 42] [Article Influence: 4.5] [Reference Citation Analysis]
586 Cupp J, Koong A, Fisher G, Norton J, Goodman K. Tissue Effects after Stereotactic Body Radiotherapy using Cyberknife for Patients with Abdominal Malignancies. Clinical Oncology 2008;20:69-75. [DOI: 10.1016/j.clon.2007.08.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
587 Song CW, Glatstein E, Marks LB, Emami B, Grimm J, Sperduto PW, Kim MS, Hui S, Dusenbery KE, Cho LC. Biological Principles of Stereotactic Body Radiation Therapy (SBRT) and Stereotactic Radiation Surgery (SRS): Indirect Cell Death. Int J Radiat Oncol Biol Phys 2021;110:21-34. [PMID: 30836165 DOI: 10.1016/j.ijrobp.2019.02.047] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
588 Henry B, Möller C, Dimanche-Boitrel MT, Gulbins E, Becker KA. Targeting the ceramide system in cancer. Cancer Lett. 2013;332:286-294. [PMID: 21862212 DOI: 10.1016/j.canlet.2011.07.010] [Cited by in Crossref: 47] [Cited by in F6Publishing: 52] [Article Influence: 4.3] [Reference Citation Analysis]
589 Perrotta C, Bizzozero L, Cazzato D, Morlacchi S, Assi E, Simbari F, Zhang Y, Gulbins E, Bassi MT, Rosa P, Clementi E. Syntaxin 4 is required for acid sphingomyelinase activity and apoptotic function. J Biol Chem 2010;285:40240-51. [PMID: 20956541 DOI: 10.1074/jbc.M110.139287] [Cited by in Crossref: 48] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
590 Nakazawa T, Adachi S, Kitano M, Isobe Y, Kokubu S, Hidaka H, Ono K, Okuwaki Y, Watanabe M, Shibuya A, Saigenji K. Potential prognostic benefits of radiotherapy as an initial treatment for patients with unresectable advanced hepatocellular carcinoma with invasion to intrahepatic large vessels. Oncology. 2007;73:90-97. [PMID: 18337620 DOI: 10.1159/000120996] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
591 Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B, Oh EY, Gaber MW, Finklestein D, Allen M, Frank A, Bayazitov IT, Zakharenko SS, Gajjar A, Davidoff A, Gilbertson RJ. A perivascular niche for brain tumor stem cells. Cancer Cell. 2007;11:69-82. [PMID: 17222791 DOI: 10.1016/j.ccr.2006.11.020] [Cited by in Crossref: 1485] [Cited by in F6Publishing: 1343] [Article Influence: 99.0] [Reference Citation Analysis]
592 Zhang XY, Sun YS, Tang L, Xue WC, Zhang XP. Correlation of diffusion-weighted imaging data with apoptotic and proliferation indexes in CT26 colorectal tumor homografts in balb/c mouse. J Magn Reson Imaging 2011;33:1171-6. [PMID: 21509876 DOI: 10.1002/jmri.22558] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
593 Massabeau C, Rouquette I, Lauwers-cances V, Mazières J, Bachaud J, Armand J, Delisle M, Favre G, Toulas C, Cohen-jonathan-moyal E. Basic Fibroblast Growth Factor-2/β3 Integrin Expression Profile: Signature of Local Progression After Chemoradiotherapy for Patients With Locally Advanced Non–Small-Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics 2009;75:696-702. [DOI: 10.1016/j.ijrobp.2008.11.050] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
594 Li S, Shen L. Radiobiology of stereotactic ablative radiotherapy (SABR): perspectives of clinical oncologists. J Cancer 2020;11:5056-68. [PMID: 32742453 DOI: 10.7150/jca.44408] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
595 Fontanella AN, Boss MK, Hadsell M, Zhang J, Schroeder T, Berman KG, Dewhirst MW, Chang S, Palmer GM. Effects of high-dose microbeam irradiation on tumor microvascular function and angiogenesis. Radiat Res 2015;183:147-58. [PMID: 25574586 DOI: 10.1667/RR13712.1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
596 Ferranti CS, Cheng J, Thompson C, Zhang J, Rotolo JA, Buddaseth S, Fuks Z, Kolesnick RN. Fusion of lysosomes to plasma membrane initiates radiation-induced apoptosis. J Cell Biol 2020;219:e201903176. [PMID: 32328634 DOI: 10.1083/jcb.201903176] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
597 Ogretmen B, Hannun YA. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer. 2004;4:604-616. [PMID: 15286740 DOI: 10.1038/nrc1411] [Cited by in Crossref: 891] [Cited by in F6Publishing: 839] [Article Influence: 49.5] [Reference Citation Analysis]
598 Lesueur P, Lequesne J, Barraux V, Kao W, Geffrelot J, Grellard JM, Habrand JL, Emery E, Marie B, Thariat J, Stefan D. Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer). Radiat Oncol 2018;13:138. [PMID: 30055640 DOI: 10.1186/s13014-018-1083-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
599 Schenck M, Carpinteiro A, Grassmé H, Lang F, Gulbins E. Ceramide: Physiological and pathophysiological aspects. Archives of Biochemistry and Biophysics 2007;462:171-5. [DOI: 10.1016/j.abb.2007.03.031] [Cited by in Crossref: 74] [Cited by in F6Publishing: 68] [Article Influence: 4.9] [Reference Citation Analysis]
600 Ch'ang HJ, Maj JG, Paris F, Xing HR, Zhang J, Truman JP, Cardon-Cardo C, Haimovitz-Friedman A, Kolesnick R, Fuks Z. ATM regulates target switching to escalating doses of radiation in the intestines. Nat Med 2005;11:484-90. [PMID: 15864314 DOI: 10.1038/nm1237] [Cited by in Crossref: 103] [Cited by in F6Publishing: 87] [Article Influence: 6.1] [Reference Citation Analysis]
601 Clément-Colmou K, Potiron V, Pietri M, Guillonneau M, Jouglar E, Chiavassa S, Delpon G, Paris F, Supiot S. Influence of Radiotherapy Fractionation Schedule on the Tumor Vascular Microenvironment in Prostate and Lung Cancer Models. Cancers (Basel) 2020;12:E121. [PMID: 31906502 DOI: 10.3390/cancers12010121] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
602 Oh E, Park M, Song M, Lee H, Cho YU, Kim SJ, Chu Y, Choi EK, Park HJ. Radiation-induced angiogenic signaling pathway in endothelial cells obtained from normal and cancer tissue of human breast. Oncogene 2014;33:1229-38. [DOI: 10.1038/onc.2013.70] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
603 Tong WY, Folkert MR, Greenfield JP, Yamada Y, Wolden SL. Intraoperative phosphorus-32 brachytherapy plaque for multiply recurrent high-risk epidural neuroblastoma: Case report. PED 2014;13:388-92. [DOI: 10.3171/2014.1.peds13121] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
604 Singh S, Pandey S, Chawla AS, Bhatt AN, Roy BG, Saluja D, Dwarakanath BS. Dietary 2-deoxy-D-glucose impairs tumour growth and metastasis by inhibiting angiogenesis. Eur J Cancer 2019;123:11-24. [PMID: 31670076 DOI: 10.1016/j.ejca.2019.09.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
605 Klein D, Schmitz T, Verhelst V, Panic A, Schenck M, Reis H, Drab M, Sak A, Herskind C, Maier P, Jendrossek V. Endothelial Caveolin-1 regulates the radiation response of epithelial prostate tumors. Oncogenesis 2015;4:e148. [PMID: 25985209 DOI: 10.1038/oncsis.2015.9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
606 Her S, Jaffray DA, Allen C. Gold nanoparticles for applications in cancer radiotherapy: Mechanisms and recent advancements. Adv Drug Deliv Rev. 2017;109:84-101. [PMID: 26712711 DOI: 10.1016/j.addr.2015.12.012] [Cited by in Crossref: 368] [Cited by in F6Publishing: 306] [Article Influence: 52.6] [Reference Citation Analysis]
607 Willers H, Held KD. Introduction to clinical radiation biology. Hematol Oncol Clin North Am 2006;20:1-24. [PMID: 16580554 DOI: 10.1016/j.hoc.2006.01.007] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 2.4] [Reference Citation Analysis]
608 Ganss R. Tumor stroma fosters neovascularization by recruitment of progenitor cells into the tumor bed. J Cell Mol Med 2006;10:857-65. [PMID: 17125590 DOI: 10.1111/j.1582-4934.2006.tb00530.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
609 Nishino M, Soejima K, Mitsudomi T. Brain metastases in oncogene-driven non-small cell lung cancer. Transl Lung Cancer Res 2019;8:S298-307. [PMID: 31857953 DOI: 10.21037/tlcr.2019.05.15] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
610 Kupelian P, Mehta NH, King C, Steinberg M, Finkelstein SE, Fernandez E. Stereotactic body radiation therapy for prostate cancer: Rational and reasonable. Practical Radiation Oncology 2015;5:188-92. [DOI: 10.1016/j.prro.2014.08.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
611 Butler JM, Kobayashi H, Rafii S. Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors. Nat Rev Cancer. 2010;10:138-146. [PMID: 20094048 DOI: 10.1038/nrc2791] [Cited by in Crossref: 378] [Cited by in F6Publishing: 344] [Article Influence: 31.5] [Reference Citation Analysis]
612 Kraemer A, Barjaktarovic Z, Sarioglu H, Winkler K, Eckardt-Schupp F, Tapio S, Atkinson MJ, Moertl S. Cell survival following radiation exposure requires miR-525-3p mediated suppression of ARRB1 and TXN1. PLoS One 2013;8:e77484. [PMID: 24147004 DOI: 10.1371/journal.pone.0077484] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
613 Yang H, Li L, Shi M, Wang J, Xiao F, Zhou B, Diao L, Long X, Liu X, Xu L. In vivo study of breast carcinoma radiosensitization by targeting eIF4E. Biochemical and Biophysical Research Communications 2012;423:878-83. [DOI: 10.1016/j.bbrc.2012.06.064] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
614 Kirkpatrick JP, Meyer JJ, Marks LB. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Semin Radiat Oncol. 2008;18:240-243. [PMID: 18725110 DOI: 10.1016/j.semradonc.2008.04.005] [Cited by in Crossref: 332] [Cited by in F6Publishing: 251] [Article Influence: 23.7] [Reference Citation Analysis]
615 Fang S, Salven P. Stem cells in tumor angiogenesis. Journal of Molecular and Cellular Cardiology 2011;50:290-5. [DOI: 10.1016/j.yjmcc.2010.10.024] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 3.5] [Reference Citation Analysis]
616 Breiden B, Sandhoff K. Acid Sphingomyelinase, a Lysosomal and Secretory Phospholipase C, Is Key for Cellular Phospholipid Catabolism. Int J Mol Sci 2021;22:9001. [PMID: 34445706 DOI: 10.3390/ijms22169001] [Reference Citation Analysis]
617 El Kaffas A, Tran W, Czarnota GJ. Vascular Strategies for Enhancing Tumour Response to Radiation Therapy. Technol Cancer Res Treat 2012;11:421-32. [DOI: 10.7785/tcrt.2012.500265] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
618 Golden EB, Pellicciotta I, Demaria S, Barcellos-Hoff MH, Formenti SC. The convergence of radiation and immunogenic cell death signaling pathways. Front Oncol 2012;2:88. [PMID: 22891162 DOI: 10.3389/fonc.2012.00088] [Cited by in Crossref: 148] [Cited by in F6Publishing: 151] [Article Influence: 14.8] [Reference Citation Analysis]
619 Alongi F, De Bari B, Scorsetti M. Could Single-high-dose Radiotherapy be Considered the New Frontier of Stereotactic Ablative Radiation Therapy? Tumori Journal 2018;100:e92-3. [DOI: 10.1177/1578.17244] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
620 Savarin M, Kamensek U, Cemazar M, Heller R, Sersa G. Electrotransfer of plasmid DNA radiosensitizes B16F10 tumors through activation of immune response. Radiol Oncol 2017;51:30-9. [PMID: 28265230 DOI: 10.1515/raon-2017-0011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
621 Dome B, Timar J, Ladanyi A, Paku S, Renyi-Vamos F, Klepetko W, Lang G, Dome P, Bogos K, Tovari J. Circulating endothelial cells, bone marrow-derived endothelial progenitor cells and proangiogenic hematopoietic cells in cancer: From biology to therapy. Crit Rev Oncol Hematol 2009;69:108-24. [PMID: 18768327 DOI: 10.1016/j.critrevonc.2008.06.009] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 3.4] [Reference Citation Analysis]
622 Alite F, Stang K, Balasubramanian N, Adams W, Shaikh MP, Small C, Sethi A, Nagda S, Emami B, Harkenrider MM. Local control dependence on consecutive vs. nonconsecutive fractionation in lung stereotactic body radiation therapy. Radiotherapy and Oncology 2016;121:9-14. [DOI: 10.1016/j.radonc.2016.07.026] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
623 Thiagarajan A, Yamada Y. Radiobiology and radiotherapy of brain metastases. Clin Exp Metastasis 2017;34:411-9. [DOI: 10.1007/s10585-017-9865-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
624 Berbeco RI, Ngwa W, Makrigiorgos GM. Localized Dose Enhancement to Tumor Blood Vessel Endothelial Cells via Megavoltage X-rays and Targeted Gold Nanoparticles: New Potential for External Beam Radiotherapy. International Journal of Radiation Oncology*Biology*Physics 2011;81:270-6. [DOI: 10.1016/j.ijrobp.2010.10.022] [Cited by in Crossref: 91] [Cited by in F6Publishing: 79] [Article Influence: 8.3] [Reference Citation Analysis]
625 Yoshikawa H, Ehrhart EJ, Charles JB, Custis JT, LaRue SM. Assessment of predictive molecular variables in feline oral squamous cell carcinoma treated with stereotactic radiation therapy. Vet Comp Oncol 2016;14:39-57. [PMID: 23815402 DOI: 10.1111/vco.12050] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
626 Fassas AB, Kiwan E, Roberts J, Burr T, Tricot G, Anaissie E, Barlogie B. Metronomic chemoimmunotherapy in a patient with refractory Waldenström's macroglobulinemia. Leukemia & Lymphoma 2009;46:1675-7. [DOI: 10.1080/10428190500217825] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
627 Leite de Oliveira R, Hamm A, Mazzone M. Growing tumor vessels: more than one way to skin a cat - implications for angiogenesis targeted cancer therapies. Mol Aspects Med 2011;32:71-87. [PMID: 21540050 DOI: 10.1016/j.mam.2011.04.001] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 6.2] [Reference Citation Analysis]
628 Sano D, Matsumoto F, Valdecanas DR, Zhao M, Molkentine DP, Takahashi Y, Hanna EY, Papadimitrakopoulou V, Heymach J, Milas L, Myers JN. Vandetanib restores head and neck squamous cell carcinoma cells' sensitivity to cisplatin and radiation in vivo and in vitro. Clin Cancer Res 2011;17:1815-27. [PMID: 21350000 DOI: 10.1158/1078-0432.CCR-10-2120] [Cited by in Crossref: 54] [Cited by in F6Publishing: 31] [Article Influence: 4.9] [Reference Citation Analysis]
629 Patel PR, Salama JK. Reirradiation for recurrent head and neck cancer. Expert Review of Anticancer Therapy 2014;12:1177-89. [DOI: 10.1586/era.12.97] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
630 Chargari C, Deutsch E, Le Péchoux C, Magné N. État des lieux des associations chimioradiothérapeutiques et place potentielle des thérapies ciblées dans les cancers bronchiques non à petites cellules. Cancer/Radiothérapie 2009;13:114-22. [DOI: 10.1016/j.canrad.2008.08.273] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
631 Orth M, Lauber K, Niyazi M, Friedl AA, Li M, Maihöfer C, Schüttrumpf L, Ernst A, Niemöller OM, Belka C. Current concepts in clinical radiation oncology. Radiat Environ Biophys 2014;53:1-29. [PMID: 24141602 DOI: 10.1007/s00411-013-0497-2] [Cited by in Crossref: 92] [Cited by in F6Publishing: 86] [Article Influence: 10.2] [Reference Citation Analysis]
632 Shaked Y, Bertolini F, Man S, Rogers MS, Cervi D, Foutz T, Rawn K, Voskas D, Dumont DJ, Ben-David Y, Lawler J, Henkin J, Huber J, Hicklin DJ, D'Amato RJ, Kerbel RS. Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis. Cancer Cell 2005;7:101-11. [PMID: 15652753 DOI: 10.1016/j.ccr.2004.11.023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 106] [Article Influence: 0.7] [Reference Citation Analysis]
633 Thibault I, Campbell M, Tseng CL, Atenafu EG, Letourneau D, Yu E, Cho BC, Lee YK, Fehlings MG, Sahgal A. Salvage Stereotactic Body Radiotherapy (SBRT) Following In-Field Failure of Initial SBRT for Spinal Metastases. Int J Radiat Oncol Biol Phys 2015;93:353-60. [PMID: 26383680 DOI: 10.1016/j.ijrobp.2015.03.029] [Cited by in Crossref: 54] [Cited by in F6Publishing: 42] [Article Influence: 7.7] [Reference Citation Analysis]
634 Schwartz DL, Bankson JA, Lemos R Jr, Lai SY, Thittai AK, He Y, Hostetter G, Demeure MJ, Von Hoff DD, Powis G. Radiosensitization and stromal imaging response correlates for the HIF-1 inhibitor PX-478 given with or without chemotherapy in pancreatic cancer. Mol Cancer Ther 2010;9:2057-67. [PMID: 20587661 DOI: 10.1158/1535-7163.MCT-09-0768] [Cited by in Crossref: 59] [Cited by in F6Publishing: 43] [Article Influence: 4.9] [Reference Citation Analysis]
635 Moyal EC. [Optimization of the radiotherapy for the gliomas: hopes and research axis for the next future]. Rev Neurol (Paris) 2011;167:656-60. [PMID: 21889179 DOI: 10.1016/j.neurol.2011.07.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
636 Rekhter M, Karathanasis S. Sphingolipids in atherosclerosis: a metabolic underpinning of vascular disease. Future Lipidology 2006;1:605-14. [DOI: 10.2217/17460875.1.5.605] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
637 Wang H, Li X, Peng R, Wang Y, Wang J. Stereotactic ablative radiotherapy for colorectal cancer liver metastasis. Semin Cancer Biol 2021;71:21-32. [PMID: 32629077 DOI: 10.1016/j.semcancer.2020.06.018] [Reference Citation Analysis]
638 Wang Y, Boerma M, Zhou D. Ionizing Radiation-Induced Endothelial Cell Senescence and Cardiovascular Diseases. Radiat Res 2016;186:153-61. [PMID: 27387862 DOI: 10.1667/RR14445.1] [Cited by in Crossref: 92] [Cited by in F6Publishing: 58] [Article Influence: 15.3] [Reference Citation Analysis]
639 Laufer I, Iorgulescu JB, Chapman T, Lis E, Shi W, Zhang Z, Cox BW, Yamada Y, Bilsky MH. Local disease control for spinal metastases following "separation surgery" and adjuvant hypofractionated or high-dose single-fraction stereotactic radiosurgery: outcome analysis in 186 patients. J Neurosurg Spine 2013;18:207-14. [PMID: 23339593 DOI: 10.3171/2012.11.SPINE12111] [Cited by in Crossref: 257] [Cited by in F6Publishing: 81] [Article Influence: 28.6] [Reference Citation Analysis]
640 Kubicek L, Milner R, An Q, Kow K, Chang M, Cooke K, Fox L, Farese J, Bacon N, Lurie D. OUTCOMES AND PROGNOSTIC FACTORS ASSOCIATED WITH CANINE SINONASAL TUMORS TREATED WITH CURATIVE INTENT CONE-BASED STEREOTACTIC RADIOSURGERY (1999-2013). Vet Radiol Ultrasound 2016;57:331-40. [PMID: 26880676 DOI: 10.1111/vru.12349] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
641 Flickinger JC, Barker FG. Clinical Results: Radiosurgery and Radiotherapy of Cranial Nerve Schwannomas. Neurosurgery Clinics of North America 2006;17:121-8. [DOI: 10.1016/j.nec.2006.02.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
642 Pagnini PG. Using the radiobiology of radioresistance and radiosurgery to rethink treatment approaches for the treatment of central nervous system metastases. World Neurosurg 2013;79:437-9. [PMID: 22381317 DOI: 10.1016/j.wneu.2011.11.022] [Reference Citation Analysis]
643 Sreevalsan S, Jutooru I, Chadalapaka G, Walker M, Safe S. 1,1-Bis(3'-indolyl)-1-(p-bromophenyl)methane and related compounds repress survivin and decrease gamma-radiation-induced survivin in colon and pancreatic cancer cells. Int J Oncol 2009;35:1191-9. [PMID: 19787275 DOI: 10.3892/ijo_00000436] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
644 d'Alessio P. Aging and the endothelium. Experimental Gerontology 2004;39:165-71. [DOI: 10.1016/j.exger.2003.10.025] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
645 Karam I, Poon I, Lee J, Liu S, Higgins K, Enepekides D, Sahgal A, Lo SS. Stereotactic body radiotherapy for head and neck cancer: an addition to the armamentarium against head and neck cancer. Future Oncology 2015;11:2937-47. [DOI: 10.2217/fon.15.236] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
646 Shaked Y. Balancing efficacy of and host immune responses to cancer therapy: the yin and yang effects. Nat Rev Clin Oncol 2016;13:611-26. [PMID: 27118493 DOI: 10.1038/nrclinonc.2016.57] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 11.8] [Reference Citation Analysis]
647 Kirsch DG, Grimm J, Guimaraes AR, Wojtkiewicz GR, Perez BA, Santiago PM, Anthony NK, Forbes T, Doppke K, Weissleder R, Jacks T. Imaging primary lung cancers in mice to study radiation biology. Int J Radiat Oncol Biol Phys 2010;76:973-7. [PMID: 20206017 DOI: 10.1016/j.ijrobp.2009.11.038] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 3.4] [Reference Citation Analysis]
648 Park MT, Oh ET, Song MJ, Kim WJ, Cho YU, Kim SJ, Han JY, Suh JK, Choi EK, Lim BU, Song CW, Park HJ. The radiosensitivity of endothelial cells isolated from human breast cancer and normal tissue in vitro. Microvasc Res 2012;84:140-8. [PMID: 22705362 DOI: 10.1016/j.mvr.2012.06.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
649 Boini KM, Xia M, Abais JM, Xu M, Li CX, Li PL. Acid sphingomyelinase gene knockout ameliorates hyperhomocysteinemic glomerular injury in mice lacking cystathionine-β-synthase. PLoS One 2012;7:e45020. [PMID: 23024785 DOI: 10.1371/journal.pone.0045020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
650 Lee TH, Chennakrishnaiah S, Audemard E, Montermini L, Meehan B, Rak J. Oncogenic ras-driven cancer cell vesiculation leads to emission of double-stranded DNA capable of interacting with target cells. Biochem Biophys Res Commun. 2014;451:295-301. [PMID: 25086355 DOI: 10.1016/j.bbrc.2014.07.109] [Cited by in Crossref: 100] [Cited by in F6Publishing: 107] [Article Influence: 12.5] [Reference Citation Analysis]
651 El Kaffas A, Al-Mahrouki A, Hashim A, Law N, Giles A, Czarnota GJ. Role of Acid Sphingomyelinase and Ceramide in Mechano-Acoustic Enhancement of Tumor Radiation Responses. J Natl Cancer Inst 2018;110:1009-18. [PMID: 29506145 DOI: 10.1093/jnci/djy011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
652 Baguley BC. Multiple drug resistance mechanisms in cancer. Mol Biotechnol. 2010;46:308-316. [PMID: 20717753 DOI: 10.1007/s12033-010-9321-2] [Cited by in Crossref: 299] [Cited by in F6Publishing: 282] [Article Influence: 27.2] [Reference Citation Analysis]
653 Randles A, Wirsching HG, Dean JA, Cheng YK, Emerson S, Pattwell SS, Holland EC, Michor F. Computational modelling of perivascular-niche dynamics for the optimization of treatment schedules for glioblastoma. Nat Biomed Eng 2021;5:346-59. [PMID: 33864039 DOI: 10.1038/s41551-021-00710-3] [Reference Citation Analysis]
654 Fidoamore A, Cristiano L, Antonosante A, d'Angelo M, Di Giacomo E, Astarita C, Giordano A, Ippoliti R, Benedetti E, Cimini A. Glioblastoma Stem Cells Microenvironment: The Paracrine Roles of the Niche in Drug and Radioresistance. Stem Cells Int 2016;2016:6809105. [PMID: 26880981 DOI: 10.1155/2016/6809105] [Cited by in Crossref: 87] [Cited by in F6Publishing: 77] [Article Influence: 14.5] [Reference Citation Analysis]
655 Gao C, Kozlowska A, Nechaev S, Li H, Zhang Q, Hossain DM, Kowolik CM, Chu P, Swiderski P, Diamond DJ, Pal SK, Raubitschek A, Kortylewski M. TLR9 signaling in the tumor microenvironment initiates cancer recurrence after radiotherapy. Cancer Res 2013;73:7211-21. [PMID: 24154870 DOI: 10.1158/0008-5472.CAN-13-1314] [Cited by in Crossref: 51] [Cited by in F6Publishing: 38] [Article Influence: 5.7] [Reference Citation Analysis]
656 Karam I, Yao M, Heron DE, Poon I, Koyfman SA, Yom SS, Siddiqui F, Lartigau E, Cengiz M, Yamazaki H, Hara W, Phan J, Vargo JA, Lee V, Foote RL, Harter KW, Lee NY, Sahgal A, Lo SS. Survey of current practices from the International Stereotactic Body Radiotherapy Consortium (ISBRTC) for head and neck cancers. Future Oncology 2017;13:603-13. [DOI: 10.2217/fon-2016-0403] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
657 Kranjc Brezar S, Mrak V, Bosnjak M, Savarin M, Sersa G, Cemazar M. Intratumoral Gene Electrotransfer of Plasmid DNA Encoding shRNA against Melanoma Cell Adhesion Molecule Radiosensitizes Tumors by Antivascular Effects and Activation of an Immune Response. Vaccines (Basel) 2020;8:E135. [PMID: 32204304 DOI: 10.3390/vaccines8010135] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
658 Pierini S, Mishra A, Perales-Linares R, Uribe-Herranz M, Beghi S, Giglio A, Pustylnikov S, Costabile F, Rafail S, Amici A, Facciponte JG, Koumenis C, Facciabene A. Combination of vasculature targeting, hypofractionated radiotherapy, and immune checkpoint inhibitor elicits potent antitumor immune response and blocks tumor progression. J Immunother Cancer 2021;9:e001636. [PMID: 33563772 DOI: 10.1136/jitc-2020-001636] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
659 Rana S, Naik A, Pillai S, Vetto J, Pommier R, Kubicky CD. Outcomes of intraoperative radiotherapy for early-stage breast cancer: Experience from a multidisciplinary breast oncology program. Am J Surg 2020;219:655-9. [PMID: 31242962 DOI: 10.1016/j.amjsurg.2019.06.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
660 Bock J, Liebisch G, Schweimer J, Schmitz G, Rogler G. Exogenous sphingomyelinase causes impaired intestinal epithelial barrier function. World J Gastroenterol 2007; 13(39): 5217-5225 [PMID: 17876892 DOI: 10.3748/wjg.v13.i39.5217] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
661 Moding EJ, Lee CL, Castle KD, Oh P, Mao L, Zha S, Min HD, Ma Y, Das S, Kirsch DG. Atm deletion with dual recombinase technology preferentially radiosensitizes tumor endothelium. J Clin Invest 2014;124:3325-38. [PMID: 25036710 DOI: 10.1172/JCI73932] [Cited by in Crossref: 46] [Cited by in F6Publishing: 32] [Article Influence: 5.8] [Reference Citation Analysis]
662 Chi K, Wang Y, Kao S. Improving Radioresponse Through Modification of the Tumor Immunological Microenvironment. Cancer Biotherapy and Radiopharmaceuticals 2012;27:6-11. [DOI: 10.1089/cbr.2011.1048] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
663 García-figueiras R, Goh VJ, Padhani AR, Baleato-gonzález S, Garrido M, León L, Gómez-caamaño A. CT Perfusion in Oncologic Imaging: A Useful Tool? American Journal of Roentgenology 2013;200:8-19. [DOI: 10.2214/ajr.11.8476] [Cited by in Crossref: 108] [Cited by in F6Publishing: 44] [Article Influence: 12.0] [Reference Citation Analysis]
664 Thompson RF, Maity A. Radiotherapy and the tumor microenvironment: mutual influence and clinical implications. Adv Exp Med Biol 2014;772:147-65. [PMID: 24272358 DOI: 10.1007/978-1-4614-5915-6_7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
665 Cohen-inbar O, Lee C, Sheehan JP. The Contemporary Role of Stereotactic Radiosurgery in the Treatment of Meningiomas. Neurosurgery Clinics of North America 2016;27:215-28. [DOI: 10.1016/j.nec.2015.11.006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
666 Kanthou C, Tozer G. Targeting the vasculature of tumours: combining VEGF pathway inhibitors with radiotherapy. Br J Radiol 2019;92:20180405. [PMID: 30160184 DOI: 10.1259/bjr.20180405] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
667 Jani A, Shaikh F, Barton S, Willis C, Banerjee D, Mitchell J, Hernandez SL, Hei T, Kadenhe-Chiweshe A, Yamashiro DJ, Connolly EP. High-Dose, Single-Fraction Irradiation Rapidly Reduces Tumor Vasculature and Perfusion in a Xenograft Model of Neuroblastoma. Int J Radiat Oncol Biol Phys 2016;94:1173-80. [PMID: 26907918 DOI: 10.1016/j.ijrobp.2015.12.367] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
668 Williams KJ, Telfer BA, Shannon AM, Babur M, Stratford IJ, Wedge SR. Inhibition of vascular endothelial growth factor signalling using cediranib (RECENTIN; AZD2171) enhances radiation response and causes substantial physiological changes in lung tumour xenografts. Br J Radiol 2008;81 Spec No 1:S21-7. [PMID: 18819995 DOI: 10.1259/bjr/59853976] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
669 Watson AJ. Apoptosis and colorectal cancer. Gut. 2004;53:1701-1709. [PMID: 15479695 DOI: 10.1136/gut.2004.052704] [Cited by in Crossref: 99] [Cited by in F6Publishing: 89] [Article Influence: 5.5] [Reference Citation Analysis]
670 Nabavizadeh N, Waller JG, Fain R, Chen Y, Degnin CR, Elliott DA, Mullins BT, Patel IA, Dyer BA, Fakhoury K, Naugler WE, Farsad K, Tanyi JA, Fuss M, Thomas CR, Hung AY. Safety and Efficacy of Accelerated Hypofractionation and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Patients With Varying Degrees of Hepatic Impairment. International Journal of Radiation Oncology*Biology*Physics 2018;100:577-85. [DOI: 10.1016/j.ijrobp.2017.11.030] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
671 Lacerda Q, Tantawi M, Leeper DB, Wheatley MA, Eisenbrey JR. Emerging Applications of Ultrasound-Contrast Agents in Radiation Therapy. Ultrasound Med Biol 2021;47:1465-74. [PMID: 33653626 DOI: 10.1016/j.ultrasmedbio.2021.01.032] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
672 Hielscher A, Gerecht S. Hypoxia and free radicals: role in tumor progression and the use of engineering-based platforms to address these relationships. Free Radic Biol Med 2015;79:281-91. [PMID: 25257256 DOI: 10.1016/j.freeradbiomed.2014.09.015] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 5.1] [Reference Citation Analysis]
673 Lee HY, Kim N, Goo JM, Chie EK, Song HJ. Perfusion parameters as potential imaging biomarkers for the early prediction of radiotherapy response in a rat tumor model. Diagn Interv Radiol 2016;22:231-40. [PMID: 27023149 DOI: 10.5152/dir.2015.15171] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
674 Kim DD, Eng C. The promise of mTOR inhibitors in the treatment of colorectal cancer. Expert Opin Investig Drugs 2012;21:1775-88. [PMID: 22978346 DOI: 10.1517/13543784.2012.721353] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
675 Burrell K, Hill RP, Zadeh G. High-resolution in-vivo analysis of normal brain response to cranial irradiation. PLoS One 2012;7:e38366. [PMID: 22675549 DOI: 10.1371/journal.pone.0038366] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
676 Provencio M, Sánchez A, Garrido P, Valcárcel F. New molecular targeted therapies integrated with radiation therapy in lung cancer. Clin Lung Cancer 2010;11:91-7. [PMID: 20199974 DOI: 10.3816/CLC.2010.n.012] [Cited by in Crossref: 44] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
677 Ding D, Yen CP, Starke RM, Lee CC, Sheehan JP. Unyielding progress: recent advances in the treatment of central nervous system neoplasms with radiosurgery and radiation therapy. J Neurooncol 2014;119:513-29. [PMID: 25119001 DOI: 10.1007/s11060-014-1501-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
678 Faulhaber O, Bristow RG. Basis of Cell Kill Following Clinical Radiotherapy. Application of Apoptosis to Cancer Treatment. Berlin/Heidelberg: Springer-Verlag; 2005. pp. 293-320. [DOI: 10.1007/1-4020-3302-8_13] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
679 Bilsky MH, Gerszten P, Laufer I, Yamada Y. Radiation for Primary Spine Tumors. Neurosurgery Clinics of North America 2008;19:119-23. [DOI: 10.1016/j.nec.2007.09.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
680 Simeonova AO, Fleckenstein K, Wertz H, Frauenfeld A, Boda-Heggemann J, Lohr F, Wenz F. Are three doses of stereotactic ablative radiotherapy (SABR) more effective than 30 doses of conventional radiotherapy? Transl Lung Cancer Res 2012;1:45-53. [PMID: 25806154 DOI: 10.3978/j.issn.2218-6751.10.01] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
681 Cheng M, Bhujwalla ZM, Glunde K. Targeting Phospholipid Metabolism in Cancer. Front Oncol 2016;6:266. [PMID: 28083512 DOI: 10.3389/fonc.2016.00266] [Cited by in Crossref: 70] [Cited by in F6Publishing: 66] [Article Influence: 11.7] [Reference Citation Analysis]
682 Shi M, Guo X, Shu M, Li L. Enhancing tumor radiosensitivity by intracellular delivery of survivin antagonists. Medical Hypotheses 2007;68:1056-8. [DOI: 10.1016/j.mehy.2006.09.048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
683 Winn RK, Harlan JM. The role of endothelial cell apoptosis in inflammatory and immune diseases. J Thromb Haemost 2005;3:1815-24. [PMID: 16102048 DOI: 10.1111/j.1538-7836.2005.01378.x] [Cited by in Crossref: 97] [Cited by in F6Publishing: 88] [Article Influence: 5.7] [Reference Citation Analysis]
684 Jaffray DA. Image-guided radiotherapy: from current concept to future perspectives. Nat Rev Clin Oncol 2012;9:688-99. [DOI: 10.1038/nrclinonc.2012.194] [Cited by in Crossref: 247] [Cited by in F6Publishing: 218] [Article Influence: 24.7] [Reference Citation Analysis]
685 Brustugun OT. Hypoxia as a cause of treatment failure in non-small cell carcinoma of the lung. Semin Radiat Oncol 2015;25:87-92. [PMID: 25771412 DOI: 10.1016/j.semradonc.2014.11.006] [Cited by in Crossref: 17]